Role of unique Helicobacter pylori proteins in the Cag pathogenicity island-encoded type IV secretion system by Shaffer, Carrie Leigh
 
 
 
 
ROLE OF UNIQUE HELICOBACTER PYLORI PROTEINS IN THE CAG 
  
PATHOGENICITY ISLAND-ENCODED TYPE IV SECRETION SYSTEM 
 
By 
Carrie Leigh Shaffer 
 
Dissertation 
Submitted to the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements 
for the degree of 
DOCTOR OF PHILOSOPHY 
in 
Microbiology and Immunology 
December, 2011 
Nashville, Tennessee 
 
Approved: 
D. Borden Lacy, PhD 
 
Seth R. Bordenstein, PhD 
 
Timothy L. Cover, MD 
 
Andrew J. Link, PhD 
 
Eric P. Skaar, PhD, MPH 
 
Roy Zent, MD, PhD  
 
 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
For my dad – you’ve always been my hero. 
  
 
 
iii 
 
Acknowledgements 
 
 First and foremost, I would like to thank my incredible mentor Dr. Timothy L. 
Cover for inviting me to join his lab and pursue all of my varied curiosities.  I appreciate 
Dr. Cover’s continual patience, his kindness, and most important, his sense of humor.  
He always sees the silver lining in every situation, and provides enormous 
encouragement during difficult times, including millennia flooding in a metropolitan area.  
His enthusiasm for our work, and an ever curious mind provided a source of inspiration 
for me and all of the members of his lab.  Tim, I am honored to have been a member of 
your lab, and thankful for the guidance you have provided that has made me the 
scientist that I am today.  
 I would also like to thank my esteemed committee for their guidance and very 
helpful suggestions throughout my training.  Thank you to my Chair, Dr. Borden Lacy, for 
your support; Dr. Eric Skaar for your sense of humor, enthusiasm for teaching, and for a 
fellow bacteriologist’s insight; Dr. Andy Link for your sarcastic (and very funny) 
comments, and expertise in mass spectrometry; and Dr. Seth Bordenstein and Dr. Roy 
Zent for providing support to my project from an evolutionary biology and human host 
perspective, respectively.  Thank you to the faculty of the Department of Microbiology 
and Immunology, as well as the amazing Jean Tidwell.  I’d like to thank my classmates 
for all of the laughter, hilarious comments, and camaraderie during our training. I 
especially thank Major John Schmitt for keeping me sane. 
Thank you to members of the Cover Lab for helpful ideas and suggestions in lab 
meetings, and for valuable contributions in collaborative efforts.  Thank you to my 
pseudo-mentor Dr. Hayes McDonald for hours of (often hilarious) conversation, and for 
 
 
iv 
 
teaching me the intricacies of mass spectrometry.  Thank you to the most wonderful, 
knowledgeable Ms. Salisha Hill for all of the beautiful mass spectrometry results – and a 
special thanks to Salisha and Dr. Kristie Rose for all of the laughter during my frequent 
visits to the mass spectrometry facility.  I would like to thank Kristie for all of her 
expertise and perspective during collaborative efforts, especially in projects involving 
very strange, post-translationally modified proteins. 
And finally, thank you to my friends and family for your continual support and 
encouragement.  I would like to especially thank my mom, dad, and sister for teaching 
me how to laugh, and for never doubting me.  Your support and love has allowed me to 
succeed.  Thank you to my best friend, Jamie Floyd, for being my partner-in-crime, my 
fellow explorer in all of our travel expeditions, and for the endless laughs, the obnoxious 
and ridiculous number of inside jokes that we share, consuming massive amounts of 
food (most meals enjoyed in silence) together, and for endless support and friendship.  
Thank you to one of my dearest friends Dr. Stacy Duncan, for bringing joy to the lab 
environment – I will miss the sounds of our laughter ringing through the lab.  Thank you 
to Brad Voss for helping me deal with a demolished condo after the Nashville flood of 
2010, and for sharing countless numbers of meals, and many, many laughs. 
This work was supported by NIH R01 AI068009, P01 CA116087, the Department 
of Veterans Affairs, Vanderbilt Digestive Diseases Research Center (DK 058404), and 
Vanderbilt Ingram Cancer Center. 
  
 
 
v 
 
TABLE OF CONTENTS 
 
 
 Page 
 
DEDICATION  ................................................................................................................... ii 
 
ACKNOWLEDGEMENTS  ................................................................................................ iii 
 
LIST OF TABLES  ............................................................................................................ vii 
 
LIST OF FIGURES  ......................................................................................................... viii 
 
LIST OF ABBREVIATIONS  ............................................................................................. ix 
 
Chapter 
 
I. INTRODUCTION ............................................................................................................ 1 
 
Bacteriology is a risky business  ..................................................................... 1 
Clinical features of infection by Helicobacter pylori and its role in        
causation of severe gastric disease  ............................................................... 2 
Genetic diversity of Helicobacter pylori and the cag pathogenicity island ....... 3 
Helicobacter pylori cag PAI-dependent effects on the host gastric 
epithelium… ...................................................................................................  7 
Versatility of bacterial type IV secretion systems ............................................ 9 
Organization of the cag PAI-encoded type IV secretion system ................... 11 
 
 
II. IDENTIFICATION OF HELICOBACTER PYLORI PROTEINS THAT INTERACT   
WITH THE TYPE IV SECRETION SYSTEM PILUS COMPONENT CagL ..................... 19 
 
Introduction ................................................................................................... 19 
Methods ........................................................................................................ 20 
Results .......................................................................................................... 30 
Identification of Cag proteins that co-purify with CagL ............................. 30 
CagL stability is impaired in the absence of CagH and CagI ................... 46 
Functional properties of CagH and CagI ................................................. 50 
Localization of CagH, CagI, and CagL  ................................................... 51 
Discussion ..................................................................................................... 57 
 
 
III. ROLE OF UNIQUE HELICOBACTER PYLORI CAG PROTEINS IN BIOGENESIS   
OF THE TYPE IV SECRETION SYSTEM PILUS AT THE INTERFACE OF      
BACTERIA AND GASTRIC EPITHELIAL CELLS  .......................................................... 62 
 
Introduction ................................................................................................... 62 
Methods ........................................................................................................ 64 
Results .......................................................................................................... 65 
CagH, CagI, and CagL have key roles in T4SS pilus formation .............. 65 
 
 
vi 
 
Analysis of a conserved C-terminal motif ................................................. 73 
Discussion ..................................................................................................... 81 
 
 
IV. FURTHER STUDIES OF THE HELICOBACTER PYLORI CAG TYPE IV 
SECRETION SYSTEM ................................................................................................... 85 
Introduction ................................................................................................... 85 
Methods ........................................................................................................ 90 
Results .......................................................................................................... 92 
Chemical cross-linking and immunoaffinity purification of T4SS   
complexes containing CagU  ................................................................... 92 
Localization of CagU .............................................................................. 101 
Analysis of CagA interactions during type IV secretion  ........................ 103 
Shearing of H. pylori surface structures  ................................................ 110 
Discussion ................................................................................................... 115 
 
 
V. CONCLUSIONS ....................................................................................................... 123 
 
Summary ..................................................................................................... 123 
Future directions ......................................................................................... 127 
Elucidate the mechanism by which dimensions and abundance of     
T4SS pili are controlled .......................................................................... 127 
Determine the role the non-homologous components play in        
formation of the T4SS apparatus ........................................................... 130 
Identify T4SS pilus components in sheared fractions from                        
H. pylori-gastric epithelial cell co-culture ............................................... 133 
Evaluate protein-protein interactions and functions of additional          
T4SS components ................................................................................. 134 
 
LIST OF PUBLICATIONS ............................................................................................. 137 
 
BIBLIOGRAPHY ........................................................................................................... 138 
   
 
 
vii 
 
LIST OF TABLES 
 
Table Page 
1-1. Genetic analysis of proteins encoded by the cag pathogenicity island ...................... 5 
2-1. Cag proteins that co-purify with CagL ...................................................................... 33 
2-2. Cag proteins identified in H. pylori whole cell lysate ................................................ 36 
2-3. Cag proteins that co-purify with epitope-tagged CagH, CagI, and CagL ................. 38 
2-4. Proteins identified in immunoaffinity-purified preparations of CagH-HA and       
CagL-HA.. ....................................................................................................................... 43 
2-5. Cag proteins that co-purify with CagL in the absence of CagH or CagI................... 49 
3-1. Analysis of type IV secretion system pili .................................................................. 67 
3-2. Co-purification of CagH, CagI, and CagL from H. pylori attached to gastric    
epithelial cells .................................................................................................................. 72 
4-1. Cag proteins that interact with CagU-HA in the presence or absence of chemical 
cross-links ..................................................................................................................... 100 
4-2. Cag proteins purified by anti-CagA in the presence or absence of host cell 
contact…. ...................................................................................................................... 107 
4-3. Selected outer membrane proteins purified by anti-CagA from H. pylori in the 
presence or absence of host cell contact ...................................................................... 111 
4-4. Cag proteins identified in sheared fractions of a hyperpiliated H. pylori strain…. .. 113 
 
  
 
 
viii 
 
LIST OF FIGURES 
 
Figure  Page 
1-1. Gene arrangement of the cag pathogenicity island (cag PAI) in H. pylori 26695 ....... 6 
 
1-2. Depiction of the cag T4SS of H. pylori ..................................................................... 14 
 
1-3. Localization of CagL to the cag T4SS pilus and surface of H. pylori  ...................... 16 
 
2-1. Functional analysis of CagL  .................................................................................... 31 
 
2-2. Related properties of CagH, CagI, and CagL  ......................................................... 35 
 
2-3. Generation of unmarked, in-frame isogenic mutants  .............................................. 40 
 
2-4. Functional analysis of CagH and CagI  .................................................................... 41 
 
2-5. Analysis of CagL stability in ΔcagH and ΔcagI mutants........................................... 47 
 
2-6. Localization of CagH and CagI ................................................................................ 52 
 
2-7. Immunoelectron microscopy analysis of whole bacterial cells ................................. 54 
 
2-8. Localization of CagL, CagH, and CagI in detergent-free lysates  ............................ 56 
 
3-1. Role of CagI and CagL in pilus formation  ............................................................... 66 
 
3-2. Analysis of pili formed by a ΔcagH mutant strain ..................................................... 69 
 
3-3. Identification of a conserved C-terminal motif in CagH, CagI, and CagL  ................ 74 
 
3-4. Functional analysis of a conserved C-terminal motif in CagH, CagI, and CagL  ..... 76 
 
3-5. Localization of C-terminally truncated CagH and CagI  ........................................... 78 
 
3-6. The C-terminal motif of CagI and CagL is required for pilus formation .................... 80 
 
4-1. Immunoaffinity purification of CagU-HA form whole cell lysate.  .............................. 94 
 
4-2. Chemical cross-linking strategy to capture CagU-HA interactions  .......................... 97 
 
4-3. Localization of CagU  ............................................................................................. 102 
 
4-4. Purification of CagA and interacting proteins from H. pylori .................................. 105 
 
4-5. Analysis of sheared fractions from several H. pylori strains .................................. 112 
  
 
 
ix 
 
LIST OF ABBREVIATIONS 
 
 
PMN    polymorphonuclear neutrophil 
IARC    International Agency for Research on Cancer 
MALT    mucosa-associated lymphoid tissue 
MLST    multilocus sequence typing 
PAI    pathogenicity island 
T4SS    type IV secretion system 
Y2H    yeast 2-hybrid 
WT    wild-type 
MudPIT   Multidimensional Protein Identification Technology 
SCX    strong cation exchange 
MS    mass spectrometry 
GST    glutathione S-transferase 
SDS    sodium dodecyl sulfate 
PAGE    polyacrylamide gel electrophoresis 
HA    hemagglutinin 
FBS    fetal bovine serum 
HEPES   4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
ELISA    enzyme-linked immunosorbent assay 
MOI    multiplicity of infection 
EDTA    ethylenedinitrilo-tetraacetic acid 
NP-40    nonyl phenoxypolyethoxylethanol 
PCR    polymerase chain reaction 
PBS    phosphate-buffered saline 
 
 
x 
 
RIPA    radio-immunoprecipitation assay 
DTT    dithiothreitol 
TBS    tris-buffered saline 
HPLC    high pressure liquid chromatography 
ACN    acetonitrile 
FDR    false discovery rate 
PMSF    phenylmethylsulphonyl fluoride 
TEM    transmission electron microscopy 
FESEM   field emission scanning electron microscopy 
ANOVA   analysis of variance 
CA    carbonic anyhdrase 
PK    proteinase K 
OMP    outer membrane protein 
T3SS    type III secretion system 
PSSM    position-specific scoring matrix 
CDD    conserved domain database 
DSP    dithiobis[succinimidyl propionate] 
DMSO    dimethyl sulfoxide 
TCA    trichloroacetic acid 
RT-PCR   real-time polymerase chain reaction 
Fur    ferric uptake regulator 
TAP    tobacco acid pyrophosphatase 
MRM    multiple reaction monitoring 
 
  
 
 
1 
 
CHAPTER I 
 
INTRODUCTION 
 
Bacteriology is a risky business 
Oftentimes, the difference between enormous success and miserable failure is 
having the courage to take calculated risks.  Risky behavior frequently results in adverse 
consequences; however, a high risk-high reward mentality combined with the intestinal 
fortitude required to participate in such behavior will, on occasion, result in spectacular 
success.  Calculated risk was the driving force behind the team of Dr. Barry Marshall 
and Dr. J. Robin Warren, two Australian physicians who in 1984 were first able to culture 
a bacterium related to Campylobacter from a gastric biopsy acquired from a patient 
presenting with gastritis [1].  This novel bacterium was described as small, spiral-
shaped, and having up to five unipolar flagella, differentiating it from Campylobacter, 
which have single polar flagella.  Although an association between this novel ‘Pyloric 
Campylobacter’ and gastritis had been described in multiple countries by 1985 [2,3], it 
remained unclear whether this bacterium was the primary cause of gastritis, or if the 
bacterium was an opportunistic commensal of the abnormal gastric mucosa.  Moreover, 
the contribution, if any, that the bacteria were making to the development of gastric 
diseases other than gastritis could not be ascertained.  Therefore, Marshall considered it 
important to fulfill Koch’s Postulates, utilizing himself as the voluntary human subject [4].  
Marshall consumed a liquid culture of ‘Pyloric Campylobacter’ containing 
approximately 109 colony forming units, and developed acute gastritis within 10 days 
post-ingestion.   Gastric biopsy at 10 days post-infection demonstrated the presence of 
polymorphonuclear neutrophil (PMN) infiltrates, abnormal gastric epithelial cells, and 
‘Pyloric Campylobacter’ attached to the luminal surface of the antral epithelial cells  [4].  
 
 
2 
 
At 14 days post-ingestion, Marshall initiated antibiotic therapy, which was able to 
completely resolve his symptoms within 24 hours [4].   
This risky experiment was the first to report a direct association of infection by 
‘Pyloric Campylobacter’ (later renamed Helicobacter pylori) with development of acute 
gastritis, providing resolution to a medical curiosity that had persisted for decades.  
Marshall and Warren’s research reintroduced the concept, first proposed at the turn of 
the century, that a microorganism was the causative agent of gastric disease.  About a 
decade after Marshall’s famous experiment (or period of questionable sanity, depending 
on how one views his methodology), the World Health Organization International Agency 
for Research on Cancer (IARC) designated H. pylori infection as a class I carcinogen [5], 
recognizing the important role of the bacterium as a contributing factor in the 
development of gastric cancer.  In 2005, Marshall’s calculated risk, in addition to work 
performed with Dr. Warren, culminated in international recognition when the Australian 
duo received the Nobel Prize in Physiology or Medicine ‘for their discovery of the 
bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease.’ 
Clinical features of infection by Helicobacter pylori and its role in causation of 
severe gastric disease 
Arguably one of the most successful human pathogens, the Gram-negative H. 
pylori has been in intimate association with the human host for an estimated 60,000-
100,000 years [6,7,8,9], and currently colonizes the gastric mucosa of approximately 
50% of the global population [10].  Infection by H. pylori is almost always accompanied 
by superficial chronic gastritis [11].  In the absence of effective antibiotic therapy, 
colonization of the stomach by H. pylori persists for decades or the lifetime of the 
individual.  The majority of H. pylori-infected individuals do not develop symptoms 
related to their infection; however, the presence of H. pylori is associated with an 
increased risk for the development of several severe gastric diseases including peptic 
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ulcers, gastric adenocarcinoma, and mucosa-associated lymphoid tissue (MALT) 
lymphoma [5,12,13,14,15,16,17,18,19,20,21].  Gastric adenocarcinoma is the second 
leading cause of cancer-related death world-wide.  The incidence of gastric cancer 
varies geographically, with the highest rates occuring in Japan, China, South America, 
and Eastern European nations [22].    
Epidemiological case-control studies have demonstrated a significantly higher 
incidence of gastric cancer in H. pylori-infected individuals than in uninfected persons.  
Infection by H. pylori is reported to increase the risk of gastric cancer 2-16 fold [21]. 
Additionally, H. pylori infection is significantly more prevalent in patients with peptic ulcer 
disease and gastric lymphoma, as compared to age-matched controls [18,20].  Recent 
evidence suggests that infection with H. pylori contributes to iron deficiency anemia [23].  
However, in some cases, infection by H. pylori may be beneficial to the host by serving 
to protect against development of certain diseases, including esophageal reflux disease, 
and cancer of the cardia and esophagus.  In addition, infection by H. pylori may lead to 
secondary effects that may help to prevent Mycobacterium tuberculosis infection from 
progressing to active tuberculosis [24], and may play a role in providing protection 
against development of asthma [25].  The protective properties of infection by H. pylori 
are intriguing, but nonetheless, many years of investigation will be required to determine 
the mechanisms by which H. pylori may provide benefits to its host. 
Genetic diversity of Helicobacter pylori and the cag pathogenicity island 
H. pylori infection can result in a broad range of clinical outcomes.  The clinical 
outcomes of infection are likely determined by a combination of factors, including host 
genetic and physiologic factors, environmental factors, and genetic diversity of the 
bacterial strain. Nearly every strain of H. pylori is unique at the DNA level [26].  
Comparative analysis of multiple H. pylori strains using methods such as multilocus 
sequence typing (MLST) [6,8,9,27,28] and DNA microarray [29,30] have revealed 
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considerable differences among H. pylori strains [31,32].  One striking difference in the 
gene content among strains is the presence or absence of a 40-kilobase chromosomal 
region referred to as the cag pathogenicity island (cag PAI) [33,34].  The cag PAI is 
harbored by approximately 50% of H. pylori isolates in the United States, and can be 
present in as many as 90% of H. pylori isolates from East Asian nations [35].  
Additionally, analysis of H. pylori isolates from patients with gastritis compared with H. 
pylori isolates from patients with gastric cancer or peptic ulcer disease revealed several 
genetic markers associated with higher virulence.  The cag PAI, type s1 vacA alleles, 
type I hopQ alleles, and functional babA alleles are more common in strains associated 
with severe gastric disease, with several of these virulence determinants frequently 
occurring together in a single isolate [21,36,37,38,39,40,41].  
The G+C content of the cag PAI is substantially different from the G+C content of 
the H. pylori chromosome, suggesting that the island was acquired via horizontal gene 
transfer from an unidentified source [31].  Annotation of the cag PAI indicates that 
approximately 27 proteins are encoded within the island, some of which are homologous 
to components of the prototypical Agrobacterium type IV secretion system (T4SS) 
(Figure 1-1) [42].  However, in some cases, the level of sequence homology of cag 
genes to vir genes is quite weak, demonstrating a phylogenetic divergence from a 
common ancestor.  Table 1 lists multiple commonly used cag gene designations.   
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Figure 1-1. Gene arrangement of the cag pathogenicity island (cag PAI) in H. pylori 
26695.  The cag PAI is a 40-kilobase chromosomal region which encodes 27 proteins 
that are involved in the formation of a type IV secretion system (T4SS).  Some of the 
genes within the cag PAI have similarity to components of the T4SS of the plant 
pathogen Agrobacterium tumefaciens (red arrows).  The T4SS is utilized to translocate 
the oncoprotein CagA (yellow arrow) into the host gastric epithelial cell.  In addition to 
CagA translocation, the T4SS also induces the production of IL-8 by gastric epithelial 
cells.  Genes indicated by dark red and dark green arrows are required for both CagA 
translocation and induction of IL-8.  Some genes are required for CagA translocation, but 
are not involved in eliciting IL-8 synthesis and secretion by gastric epithelial cells (light 
red and light green arrows).  Seven genes encoded within the cag PAI are not required 
for either CagA translocation or induction of IL-8 secretion (indicated by red dots). Image 
reprinted from [7].  
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Helicobacter pylori cag PAI-dependent effects on the host gastric epithelium 
CagA, a 140 kilodalton immunodominant antigen, enters gastric epithelial cells 
and causes numerous cellular alterations.  Additional proteins encoded by the cag PAI 
assemble into a type IV secretion system (T4SS) that ushers CagA into gastric epithelial 
cells [43,44]. Following translocation, CagA is phosphorylated by host cell kinases at 
tyrosine residues contained within EPIYA motifs in the C-terminal region of the protein 
[43,44,45].  CagA, in both phosphorylated and non-phosphorylated forms, is able to 
interact with host cell signaling proteins, resulting in an assortment of consequences, 
including cytoskeletal alterations, disruption of cellular junctions, and altered cellular 
adhesion and polarity [42,45,46,47].   
Within gastric epithelial cells, phosphotyrosine-CagA activates SHP-2 [48], 
leading to dephosphorylation of multiple cell proteins, and inactivation of the catalytic 
activity of c-Src tyrosine kinase [49].  This cascade inactivates multiple cellular proteins, 
including the actin-binding protein cortactin [49], prompting the gastric epithelium to 
undergo cytoskeletal rearrangements that ultimately result in a vast morphological 
change referred to as the hummingbird phenotype.  CagA has been shown to interact 
with Grb-2, resulting in activation of the Ras/MEK/ERK signaling pathway, cell 
scattering, membrane ruffling, and cell proliferation [50].  Interaction of CagA with the 
hepatocyte growth factor receptor c-Met results in an increase in cell motility [51].  CagA 
has been shown to co-localize with the intercellular junction proteins ZO-1 and JAM, 
resulting in the disruption of tight junctions to allow for bacterial invasion to the 
basolateral surface of polarized epithelial cells [47].  Furthermore, CagA has the ability to 
stimulate a change in polarized cell monolayers, leading to a shift from a polarized to an 
invasive phenotype [52]. Notably, activation of β-catenin by CagA leads to a 
transcriptional upregulation of oncogenes [53].  
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Numerous proteins encoded by the cag PAI are required for the activation of pro-
inflammatory signal transduction pathways in gastric epithelial cells. The most well 
characterized H. pylori-induced pro-inflammatory response is the expression and 
secretion of the cytokine IL-8 by gastric epithelial cells, in response to co-culture with 
cag PAI-positive strains [54,55].  One mechanism leading to IL-8 induction involves entry 
of H. pylori peptidoglycan into the epithelial cell cytoplasm, where it is recognized by the 
pathogen recognition molecule NOD1; entry of peptidoglycan into the cytoplasm occurs 
through a cag PAI-dependent process [56]. A second mechanism leading to IL-8 
induction involves translocation of CagA.  The CagA protein can induce upregulation of 
IL-8 transcription via activation of the Ras/Raf signaling pathway [57]; however, most 
reports suggest that IL-8 activation is dependent upon cag PAI proteins other than 
CagA, and IL-8 stimulation occurs in a CagA-independent manner that is strain-specific 
[57,58,59,60].  Additional CagA-independent effects of the cag PAI on the host cell 
include alteration of epithelial gene transcription (such as MMP-7 [61]), and 
transactivation of the EGF receptor [62,63]. 
CagL is a 26 kDa protein component of the cag T4SS that lacks homologs in 
other bacterial species.  H. pylori mutants lacking cagL are defective in the ability to 
translocate CagA into host cells and do not stimulate production of IL-8 by gastric 
epithelial cells [55,64].   An important feature of CagL is its ability to bind α5β1 integrin 
[64].   CagL contains a canonical integrin-binding RGD motif, but there is not uniform 
agreement about the functional significance of this RGD motif in mediating binding of H. 
pylori to α5β1 integrin [64,65].  A recent study reported that recombinantly expressed 
CagL functionally mimics fibronectin in its ability to induce focal adhesion formation in 
mouse fibroblasts and stimulate spreading of AGS cells [66].  Another study reported 
that CagL mediates dissociation of ADAM17 from α5β1 integrin [67]. This leads to NFκB-
mediated repression of the gastric H,K-adenosine triphosphate α-subunit (HKα), which 
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may ultimately contribute to transient hypochlorhydria in H. pylori-infected individuals 
[67].  Recently it was reported that, in addition to CagL, three other H. pylori proteins 
encoded by the cag PAI (CagA, CagI, and CagY) can interact with β1 integrin [65].  
Interactions of these three Cag proteins with β1 integrin have been detected using 
several approaches, including yeast two-hybrid screening, analysis of interactions 
between these proteins and integrin on the surface of gastric epithelial cells, and surface 
plasmon resonance analysis [65]. 
Versatility of bacterial type IV secretion systems 
Type IV secretion systems (T4SS) are utilized by a wide variety of bacterial 
species for delivery of effector proteins or DNA-protein complexes into an assortment of 
recipient cells, including mammalian cells, plant cells, fungi, or other bacteria 
[68,69,70,71,72].  T4SSs are distinguished from other bacterial secretion system types 
as a result of their ability to translocate both proteins and nucleoprotein complexes into 
the recipient cell.  The T4SS family is subdivided into three subfamilies of translocation 
families, each of which can contribute to bacterial pathogenesis.  The largest subfamily 
consists of DNA conjugation systems, and these T4SSs are present in most species of 
Gram-negative and Gram-positive bacteria [69].  The function of these conjugation 
systems is to mediate DNA transfer between bacteria of the same or different species, 
as well as introduction of bacterial DNA into phylogentically diverse recipients such as 
fungi, plant, or mammalian cells.  These systems contribute to pathogenicity by allowing 
bacteria to constantly expand or reduce their genomic content, to allow for enhancement 
of bacterial fitness in a variety of environmental conditions which may include infection of 
a human host.  This family of T4SSs can mediate the widespread dissemination of 
mobile genetic elements between bacteria, which can lead to rapid emergence of 
antibiotic resistance among populations of clinically relevant pathogens. 
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The second subfamily consists of DNA uptake and release systems that function 
in the absence of host cell contact [69].  This is the most recently discovered subfamily 
of T4SSs, and is currently comprised of two DNA competency (uptake) systems – the 
Campylobacter jejuni Cjb/VirB system, and the Helicobacter pylori ComB system 
[73,74,75] – as well as the F-plasmid Tra-like DNA-release system encoded by the 
gonococcal genetic island of Neisseria gonorrhoeae [76].   As with DNA conjugation 
machinery, the DNA uptake and release subfamily of T4SSs likely contributes to 
genome plasticity via exchange of mobile elements that contain genes which are 
advantageous for survival. 
The third subfamily, perhaps most relevant to bacterial pathogenesis, is the type 
IV secretion effector/translocator systems.  This subfamily has an important role in the 
infection process of several prominent bacterial pathogens of both plants and mammals 
[69].  These T4SSs are similar to type III secretion systems in that they deliver their 
effector molecules through a needle-like appendage, and both systems require direct 
contact of bacteria with the host cell for delivery of cargo to the eukaryotic cytoplasm.  
The prototypical effector/translocator T4SS is present in the plant pathogen 
Agrobacterium tumefaciens [69,71].  In addition to H. pylori, T4SSs are present in a 
number of medically-relevant Gram-negative bacteria including Legionella pneumophlia, 
Bordetella pertussis, Rickettsia prowazekii, Coxiella burnetii, and Brucella suis [69].  Of 
note, Bordetella pertussis utilizes an effector/translocator T4SS to export pertussis toxin 
to the extracellular environment, where it is able to bind and enter the host cell through 
the endosomal pathway [69]. 
Our current understanding of bacterial T4SSs is based in large part on elegant 
studies of the Agrobacterium tumefaciens T4SS, which translocates bacterial DNA into 
plant cells [69,71].  The Agrobacterium VirB-VirD system is the most extensively 
characterized T4SS, and can be utilized as a model system for understanding the 
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function of T4SS in other bacterial species.  The Agrobacterium T4SS is comprised of 11 
proteins, termed VirB1-VirB11, encoded by the virB operon, and one additional protein 
encoded by the virD operon (VirD4) [69,71].  These Vir proteins have been classified into 
three functional categories according to cellular localization.  VirB4, VirB11, and VirD4 
are present in the inner membrane; VirB6, VirB7, VirB8, VirB9, VirB10 are involved in 
formation of a core complex; and the T4SS pilus is comprised of the major pilin 
component VirB2, and minor pilin component VirB5 [71]. 
Organization of the cag PAI-encoded type IV secretion system 
Thus far there has been relatively little study of the H. pylori cag T4SS.  Initial 
identification of bacterial genes required for function of the H. pylori cag T4SS was 
accomplished by systematic transposon mutagenesis of genes within the cag PAI [55], 
or by inserting antibiotic cassettes into selected genes within the cag PAI [33,34,77].  
One study reported that 17 cag genes are required for translocation of CagA into gastric 
epithelial cells, and 14 cag genes influence the secretion of IL-8 (Table 1) [55].  Several 
of these genes encode products that exhibit low-level sequence similarity to components 
found in the T4SSs of A. tumefaciens and other bacterial species [42,43,46].  At least 
nine of the cag genes that are reported to be required for function of the cag T4SS lack 
homologs in other bacterial species (Table 1) [42,55,78].  The functions of the encoded 
proteins remain largely uncharacterized.  Structural analyses have been undertaken for 
several components of the cag T4SS [79], and several studies have shown that Cag 
proteins can interact to form subassemblies [78,80,81].  Overall, there is only a very 
limited understanding of the structural organization and architecture of the cag T4SS 
apparatus. 
Few structural studies of components of the cag T4SS have been performed.   
Currently, crystal structures are available for a small number of Cag proteins.  Available 
structures include the H. pylori VirB11 homolog [82], an ATPase that organizes into 
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hexameric structures and is required for CagA translocation; CagZ, a protein that 
interacts with and stabilizes Cag5 (a VirD4 homolog) [83]; CagS, a protein that does not 
have homologous components in other T4SSs, but is not essential for CagA 
translocation or induction of IL-8 synthesis and secretion [84]; CagD, a unique 
component that forms covalent disulfide-linked homodimers [85], and is reported by one 
study, but not another, to have a role in CagA translocation; and 12 amino acid residues 
of CagA in co-crystal structure with MARK2 [86], one of approximately 20 host proteins 
with which CagA interacts. 
Multiple studies have employed immunoprecipitation or yeast 2-hybrid (Y2H) 
methods to evaluate Cag protein-protein interactions.  Y2H screening of Cag protein 
interactions has produced variable results.  One study utilized Y2H methodology in an 
attempt to generate a comprehensive protein interaction map of H. pylori, but detected 
very few Cag protein interactions [87,88].  Other studies utilizing Y2H methods 
discovered multiple interactions among Cag proteins [81].  Perhaps the most well 
characterized Cag protein-protein interaction is that of the effector molecule CagA with 
its chaperone-like protein CagF.  This CagA-CagF interaction has been described in a 
number of publications, and has been detected using immunoprecipitation approaches 
[89].  Recently, Y2H methods were used to demonstrate an interaction between the 
coupling protein Cag5 (VirD4) and CagA, as well as a stabilizing interaction between 
CagZ and Cag5 [90]. 
Immunoprecipitation methods have been used to identify a number of potential 
Cag-Cag interactions.  Cag5, CagT, CagN, CagD, and Cag1 were suggested to co-
immunoprecipitate with Cag3 [78].  In addition, low levels of CagM, CagX, CagC, CagE, 
and the VirB11 homolog were also present in Cag3 immunoaffinity purifications [78].   
Y2H analysis also indicates that Cag3 can interact with CagV, CagT, CagM, and CagG 
[81].  The interaction between Cag3 and CagT has been detected by multiple 
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independent methods [78,81].  Y2H screening and immunoprecipitation methods were 
also exploited to identify a Cag subassembly at the outer bacterial membrane consisting 
of CagM and the Vir homologs CagY, CagT, and CagX [80]. 
Several studies have reported localization of Cag proteins to specific subcellullar 
locations.  Cag3, a protein unique to H. pylori, was found to be surface-exposed on the 
outer membrane, with a small proportion of the protein distributed to the soluble fraction 
[78].  CagN, a protein not required for CagA translocation and IL-8 induction, is a 
membrane-associated protein that is processed at the C-terminus [91].  CagY, a large 
protein that has low-level relatedness to VirB10, may also be localized to multiple 
subcellular locations, including the surface of the bacteria [92]. 
Surface-exposed pili are an important feature of T4SSs [69,93]. The T4SS pili of 
A. tumefaciens are comprised of VirB2 (the major pilin subunit) and VirB5 (the minor pilin 
subunit) [69,93]. When H. pylori is in contact with gastric epithelial cells, the bacteria 
express pili that are associated with the cag T4SS (Figure 1-2 A, B) [64,92,94,95].  
Relatively little is known about the composition and biogenesis of these H. pylori pili.  In 
contrast to T4SS pili from other bacterial species, the H. pylori T4SS pili are reported to 
be sheathed organelles [92].  One study reported that CagY may be a component of the 
pilus sheath [92].  It is thought that the presence of numerous repeated sequences in 
cagY allows for frequent intragenic recombination events, producing in-frame 
rearrangements [96].  These intragenic rearrangements may play a key role in the ability 
of the bacteria to evade the host immune response by increasing antigenic variation [96].   
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Figure 1-2.  Depiction of the cag T4SS of H. pylori.  A.  Our current understanding of 
the cag T4SS structure and organization is based largely upon studies of the T4SS of 
Agrobacterium.  The cag T4SS is a bi-membrane-spanning macromolecular structure 
which includes a pilus that extends from the bacterium to the surface of the host gastric 
epithelial cell.  The proposed model of the cag T4SS is shown, with location and 
assembly of the Vir homologs (VirB1-VirB11) depicted according to the corresponding 
localization within the Agrobacterium T4SS.  The unique H. pylori protein CagL contains 
an RGD motif and is thought to interact with and activate host α5β1 integrin to facilitate 
translocation of CagA (image reprinted from [64]).  B.  When in intimate contact with 
gastric epithelial cells, cag PAI-positive strains of H. pylori generate T4SS pili.  These 
T4SS pili can be imaged by scanning electron microscopy (image reprinted from [92]). 
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H. pylori CagC is reported to be a VirB2 homolog [94], but there is not yet 
convincing evidence that CagC is a major component of H. pylori pili.  Several of the H. 
pylori proteins (CagY, CagT, and CagX) that have been localized to the pili by 
immunogold staining [92,95] are distantly related to core complex components in other 
T4SS (VirB10, VirB7, and VirB9, respectively).  H. pylori CagL has also been localized to 
pili by immunogold staining and it is suggested that it is a minor pilus component (Figure 
1-3) [64]; however, CagL and VirB5 do not exhibit any detectable sequence similarity. In 
various studies, CagL has been detected as a constituent of the T4SS pilus (Figure 1-3 
B) [64], on the surface of H. pylori (Figure 1-3 A, C) [66], or as a protein localized to the 
soluble fraction of H. pylori lysates [80,92].   Taken together, these findings suggest that 
the pili associated with the H. pylori cag T4SS are considerably different from the T4SS 
pili of A. tumefaciens and other known bacterial T4SSs.  
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Figure 1-3.  Localization of CagL to the cag T4SS pilus and surface of H. pylori.  
Immunogold labeling was utilized to localize CagL to the surface of WT H. pylori in the 
absence of host cell contact (A, C).  When in contact with gastric epithelial cells, CagL 
can be localized along the length and tip of T4SS pilus structures (B).  CagL cannot be 
detected by immunogold labeling in a ΔcagL isogenic mutant (C).  Panels A and B 
reprinted from [64]; Panel C reprinted from [66].  
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Despite the efforts of multiple talented groups and more than two decades of 
research, there is still much to discover about H. pylori, and in particular, significant 
knowledge gaps exist in the area of the architecture and topology of the cag T4SS.  It is 
unclear how the cag T4SS assembles prior to translocation of CagA into gastric 
epithelial cells.  Furthermore, the molecular mechanism by which CagA is shuttled into 
the host cell has not been elucidated.  The function of many Cag proteins, especially 
those without homologs in other bacterial T4SSs, remains unexplored.   
This thesis primarily focuses on the requirement of non-homologous Cag 
proteins in mediating translocation of CagA through biogenesis of the T4SS pilus 
structure at the interface of the bacteria and host cell.  In Chapter II, we utilize a robust 
mass spectrometry method to identify components of a T4SS subassembly that contains 
the pilus component CagL, establishing a powerful new tool for analyzing Cag protein-
protein interactions.  We provide evidence that components of this CagL-containing 
subassembly are required for CagA translocation and induction of IL-8 synthesis and 
secretion, and that these components share multiple properties including co-transcription 
and protein sequence relatedness.   
In Chapter III, we demonstrate that each of the proteins identified in the CagL 
T4SS subassembly plays a key role in formation of the T4SS pilus between H. pylori and 
the surface of gastric epithelial cells.  We show that CagL and the novel protein CagI are 
required for formation of the T4SS pili.  CagH, a protein that interacts with CagL and 
CagI, is not required for T4SS formation.  However, H. pylori that are deficient in cagH 
exhibit a hyperpiliated phenotype, producing T4SS pili that have a dramatically altered 
morphology compared to those of wild-type (WT) H. pylori.  We identify a conserved 
flagellar hook protein K (FlgK) domain near the N-terminus of CagH that is evolutionarily-
related to FlgK of Burkholderia species.  This domain may be contributing to the role of 
CagH as a modified capping protein or molecular ruler involved in controlling dimensions 
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of the Cag T4SS pilus.  Furthermore, we identify nearly identical hexapeptide C-terminal 
motifs present in CagH, CagI, and CagL that also contribute to T4SS pilus biogenesis.  
We show that this motif in CagL and CagI is required for pilus formation.  In contrast, 
bacteria expressing CagH that is deficient in this C-terminal motif (CagHΔCT) produce 
pili with morphology and abundance similar to those of the WT strain.  These T4SSs are 
nonetheless non-functional, as deletion of the motif results in ablation of CagA 
translocation and induction of IL-8 synthesis and secretion by gastric epithelial cells. 
Finally, in Chapter IV, we utilize chemical cross-linking, immunoaffinity 
purification, and mass spectrometry strategies to identify CagA protein interactions 
occurring in H. pylori in the context of host-cell contact.  We identify several CagA 
interactions occurring in bacteria in contact with the host cell that differ from interactions 
of CagA in bacteria that have not been co-cultured with gastric epithelial cells.  Chemical 
cross-linking strategies are also employed to analyze interactions of the unique T4SS 
component CagU.  Experiments with epitope-tagged CagU suggest that CagU may 
homodimerize during T4SS apparatus assembly.  Furthermore, we utilize mass 
spectrometry to analyze sheared preparations derived from WT, hyperpiliated ΔcagH 
bacteria, and non-piliated bacteria that had been in contact with gastric epithelial cells.  
These sheared preparations are predicted to contain surface components, such as pili, 
and analysis of these preparations may allow the composition of pili to be determined. 
Findings described in this thesis provide important insights into the architecture and 
function of the cag T4SS, and establish the foundation for additional studies aimed to 
elucidate the assembly of the cag PAI-encoded T4SS, as well as the molecular 
mechanism by which the oncoprotein CagA is translocated into the host gastric cell. 
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CHAPTER II 
 
 
IDENTIFICATION OF HELICOBACTER PYLORI CAG PROTEINS THAT INTERACT 
WITH THE TYPE IV SECRETION SYSTEM PILUS COMPONENT CAGL 
 
 
Introduction 
 
The H. pylori cag pathogenicity island (cag PAI) encodes components of a type 
IV secretion system (T4SS) that translocates the bacterial oncoprotein CagA and 
peptidoglycan into gastric epithelial cells [42,43,44,46,97]. Presumably, the assembly 
and function of the T4SS apparatus is dependent upon multiple Cag protein-protein 
interactions.  Analysis of protein-protein interactions has been a well-established method 
utilized to understand the assembly of many bacterial T4SSs [81,98,99,100].  Yeast 2-
hybrid (Y2H) analyses from multiple groups have identified a number of homotypic and 
heterotypic interactions among Cag proteins, providing evidence that Cag proteins 
physically interact to form T4SS subassemblies and complexes [81,88,90,101].  
However, Y2H analyses are often associated with a high rate of both false-positive and 
false-negative results, and it is possible that Cag protein interactions identified in yeast 
do not occur in H. pylori [81].  Classic immunoprecipitation methods have also provided 
evidence of Cag protein interactions among endogenously-expressed Cag proteins 
[78,80]; however, this methodology is often limited by the lack of antibodies directed 
against potential interacting partners.  Furthermore, although some components of the 
Cag T4SS have homology to constituents of the Agrobacterium T4SS, substantial 
differences are likely to exist between the two secretion systems.   
In order to analyze Cag protein-protein interactions, we sought to overcome 
limitations associated with traditional co-immunoprecipitation methods.  Moreover, we 
endeavored to identify Cag protein interactions that occur endogenously within H. pylori 
in the absence of host cell contact, and conditions under which the T4SS has formed in 
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the presence of host cell contact.  We therefore employed an immunoaffinity purification 
method to isolate Cag protein complexes or subassemblies, and identified all potential 
interacting proteins by a sophisticated and robust mass spectrometry method known as 
Multidimensional Protein Identification Technology (MudPIT).     
CagL is a specialized component of the cag T4SS that binds the host receptor 
α5β1 integrin.  H. pylori CagL has also been localized to pili by immunogold staining and 
it is suggested that it is a minor pilus component [64]; however, CagL and VirB5 do not 
exhibit any detectable sequence similarity. CagL contains a canonical integrin-binding 
RGD motif, but there is not uniform agreement about the functional significance of this 
RGD motif in mediating binding of H. pylori to α5β1 integrin.   Recently it was reported 
that, in addition to CagL, three other H. pylori proteins encoded by the cag PAI (CagA, 
CagI, and CagY) can interact with β1 integrin [65].  Since CagL is an important 
component of the cag T4SS that interacts directly with epithelial cells, we hypothesized 
that CagL might physically interact with other T4SS components, and that such 
interactions might be required for CagL export, localization, stability, or activity.   Here, 
we show that two other proteins encoded by the cag PAI (CagH and CagI) co-purify with 
CagL, and we provide evidence that these three proteins are components of one or 
more subassemblies associated with the cag T4SS.  CagL, CagI, and CagH are not 
homologous to components of T4SSs in other bacterial species, but we demonstrate 
that all three proteins are essential for activity of the cag T4SS.  
Methods 
Bacterial strains and growth conditions.  H. pylori 26695 and its cag isogenic mutant 
derivative strains were grown on trypticase soy agar plates supplemented with 5% 
sheep blood or Brucella agar plates supplemented with 5% fetal bovine serum at 37°C in 
room air containing 5% CO2.   H. pylori mutant strains were selected based on 
resistance to chloramphenicol (5 µg/ml), kanamycin (10 µg/ml), or metronidazole (7.5 to 
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15 µg/ml).  E. coli strain DH5α, used for plasmid propagation, was grown on Luria-
Bertani agar plates or in Luria-Bertani liquid medium supplemented with ampicillin (50 
µg/ml), chloramphenicol (25 µg/ml), or kanamycin (10 µg/ml), as appropriate. 
Generation of rabbit polyclonal anti-CagL serum.     CagL derived from H. pylori 26695 
(and lacking a putative signal sequence) was expressed as a GST fusion protein from 
pGEX-6P-1 vector (GE Healthcare, formerly Amersham).  CagL-GST was purified using 
gluthathione beads [81].   Rabbits were then immunized with purified CagL-GST.    
Immunoblot analysis.  To detect expression of Cag proteins, individual samples were 
separated by SDS-PAGE (4-20% gradient), transferred to a nitrocellulose membrane, 
and subsequently immunoblotted using rabbit polyclonal antiserum raised against 
recombinant CagL, or mouse monoclonal antibodies reactive with FLAG or HA epitopes 
(Sigma).  To confirm similar loading of samples, immunoblotting using either a 
monoclonal mouse antibody (Santa Cruz) or a rabbit polyclonal antiserum to H. pylori 
HspB, a GroEL homolog, was utilized [102].  Horseradish peroxidase-conjugated anti-
rabbit IgG or anti-mouse IgG was used as the second antibody. Signals were generated 
by enhanced chemiluminescence reaction and detection by exposure to X-ray film. 
Cell culture methods.  AGS human gastric epithelial cells were grown in the presence of 
5% CO2 in RPMI medium containing 10% FBS, 2 mM L-glutamine, and 10 mM HEPES 
buffer.  
IL-8 secretion by gastric cells in contact with H. pylori.   H. pylori strains were co-cultured 
with AGS cells at a multiplicity of infection of 100:1, and IL-8 secretion was analyzed 
using an anti-human IL-8 sandwich ELISA (R&D).  Levels of IL-8 secreted by AGS cells 
in contact with isogenic cag mutants were compared to levels secreted by AGS cells in 
response to infection with WT H. pylori 26695. 
CagA translocation assay.  Translocation of CagA into AGS cells was analyzed by co-
culturing H. pylori strains with AGS cells and detecting tyrosine phosphorylation of CagA, 
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as previously described [81,103]. Briefly, H. pylori and AGS human gastric cells were co-
cultured at a MOI of 100:1 for 24 h at 37°C.  Cells were lysed in NP-40 lysis buffer 
containing Complete Mini EDTA-free Protease Inhibitor (Roche) and 2 mM sodium 
orthovanadate, and CagA translocation was assessed by separating the soluble fraction 
using 7.5% SDS-PAGE and immunoblotting with an anti-phosphotyrosine antibody (α-
PY99, Santa Cruz). 
Synthesis of a cat-rdxA cassette.   To facilitate introduction of unmarked mutations into 
H. pylori chromosomal genes of interest, a cat-rdxA cassette was synthesized and 
cloned into pUC57 vector (Genscript).  This cassette confers resistance to 
chloramphenicol mediated by the chloramphenicol acetyl-transferase (cat) gene from 
Campylobacter coli, and susceptibility to metronidazole is mediated by an intact rdxA 
gene (HP0954) from H. pylori 26695.   Both genes are in the same orientation, with cat 
upstream from rdxA.   Expression of cat is driven by the C. coli cat promoter, and 
expression of rdxA is driven by the H. pylori vacA promoter.   The two genes are 
separated by a presumed C. coli cat terminator, and a ФT7 terminator is located at the 
3’-distal end of the rdxA gene.    
Mutagenesis of H. pylori cag genes.  To construct a ΔcagL mutant strain, we PCR-
amplified cagL along with approximately 0.5 kb of flanking DNA from H. pylori 26695 
genomic DNA using Amplitaq Gold (ABI), and cloned the PCR product into pGEM-T 
Easy (Promega).    By using this plasmid as a template for inverse PCR and then ligating 
the PCR product, we generated a modified plasmid lacking cagL and containing a 
BamHI site at the site of the deletion. A kanamycin resistance cassette was cloned into 
the BamHI site to yield pCSLK2-4.   H. pylori 26695 was transformed with pCSLK2-4 
(which is unable to replicate in H. pylori), and single colonies resistant to kanamycin 
were selected.   PCR and sequencing were used to confirm that the kanamycin cassette 
had inserted into the cagL locus in the same orientation as operon transcription.   
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To generate unmarked mutant strains, we used a new method that is a variant of 
counterselection methods used previously in H. pylori (Figure 2-3) [104,105].   As a first 
step, the rdxA gene, which confers resistance to metronidazole, as well as 
approximately 0.5 kb of flanking DNA on each side, was PCR-amplified from H. pylori 
26695 and cloned into pGEM-T Easy to yield pMM670.   By using pMM670 as the 
template for inverse PCR and then ligating the PCR product, we generated a modified 
plasmid (pMM672) in which the coding region of rdxA was deleted.  Transformation of H. 
pylori 26695 with pMM672 (which is unable to replicate in H. pylori) and selection for 
metronidazole-resistant colonies resulted in the recovery of a mutant in which the rdxA 
locus was deleted (H. pylori ΔrdxA) (Figure 2-3A).    
For each cag gene of interest, we PCR-amplified the relevant gene as well as 
approximately 0.5 kb of flanking DNA on each side from H. pylori 26695 genomic DNA, 
and cloned these sequences into pGEM-T Easy.    By using these plasmids as 
templates for inverse PCR and then ligating the PCR products, we generated modified 
plasmids lacking the cag gene of interest and containing a BamHI site at the site of the 
deletion.  A cat-rdxA cassette (described above) was then cloned into the BamHI site.    
Plasmids containing the cat-rdxA cassette (which are unable to replicate in H. pylori) 
were transformed into H. pylori ΔrdxA, and single colonies resistant to chloramphenicol 
and susceptible to metronidazole were selected (Figure 2-3A, B).   PCR analysis 
confirmed that the cat-rdxA cassette had inserted into the desired chromosomal site and 
that the relevant cag genes were deleted.    To generate unmarked mutants, strains 
containing the cat-rdxA cassette were transformed with plasmids harboring the desired 
mutations, and transformants resistant to metronidazole were selected (Figure 2-3A, B).    
A similar approach was used to introduce a gene encoding a C-terminally truncated form 
of CagL into the endogenous cagL locus.  
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To complement mutants in cis at a heterologous chromosomal locus, we used a 
plasmid derived from pAD1 [106], which allows genes of interest to be introduced into 
the H. pylori chromosomal ureA locus.  The modified pAD1 plasmid contains a 
chloramphenicol resistance cassette, restriction sites to allow cloning of a gene of 
interest into a site downstream from the ureA promoter and a ribosomal binding site, and 
flanking sequences derived from the ureA locus.  Plasmids were constructed to allow 
expression of epitope-tagged forms of CagH, CagI, and CagL, and in addition, plasmids 
were constructed to allow expression of untagged forms of CagI and CagL. CagL was 
expressed as a protein containing a hemagglutinin (HA) tag introduced at residue 22 
(immediately after a putative signal sequence) (Figure 2-1D).  CagH was expressed as a 
protein containing an N-terminal HA tag, and CagI was expressed with an internal FLAG 
epitope introduced at residue 51 in a region downstream of the predicted signal 
sequence (Figure 2-3C), which is predicted to be surface exposed based on 
hydrophilicity plots (ProtScale in Expasy) [107].  H. pylori strains were transformed with 
these plasmids, and chloramphenicol-resistant colonies were selected. Expression of the 
epitope-tagged proteins was verified by immunoblotting using monoclonal anti-HA or 
anti-FLAG antibodies, respectively. 
Immunoaffinity purification of Cag proteins.    WT or ΔcagL isogenic mutant bacteria 
cultured on solid media were harvested after 48 h of growth, washed once in phosphate-
buffered saline (PBS), and lysed overnight at 4°C in RIPA buffer (10 mM Tris, 100 mM 
NaCl, 1% NP-40, 0.25% deoxycholic acid, Complete Mini EDTA-free Protease Inhibitor 
(Roche), pH 7.2).  Cellular debris was removed by high speed centrifugation. CagL was 
immunoaffinity purified from bacterial lysate using polyclonal anti-CagL antibodies that 
had been covalently cross-linked to a Protein A support (Dynal, Invitrogen).  
Alternatively, CagL-HA and CagH-HA were purified from strains expressing these 
proteins using monoclonal anti-HA antibodies that had been either covalently cross-
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linked or non-covalently bound to a Protein G support (Dynal, Invitrogen). Immobilized 
anti-FLAG M2 antibody (Sigma) was utilized for immunoaffinity purification of CagI-
FLAG.  Target proteins were immunoaffinity purified at room temperature.  
Immunoaffinity purified proteins were washed in 100 bed volumes of PBS containing 
0.1% Tween-20 (PBST 0.1%) prior to elution by boiling in SDS buffer (0.3 M Tris-HCl, 
1% SDS, 10% glycerol, 100 mM DTT, Pierce), or elution by HA or FLAG peptide 
competition (20 µg/ml in PBS for HA peptide [Sigma], final concentration; 20 µg/ml in 
TBS for FLAG peptide [Sigma], final concentration).  In each case, the presence of the 
targeted protein in the immunoaffinity purified sample was verified by immunoblotting.   
To purify Cag proteins from bacteria attached to gastric epithelial cells, the WT 
strain and a strain expressing CagH-HA were each co-cultured with AGS cells (80% 
confluent) at an MOI of 100 for 5 hours prior to the addition of RIPA buffer and 
mechanical disruption of the cell monolayers.  Cells were lysed by 3 pulses of sonication 
(10 s for each pulse), followed by overnight incubation at 4°C in RIPA buffer.  Cleared 
lysates were incubated with immobilized anti-HA monoclonal antibody (Sigma) at room 
temperature.  Immunoaffinity-purified preparations were washed with 100 bed volumes 
of PBST 0.1%.  Bound proteins were eluted by HA peptide competition.     
Mass spectrometric analysis of samples.   To provide a comprehensive analysis of the 
protein content in immunoaffinity purified samples, the samples were analyzed by 
multidimensional protein identification technology (MudPIT).   Purified proteins were 
eluted from the beads, run about 2 cm into a 10% NuPAGE gel, and then subjected to 
in-gel digestion with trypsin and peptide extraction.  The resulting peptide mixtures were 
analyzed via MudPIT essentially as described [108]. Briefly, peptides were loaded via 
pressure cell (New Objective) onto a biphasic pre-column fritted using an Upchurch M-
520 filter union (IDEX). This 100-μm fused silica microcapillary column was packed with 
3 cm of 4-μm C18 reverse-phase resin (Jupiter, Phenomenex) followed by 5 cm of 
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strong cation-exchange resin (Luna SCX, Phenomenex). Once loaded, it was then 
placed in-line with a 100 µm × 20 cm, C18 packed emitter tip column (Jupiter C18, 3 µm, 
300 Å, Phenomonex) coupled to an LTQ ion trap mass spectrometer equipped with an 
Eksigent NanoLC-AS1 Autosampler 2.08, an Eksigent NanoLC-1D plus HPLC pump, 
and nanospray source.  Multidimensional separations were accomplished using 5 µl 
autosampled pulses of ammonium acetate in 0.1% formic acid (25, 50*, 75, 100, 150*, 
200, 250*, 300, 500*, 750*, 1000* mM pulses - * shorter MudPITs containing these salt 
pulses were performed on isolated proteins) followed by a 105 min reversed phase 
gradient from water 0.1% formic acid to 45% ACN 0.1% formic acid.  Tandem mass 
spectra were collected throughout the runs in a data dependent manner using dynamic 
exclusion to improve data acquisition of lower intensity peptides. These spectra were 
extracted from the instrument files using ScanSifter and searched using SEQUEST [109] 
against an H. pylori strain 26695 database that also contained common contaminants 
and reversed versions of the H. pylori proteins.  Identifications were filtered to an 
estimated desired false discovery rate (FDR) using reverse database hits and collated to 
proteins using IDPicker [110].  All reported proteins were identified with a minimum of 2 
distinct peptides. 
Real-time PCR.   Total RNA was isolated from H. pylori using Trizol Reagent (Gibco), 
according to the manufacturer’s protocol.  RNA samples were refined using the RNeasy 
Mini Kit (Qiagen), and on-column RNase-free DNase digestion.  cDNA synthesis was 
performed on 100 ng of purified RNA using the iScript cDNA synthesis kit (BioRad).   As 
a control, first strand cDNA reactions were carried out in parallel without reverse 
transcriptase. Real time PCR was executed in triplicate on an ABI StepOne Real Time 
PCR machine, using TaqMan MGB chemistry.  Abundance of cagH, cagI, and cagL 
transcripts in cag isogenic mutant strains was calculated using the ΔΔCT method, with 
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each transcript signal normalized to the abundance of the recA internal control and 
comparison to the normalized transcript levels of WT H. pylori.   
Bacterial subcellular fractionation.  Wild-type H. pylori strain 26695, as well as strains 
expressing CagL-HA, CagH-HA or CagI-FLAG, were grown on solid media for 24 h prior 
to harvest, washing, and resuspension in sonication buffer (10 mM Tris-HCL, pH 8.0, 
Complete Mini EDTA-Free Protease Inhibitor (Roche)).  Bacteria were lysed by 5 pulses 
of sonication.   Unbroken bacteria and cellular debris were removed from the lysate by 
centrifugation at 4500 x g for 10 min.  The supernatant was separated by 
ultracentrifugation (1h at 250,000 x g, 4°C) into a soluble fraction and a total membrane 
fraction.  Proteins in the soluble fraction were concentrated by methanol-chloroform 
precipitation [111] prior to solubilization in reducing SDS-PAGE buffer (Pierce).  The total 
membrane fraction was washed three times in sonication buffer, and resuspended in 
reducing SDS-PAGE buffer (Pierce).  Subcellular fractions were immunoblotted with 
anti-CagL, anti-HA and anti-FLAG antibodies, followed by appropriate secondary 
antibodies, to detect untagged CagL, CagL-HA, CagH-HA, and CagI-FLAG, respectively.    
Cleavage of surface proteins by proteinase K.  Susceptibility of surface-exposed H. 
pylori proteins to digestion with proteinase K was assessed using a modification of 
previous protocols [102].  H. pylori expressing either CagH-HA, CagI-FLAG, or CagL-HA 
were grown for 24 h on blood agar plates prior to harvesting and washing in PBS.  
Bacteria were resuspended in RMPI medium, or RPMI medium containing proteinase K 
(0-20 µg/ml).  Bacteria were incubated for 30 min on ice, and proteinase K activity then 
was abrogated by addition of PMSF (final concentration 2 mM).  After washing in RPMI 
containing 2 mM PMSF, the bacteria were resuspended in SDS sample buffer and 
analyzed by SDS-PAGE and immunoblotting.  CagH-HA, CagI-FLAG, and CagL-HA 
were detected with monoclonal anti-HA or monoclonal anti-FLAG antibodies. Cleavage 
of VacA, which is known to be present on the H. pylori surface [112,113], was assessed 
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using an anti-VacA antibody [114].  Cleavage of carbonic anhydrase was assessed 
using an antiserum raised against a periplasmic domain of this protein [115]. 
Densitometry was accomplished using Image J software [116]; band densities were 
normalized to HspB and compared to control samples that were not treated with 
proteinase K. 
Flow cytometry.  Bacteria were grown overnight in Brucella broth supplemented with 5% 
fetal bovine serum.   Bacterial cells were fixed in 4% paraformaldehyde before staining 
with primary antibody (monoclonal anti-HA [Sigma] or monoclonal anti-FLAG [Sigma]) in 
PBS supplemented with 50 mM EDTA and 0.1% BSA, followed by staining with 
secondary antibody (goat F(ab’)2 anti-mouse IgG labeled with Alexa Fluor 488) in PBS 
supplemented with 0.1% BSA. Flow cytometry data were collected on a Becton 
Dickenson LSR2 instrument using Becton Dickenson FACS Diva 6.1.3 software.  20,000 
single cell events were collected for each sample and analyzed using Tree Star Flow Jo 
8.8.2 software. 
Immunoelectron microscopy.   H. pylori cells were grown on blood agar plates for 48 h 
as described above.  Immunogold labeling was performed on whole bacterial cells as 
previously described with some modifications.  Briefly, bacterial cells were lifted onto 
formvar-coated 200 mesh copper TEM grids (Electron Microscopy Sciences).  Cells 
were washed three times with pre-warmed PBS and incubated in 1% gelatin in PBS for 
30 min at 37°C.  After blocking, mouse monoclonal primary antibodies (anti-HA or anti-
FLAG) were applied to the sample grids and incubated for 30 min at 37°C.  
Subsequently, grids were washed three times with pre-warmed PBS and a second 
blocking step was performed using 1% gelatin in PBS for 30 min at 37°C.  Then goat 
anti-mouse secondary antibodies conjugated to 10 nm colloidal gold particles (Ted Pella, 
Inc.) were applied and incubated for 30 min at 37°C.  Afterward, grids were washed 
three times with prewarmed PBS and cells were negatively stained with 1% ammonium 
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molybdate before being visualized with a Philips CM-12 transmission electron 
microscope.  
Statistical Analysis.  The statistical significance of differences in numbers of spectral 
counts of proteins detected in different immunoaffinity purified preparations was 
determined by G-test, as previously described [117]. The statistical significance of 
differences in IL-8 production or cag gene expression when comparing WT H. pylori with 
mutant strains was determined by one-way ANOVA followed by Dunnett's post-hoc test 
for multiple comparisons against a single control [118].  Statistical analysis of pilus 
dimensions was performed using a two-tailed Student’s T-Test. 
Ethics Statement.  This study was carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the 
National Institutes of Health. The protocol was approved by the Institutional Animal Care 
and Use Committee of Vanderbilt University School of Medicine (M/07/292). 
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Results 
Identification of Cag proteins that co-purify with CagL.  Previous studies have 
shown that CagL is an important component of the H. pylori cag T4SS that can bind 
α5β1 integrin [55,64,65].   We hypothesized that CagL interacts with other components 
of the cag T4SS to form one or more subassemblies.  Therefore, we sought to identify H. 
pylori proteins that co-purify with CagL.   To facilitate these studies, a cagL-deficient H. 
pylori mutant strain (ΔcagL) was generated as described in Methods.   As expected, 
CagL expression was detected by immunoblot analysis in the wild-type (WT) strain but 
not in the ΔcagL mutant strain (Figure 2-1A).  Consistent with previous reports 
[55,64,65], the ΔcagL mutant strain was defective in its ability to stimulate IL-8 secretion 
by gastric epithelial cells (Figure 2-1B) and defective in its ability to translocate CagA 
into gastric epithelial cells (Figure 2-1C).  Complementation with an epitope-tagged form 
of CagL restored the ability of the bacteria to translocate CagA into host cells and induce 
IL-8 secretion (Figure 2-1A-D). 
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Figure 2-1. Functional analysis of CagL.  (A) Immunoblot (IB) analysis indicates that 
CagL is expressed in wild-type H. pylori 26695 (WT), but not in Δcag PAI or ΔcagL 
mutants.   Complementation of ΔcagL with a gene encoding an epitope-tagged form of 
CagL (CagL-HA) results in restoration of CagL expression. (B) AGS cells were infected 
with WT H. pylori or the indicated mutants, and levels of IL-8 secreted by AGS cells were 
quantified by ELISA.  A wild-type strain was able to induce IL-8 secretion, whereas 
mutants deficient in cagL were unable to induce IL-8 secretion.   Complementation of 
CagL rescued the ability of ΔcagL to stimulate IL-8 secretion. Values from six replicate 
samples were compared to the wild-type control by ANOVA followed by Dunnett's post 
hoc test; # indicates p<0.05. (C) AGS cells were co-cultured with WT H. pylori or the 
indicated mutants, and tyrosine-phosphorylated CagA was detected using an anti-
phosphotyrosine antibody (α-PY99).  Samples also were immunoblotted with an anti-
CagA antibody and antiserum reactive with multiple H. pylori proteins (α-Hp).  The 
ΔcagL mutant was defective in ability to translocate CagA into AGS cells. (D) Schematic 
of a construct encoding an epitope-tagged form of CagL (CagL-HA), used to 
complement ΔcagL in cis from the ureA locus.  PureAB, ureAB promoter; cat, 
chloramphenicol resistance mediated by chloramphenicol acetyltransferase gene of C. 
coli.    
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We used a polyclonal anti-CagL serum to immunoaffinity-purify CagL from a wild-
type H. pylori strain, and a ΔcagL mutant strain was processed in parallel.  As expected, 
immunoblotting studies showed that CagL was immunoaffinity-purified from WT lysate 
but not ΔcagL lysate (data not shown).   The protein content of each sample was 
analyzed using multidimensional protein identification technology (MudPIT).  Numerous 
proteins were detected in each sample, but we focused in particular on proteins encoded 
by the cag PAI, since many of these are known or predicted to comprise components of 
the cag T4SS.  CagL was identified by MudPIT in the preparation derived from WT 
lysate, but was not detected in the preparation derived from ΔcagL lysate (Table 2-1).  In 
addition, the relative abundance of CagH and CagI peptides detected in affinity-purified 
preparations derived from the WT strain was significantly higher than the number of 
CagH and CagI peptides detected in preparations derived from the ΔcagL mutant strain 
(Table 2-1).   
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Table 2-1. Cag proteins that co-purify with CagL 
anti-CagLb 
Gene Number a Protein WT ΔcagL WT ΔcagL 
HP0539 CagL 19 ** 0 21 *** 0 
HP0540 CagI 33 *** 0 29 *** 0 
HP0541 CagH 17 ** 0 19 *** 0 
HP0547 CagA 33 13 32 27 
HP0522 Cag3 2 0 0 0 
HP0527 CagY 4 1 3 3 
Total Spectral Counts 3009 1054 2829 2609 
a Based on the H. pylori 26695 genome annotation  
b CagL was affinity purified from the WT strain (cultured for 48 h) using anti-CagL polyclonal 
antiserum, and a ΔcagL mutant was processed in parallel as a control.  The Table shows 
numbers of spectral counts observed by MudPIT analysis for each identified Cag protein.  
The Table shows results from two independent experiments.    
** p<0.01; *** p<0.001 when comparing WT with the ΔcagL mutant, according to the G-test 
likelihood ratio, post-spectral count normalization. 
  
 
 
34 
 
Peptides identified for CagH, CagI, and CagL covered 33% to 51% of the 
respective proteins (Figure 2-2A).  CagH and CagI co-purified with CagL from the WT 
strain in six independent experiments (data not shown).  CagA and several other Cag 
proteins were also detected in the affinity purified preparations, but the numbers of 
spectral counts corresponding to these proteins were not significantly different when 
comparing preparations derived from WT and ΔcagL mutant strains (Table 2-1).   Many 
other Cag proteins were detected by mass spectrometric analysis of crude bacterial 
lysate (Table 2-2) but were not detected in the affinity purified preparations.   These 
initial experimental results, demonstrating co-purification of CagL, CagH, and CagI, 
suggested that these three proteins are components of one or more subassemblies 
associated with the T4SS.  
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Figure 2-2.  Related properties of CagH, CagI, and CagL.  (A) CagH and CagI were 
each co-immunoaffinity purified with the target protein CagL from WT lysate.   CagH, 
CagI, and CagL peptides identified by MudPIT (pooled data from all CagL purifications 
shown in Table 2-1 and Table 2-3) are indicated.  N-terminal signal peptides (underlined) 
are predicted to be present in CagI and CagL, based on SignalP analysis [119,120]. (B) 
An alignment of CagH and CagL protein sequences reveals sequence similarity between 
the C-terminal portion of CagH and the corresponding portion of CagL (32% amino acid 
identity, 47% similarity in the region shown).  (C) Operon structure of the cag PAI region 
spanning from cagA to cagM.  Black arrows indicate transcriptional start points.  cagH, 
cagI, and cagL are contiguous genes within an operon spanning from cagC to cagL and 
a suboperon spanning from cagF to cagL.   
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Table 2-2. Cag proteins identified in H. pylori whole cell lysate  
 
Gene Number a Protein Homology b SDS c RIPA c 
HP0520 Cag1 12 10 
HP0522 Cag3   56 3 
HP0524 Cag5 VirD4 38 14 
HP0525 Cagα  VirB11 16 4 
HP0526 CagZ 4 7 
HP0527 CagY VirB10 43 5 
HP0528 CagX VirB9 21 1 
HP0529 CagW   8 10 
HP0530 CagV VirB8 29 4 
HP0531 CagU   2 5 
HP0532 CagT VirB7 26 1 
HP0534 CagS   0 2 
HP0536 CagP 2 0 
HP0537 CagM   20 6 
HP0538 CagN 1 1 
HP0540 CagI   0 4 
HP0541 CagH 0 2 
HP0543 CagF   7 56 
HP0544 CagE VirB4 67 15 
HP0545 CagD   6 12 
HP0546 CagC VirB2 7 0 
HP0547 CagA   268 114 
Total Spectral Counts 27688 33569 
a Based on the H. pylori 26695 genome annotation  
b Based on comparison to the Agrobacterium tumefaciens T4SS 
c H. pylori 26695 was cultured for 48 h and then solubilized in either 1% SDS or RIPA buffer.  
The Table shows numbers of raw spectral counts observed by MudPIT analysis for each 
identified Cag protein.    
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As another approach for identifying proteins that co-purify with CagL, we 
undertook experiments with a complemented ΔcagL mutant strain expressing CagL with 
an N-terminal hemagglutinin (HA) epitope tag (Figure 2-1D). We immunoaffinity-purified 
CagL-HA from lysate of the strain expressing CagL-HA, using an immobilized 
monoclonal anti-HA antibody; the WT strain (expressing CagL without an HA tag) was 
processed in parallel in the same manner.   CagL-HA and co-purifying proteins were 
eluted from the anti-HA affinity column by HA peptide competition, and MudPIT was 
utilized to analyze the total protein content of the samples.   Mass spectrometry 
identified only three Cag proteins in the sample purified from the strain expressing CagL-
HA: the target protein CagL-HA, CagI, and CagH (Table 2-3).  The relative abundance of 
CagL and CagI peptides detected in the preparation from the CagL-HA-expressing strain 
was significantly higher than the number of CagL and CagI peptides detected in the 
preparation from the WT strain.   Of note, compared to affinity-purified preparations of 
CagL obtained using polyclonal antiserum, the preparation of CagL-HA obtained using a 
monoclonal antibody and peptide elution had a much higher level of purity (Table 2-3 
and Table 2-2).    
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Table 2-3. Cag proteins that co-purify with epitope-tagged CagH, CagI, and CagL 
 
anti-HA b anti-FLAG c 
Gene Number a Protein WT CagH-HA 
CagL-
HA WT CagI-FLAG 
HP0540 CagI 0 203 *** 10 *** 0 170 *** 
HP0541 CagH 1 91 *** 2 0 19 *** 
HP0539 CagL 0 98 *** 21 *** 0 19 *** 
HP0547 CagA 0 2 0 47 87 
HP0544 CagE 0 0 0 6* 1 
HP0535 CagQ 1 4 0 0 0 
HP0530 CagV 0 0 0 4 4 
HP0543 CagF 0 0 0 2 2 
HP0528 CagX 0 0 0 2 6 
HP0527 CagY 0 0 0 5 4 
HP0520 Cag1 0 0 0 3 2 
Total Spectral 
Counts 208 1428 237 6310 10942 
a Based on the H. pylori 26695 genome annotation 
b CagH-HA or CagL-HA were affinity purified from strains expressing these proteins using an 
anti-HA antibody, and a WT strain was processed in parallel as a control. The Table shows 
numbers of  spectral counts observed by MudPIT analysis for each identified Cag protein.   
c  CagI-FLAG was affinity purified from a strain expressing this protein using an anti-FLAG 
antibody, and a WT strain was processed in parallel as a control.  The Table shows numbers  of 
spectral counts observed by MudPIT analysis for each identified Cag protein.  
* p<0.05; *** p<0.001 when compared to WT control, according to the G-test likelihood ratio, 
post-spectral count normalization. 
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To further investigate potential interactions among CagH, CagI, and CagL, we 
attempted to generate polyclonal antisera against CagH and CagI, but this failed to yield 
antisera that recognized the corresponding H. pylori proteins.   Therefore, we generated 
unmarked non-polar ΔcagH and ΔcagI mutants (Figure 2-3A, B), as well as 
complemented mutant strains expressing epitope-tagged forms of CagH or CagI in a 
heterologous chromosomal locus (Figure 2-3C).   CagH-HA and CagI-FLAG proteins of 
the expected masses were detected in the complemented bacteria (but not WT bacteria) 
by immunoblotting using monoclonal antibodies against the epitope tags (Figure 2-4A).    
We immunoaffinity-purified CagH-HA from lysate of the strain expressing this protein, 
and lysate from the WT strain (expressing CagH without an HA tag) was processed in 
parallel.  The relative abundance of CagH, CagI and CagL detected in the preparation 
from the CagH-HA-expressing strain was significantly higher than the number of CagH, 
CagI and CagL peptides detected in the preparation from the WT strain (Table 2-3 and 
Table 2-2).   
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Figure 2-3. Generation of unmarked, in-frame isogenic mutants.  (A)  A 
metronidazole-resistant strain of H. pylori was generated by transforming the WT strain 
with pMM672 (p-ΔrdxA); metronidazole-resistant transformants contained a deletion of 
the rdxA locus.  The cagI chromosomal locus was deleted by transforming the 
metronidazole-resistant H. pylori with p-cagI::rdxA/cat; this resulted in chloramphenicol-
resistant, metronidazole-sensitive colonies, designated cagI::rdxA/cat.  To generate a 
mutant containing an unmarked cagI deletion, H. pylori cagI::rdxA/cat was transformed 
with pΔcagI4-1, and metronidazole-resistant colonies were selected.   (B) Schematic 
illustration of the chromosomal cagH-cagI-cagL region in the WT strain, cagI::rdxA-cat 
mutant, and ΔcagI unmarked mutant.    A similar approach was used to generate an 
unmarked ΔcagH mutant strain. (C) Schematic of plasmids encoding epitope-tagged 
forms of CagH and CagI.   PureAB, ureAB promoter; cat, chloramphenicol resistance 
mediated by chloramphenicol acetyltransferase gene of C. coli.   The hemagglutinin (HA) 
epitope sequence was inserted into CagH at the N-terminus (CagH-HA), and the FLAG 
epitope was inserted at residue 51 of CagI (CagI-FLAG).  Numbers indicate position of 
residues in the epitope tagged proteins.  These plasmids were introduced into ΔcagH 
and ΔcagI mutants, respectively, and the resulting complemented strains contained 
sequences encoding CagH-HA or CagI-FLAG, inserted into the ureA locus.     
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Figure 2-4.  Functional analysis of CagH and CagI.  (A) Immunoblot analysis of 
CagH-HA and CagI-FLAG in the complemented ΔcagH and ΔcagI mutant strains, using 
monoclonal antibodies directed against the epitope tags. (B) WT H. pylori or the 
indicated mutants were co-cultured with AGS cells for 4.5 h, and IL-8 expression was 
analyzed by ELISA. ΔcagH and ΔcagI mutants were defective in ability to induce IL-8 
secretion, and complementation corrected the defect.   Values from six replicate 
samples were compared to the wild-type control by ANOVA followed by Dunnett's post 
hoc correction; # indicates p<0.05. CagL remained detectable in all strains throughout 
the assay, as demonstrated by anti-CagL immunoblot.  (C) AGS cells were co-cultured 
with WT H. pylori or the indicated mutants, and tyrosine-phosphorylated CagA was 
detected with an anti-phosphotyrosine antibody (α-PY99). Samples also were 
immunoblotted with an anti-CagA antibody and antiserum reactive with multiple H. pylori 
proteins (α-Hp).   CagA translocation was impaired in the ΔcagH and ΔcagI mutants.    
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In a similar manner, we purified CagI-FLAG from the strain expressing this 
epitope-tagged protein.  The relative abundance of CagI, CagH, and CagL detected in 
the preparation from the CagI-FLAG-expressing strain was significantly higher than the 
number of corresponding peptides detected in the preparation from the WT strain (Table 
2-3).  These experiments recapitulated the co-purification of CagH, CagI, and CagL that 
was observed in initial purifications utilizing polyclonal anti-CagL antisera (Table 2-1).  In 
individual experiments, we sometimes detected levels of other proteins besides CagH, 
CagI, and CagL that were significantly increased in affinity-purified preparations 
compared to control preparations (Table 2-4), but these results were not consistently 
reproduced and were not recapitulated when alternate members of a putative CagH-
CagI-CagL complex were targeted for purification.   
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Table 2-4.  Proteins detected in immunoaffinity-purified preparations of CagH-HA 
and CagL-HA 
 
Gene Number a Protein WT b CagH-HA b CagL-HA b 
HP0539 CagL 0 98 *** 21 *** 
HP0540 CagI 0 203 *** 10 *** 
HP0541 CagH 1 91 *** 2 
HP0547 CagA 0 2 0 
HP0535 CagQ 1 4 0 
HP0010 chaperone and heat shock protein 16 72 19 
HP0011 co-chaperone 0 4 0 
HP0025 outer membrane protein 2 1 9 3 
HP0027 isocitrate dehydrogenase 1 4 1 
HP0061 hypothetical protein 1 0 1 
HP0072 urease beta subunit 7 0 0 
HP0073 urease, alpha subunit  6 0 0 
HP0082 methyl-accepting chemotaxis transducer  0 12 0 
HP0083 ribosomal protein S9 1 1 0 
HP0086 conserved hypothetical protein 0 3 0 
HP0099 methyl-accepting chemotaxis protein 1 22 0 
HP0103 methyl-accepting chemotaxis protein 1 1 0 
HP0109 chaperone and heat shock protein 70 2 11 1 
HP0111 hypothetical protein 1 1 0 
HP0116 DNA topoisomerase I 0 7 0 
HP0153 recombinase 0 8 0 
HP0175 cell binding factor 2 2 2 1 
HP0176 fructose-bisphosphate aldolase 0 2 0 
HP0197 S-adenosylmethionine synthetase 2 0 5 0 
HP0210 chaperone and heat shock protein 0 4 0 
HP0224 peptide methionine sulfoxide reductase 2 5 0 
HP0231 hypothetical protein 2 0 1 
HP0243 neutrophil activating protein 12 0 3 
HP0264 ATP-dependent protease binding subunit 0 8 0 
HP0296 ribosomal protein L21 1 7 0 
HP0297 ribosomal protein L27 1 1 0 
HP0305 hypothetical protein 2 2 0 
HP0310 conserved hypothetical protein 0 2 0 
HP0317 outer membrane protein 9 1 25 1 
HP0319 arginyl-tRNA synthetase 1 1 0 
HP0370 biotin carboxylase 0 3 0 
HP0371 biotin carboxyl carrier protein 0 38 ** 0 
HP0390 adhesin-thiol peroxidase 2 5 0 
HP0392 histidine kinase 0 16 0 
HP0397 phosphoglycerate dehydrogenase 0 2 0 
HP0410 neuraminyllactose-binding hemagglutinin homolog 0 14 0 
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HP0415 conserved hypothetical integral membrane protein 0 3 0 
HP0417 methionyl-tRNA synthetase 0 8 0 
HP0434 hypothetical protein 0 2 1 
HP0448 hypothetical protein 0 0 2 
HP0485 catalase-like protein 3 0 1 
HP0486 hypothetical protein 0 3 0 
HP0516 heat shock protein 0 2 0 
HP0550 transcription termination factor Rho 0 2 0 
HP0558 beta ketoacyl-acyl carrier protein synthase II 0 4 0 
HP0561 3-ketoacyl-acyl carrier protein reductase 2 6 1 
HP0570 aminopeptidase 3 2 1 
HP0588 ferrodoxin-like protein 0 2 1 
HP0589 ferredoxin oxidoreductase, alpha subunit 1 8 6 
HP0590 ferredoxin oxidoreductase, beta subunit 0 3 0 
HP0591 ferredoxin oxidoreductase, gamma subunit 1 3 0 
HP0596 lipoprotein, putative 0 3 0 
HP0599 hemolysin secretion protein precursor 0 18 0 
HP0605 hypothetical protein 0 16 0 
HP0606 membrane fusion protein 3 4 4 
HP0607 acriflavine resistance protein 2 4 0 
HP0629 hypothetical protein 1 1 0 
HP0632 quinone-reactive Ni-Fe hydrogenase, large subunit 0 3 0 
HP0649 aspartate ammonia-lyase 0 3 0 
HP0657 processing protease 3 0 0 
HP0690 acetyl coenzyme A acetyltransferase  0 2 0 
HP0695 hydantoin utilization protein A 7 17 4 
HP0696 N-methylhydantoinase 4 13 3 
HP0697 hypothetical protein 0 4 0 
HP0786 preprotein translocase subunit 0 3 0 
HP0797 flagellar sheath adhesin 0 3 1 
HP0825 thioredoxin reductase 0 2 0 
HP0829 inosine-5'-monophosphate dehydrogenase 3 0 1 
HP0859 ADP-L-glycero-D-mannoheptose-6-epimerase 0 2 0 
HP0875 catalase 17 0 15 
HP0883 Holliday junction DNA helicase 0 31 0 
HP0887 vacuolating cytotoxin 7 30 10 
HP0913 outer membrane protein 21 0 1 1 
HP0978 cell division protein 0 2 0 
HP1019 serine protease 1 8 5 
HP1069 cell division protein 0 5 0 
HP1118 gamma-glutamyltranspeptidase 4 0 3 
HP1125 peptidoglycan associated lipoprotein precursor 0 3 0 
HP1126 colicin tolerance-like protein 1 1 1 
HP1131 ATP synthase F1, subunit epsilon 0 2 0 
HP1132 ATP synthase F1, subunit beta 1 24 5 
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HP1134 ATP synthase F1, subunit alpha 1 36 4 
HP1135 ATP synthase F1, subunit delta 0 7 0 
HP1147 ribosomal protein L19 0 4 0 
HP1152 signal recognition particle protein 0 2 0 
HP1172 glutamine ABC transporter 0 20 0 
HP1195 translation elongation factor EF-G 0 7 0 
HP1198 DNA-directed RNA polymerase, beta and beta' subunit 1 2 0 
HP1200 ribosomal protein L10 0 1 1 
HP1205 translation elongation factor EF-Tu 6 73 3 
HP1241 alanyl-tRNA synthetase 0 8 0 
HP1243 outer membrane protein 28 1 31 1 
HP1245 single-strand DNA-binding protein 0 125 *** 0 
HP1279 anthranilate isomerase 0 30 0 
HP1286 conserved hypothetical secreted protein 3 1 2 
HP1293 DNA-directed RNA polymerase, alpha subunit 0 5 0 
HP1301 ribosomal protein L15 4 0 2 
HP1302 ribosomal protein S5 0 3 0 
HP1304 ribosomal protein L6 2 5 1 
HP1310 ribosomal protein S17 0 2 0 
HP1314 ribosomal protein L22 1 1 0 
HP1318 ribosomal protein L4 9 1 4 
HP1319 ribosomal protein L3 0 6 1 
HP1320 ribosomal protein S10 0 4 0 
HP1325 fumarase 0 2 0 
HP1345 phosphoglycerate kinase 0 9 0 
HP1350 protease 23 29 71 *** 
HP1375 UDP-N-acetylglucosamine acyltransferase 0 5 0 
HP1385 fructose-1,6-bisphosphatase 0 2 0 
HP1399 arginase 1 1 0 
HP1428 conserved hypothetical protein 1 1 0 
HP1454 hypothetical protein 2 0 0 
HP1457 hypothetical protein 0 2 0 
HP1460 DNA polymerase III alpha-subunit 2 1 0 
HP1488 conserved hypothetical secreted protein 1 6 0 
HP1496 general stress protein 0 3 0 
HP1542 hypothetical protein 0 4 0 
HP1554 ribosomal protein S2 0 2 0 
HP1563 alkyl hydroperoxide reductase 19 18 15 
HP1588 conserved hypothetical protein 1 21 2 
  Total Spectral Counts 208 1428 237 
a Based on the H. pylori 26695 genome annotation 
b CagH-HA and CagL-HA were affinity purified from strains expressing these proteins using an 
anti-HA antibody, and a WT strain was processed in parallel as a control. The Table shows 
numbers of spectral counts observed by MudPIT analysis for each identified protein. 
** p<0.01; *** p<0.001 when compared to WT control, according to the G-test likelihood ratio, 
post-spectral count normalization.       
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Further analysis revealed that there is weak sequence similarity between the 
amino acid sequences of CagL and CagH (32% amino acid identity and 47% similarity in 
the C-terminal region, Figure 2-2B).  CagL, CagI, and CagH are encoded by contiguous 
genes in an operon (Figure 2-2C) [121].   Other genes included in this operon, upstream 
from cagH, cagI, and cagL, include cagC (encoding the putative T4SS major pilin 
component [94]), cagE (homologous to virB4, encoding an ATPase required for T4SS 
function), and cagF (encoding a chaperone protein that binds to CagA [122]).  Since we 
observed highly reproducible co-purification of CagH, CagI, and CagL, and because 
genes within an operon often have related functions, we proceeded to undertake further 
studies of all three proteins.  
CagL stability is impaired in the absence of CagH and CagI.  Previous studies have 
reported decreased stability of T4SS components if one or more interacting proteins are 
absent [80,90,93,123,124].  Based on the observed co-purification of CagI and CagH 
with CagL, we hypothesized that CagL stability might be impaired in the absence of CagI 
or CagH.   To assess CagL protein stability, we analyzed bacterial lysates prepared from 
the WT strain, ΔcagI mutant, and ΔcagH mutant, each cultured for either 24 h or 48 h.  
CagL could be detected by immunoblotting of lysates from all three strains at 24 h of 
growth (Figure 2-5A).  However, after 48 h of growth, CagL levels were markedly 
reduced in lysates from the ΔcagI and ΔcagH mutants compared to levels in WT lysate.  
CagL stability at the 48 h timepoint was increased by complementation of the mutant 
strains (Figure 2-5A).   We also evaluated the stability of CagL in the absence of two 
Cag proteins selected as controls (CagA and CagF).   We did not detect significant co-
purification of CagA or CagF with CagL in the previous experiments (Table 2-1, Table 2-
3), and neither CagA nor CagF is required for functionality of the T4SS, based on 
analysis of IL-8 induction [55].   Absence of CagA or CagF did not have any detectable 
effect on CagL stability during early or late phases of growth (Figure 2-5A).   
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Figure 2-5. Analysis of CagL stability in ΔcagH and ΔcagI mutants.  (A) H. pylori 
strains were cultured for 24 or 48 hours on solid media prior to lysis and immunoblotting 
to detect expression of CagL.   Expression of HspB, a heat shock protein homolog, was 
analyzed as a control.  In the ΔcagH and ΔcagI mutants, levels of CagL were markedly 
lower at the 48 h timepoint than at the 24 h timepoint.    CagL levels remained stable at 
both timepoints in the WT strain and the complemented mutants expressing CagH-HA or 
CagI-FLAG.  CagL stability is unaffected by absence of Cag proteins that do not interact 
with CagL (ΔcagA and ΔcagF).  (B) RT-PCR analysis of cagH, cagI, and cagL 
transcription in the indicated WT and mutant bacteria, cultured for 48 h.  cagL transcript 
levels are upregulated in the ΔcagH and ΔcagI mutants, compared to levels detected in 
the WT strain.  # indicates p<0.05 according to one-way ANOVA with Dunnett’s post hoc 
correction. 
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We also investigated the possibility that the observed reductions in CagL protein 
expression in ΔcagH and ΔcagI mutants might be attributable to a reduction in cagL 
transcription.  Analysis of cagL transcription in each of these strains by real-time PCR 
indicated that cagL transcription was not diminished, but was in fact increased in the 
ΔcagH and ΔcagI mutants compared to the WT strain at 48 h of growth (Figure 2-5B).    
Thus, the observed reduction in CagL levels in the ΔcagH and ΔcagI mutant strains is 
attributed to reduced stability of CagL, rather than decreased transcription of cagL.   
   To further investigate potential relationships among CagL, CagI, and CagH, we 
analyzed whether co-purification of CagI with CagL was dependent on the presence of 
CagH.  We used polyclonal anti-CagL antiserum to immunoaffinity purify CagL from both 
the WT strain and a ΔcagH mutant strain, each cultured for 24 h (which permitted stable 
expression of CagL in both strains). The samples were then analyzed by mass 
spectrometry. As expected, CagL was immunoaffinity purified from both the WT strain 
and the ΔcagH mutant (Table 2-5).   CagI was co-purified along with CagL from the WT 
strain, but not from the ΔcagH mutant (Table 2-5).   In a similar manner, we investigated 
whether co-purification of CagH with CagL was dependent on the presence of CagI.  
CagH was co-purified with CagL from both the WT strain and ΔcagI mutant; however, 
significantly lower levels of CagH were co-purified from the ΔcagI mutant strain (Table 2-
5).  
In summary, these experiments indicate that CagL stability is reduced in the 
absence of CagH or CagI, and co-purification of CagH or CagI with CagL is dependent 
on the presence of all three proteins.   Taken together with the previous results (Tables 
2-1, 2-3, 2-5), these data provide evidence that CagL, CagI, and CagH are components 
of one or more subassemblies associated with the cag T4SS.   
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Table 2-5.  Cag proteins that co-purify with CagL in the absence of CagH or CagI 
 
 
  
Gene Number a Protein WT b ΔcagH b ΔcagI  b 
HP0539 CagL 43 25 * 22 
HP0540 CagI 60 0 *** 0 *** 
HP0541 CagH 22 0 *** 3 ** 
HP0530 CagV 16 13 11 
HP0544 CagE 4 0 2 
HP0547 CagA 82 74 42 * 
HP0524 Cag5 6 9 3 
HP0529 CagW 2 1 6 
HP0526 CagZ 0 1 2 
HP0543 CagF 1 2 1 
HP0528 CagX 2 0 1 
HP0527 CagY 1 3 0 
Total Spectral Counts 8665 8768 6667 
a Based on the H. pylori 26695 genome annotation  
b CagL was affinity purified from the WT strain, ΔcagH and ΔcagI mutants (each cultured for 24 h) 
using anti-CagL polyclonal antiserum.  The Table shows numbers of spectral counts observed by 
MudPIT analysis for each identified Cag protein.    
*p<0.05; ** p<0.01; *** p<0.001 when comparing each of the mutant strains with WT, according to the 
G-test likelihood ratio, post-spectral count normalization. 
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Functional properties of CagH and CagI.  A previous study, which analyzed mutant 
strains containing transposon insertions in individual cag genes, provided an important 
foundation for identifying genes in the cag PAI that are required for functionality of the H. 
pylori cag T4SS. This study reported that both CagH and CagI were required for CagA 
translocation, and that CagH (but not CagI) was required for IL-8 induction [55].   A 
limitation of the methodologic approach was that unrecognized spontaneous secondary 
mutations or polar effects associated with transposon insertion into the cag PAI could 
not be confidently excluded.    To determine definitively whether CagH and CagI were 
required for the function of the cag T4SS, we analyzed the unmarked ΔcagH and ΔcagI 
deletion mutant strains and complemented mutants described in the previous section.  
In comparison to the WT strain, both the ΔcagH and ΔcagI mutants were 
defective in their ability to induce IL-8 secretion in gastric epithelial cells (Figure 2-4B).   
Complementation of these mutants with genes encoding CagH-HA and CagI-FLAG 
rescued the ability of the respective ΔcagH and ΔcagI mutants to induce IL-8 secretion 
at WT levels (Figure 2-4B).  Immunoblot analysis indicated that CagL remained intact in 
the mutant strains throughout the assay (Figure 2-4B inset), which indicates that the 
inability of these mutant strains to induce IL-8 expression is attributable to absence of 
either CagH or CagI, respectively, rather than instability of CagL. The ΔcagH and ΔcagI 
mutants were also defective in their ability to translocate CagA into gastric epithelial cells 
(Figure 2-4C).  The ability of these mutants to translocate CagA at levels comparable to 
WT was rescued by complementation with epitope-tagged versions of the corresponding 
proteins (Figure 2-4C).  These results indicate that CagH and CagI, similar to CagL, are 
required for proper function of the cag T4SS.  
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Localization of CagH, CagI, and CagL.   Since expression of CagH and CagI proteins 
in H. pylori has not been detected previously, we sought to analyze the subcellular 
localization of these proteins.   As a first approach, we investigated potential surface 
exposure of CagH, CagI, and CagL by analyzing the susceptibility of these proteins, as 
well as several controls, to digestion by proteinase K.   As expected, incubation of the 
intact bacteria with proteinase K was sufficient to cleave VacA, a protein known to be 
localized on the bacterial surface (Figure 2-6A) [112,113].   In contrast, carbonic 
anhydrase (CA), a protein known to have a periplasmic domain[115], was not 
susceptible to cleavage by proteinase K.  Similarly, CagV (a VirB8 homolog), which is 
predicted to have domains in the periplasmic space [79,80,125], was also resistant to 
cleavage by proteinase K (data now shown).   CagH-HA, CagI-FLAG, and CagL-HA 
were each susceptible to cleavage by proteinase K (Figure 2-6A), but in contrast to 
VacA, these three Cag proteins were incompletely digested.  This suggests that CagH, 
CagI, and CagL are present on the bacterial surface, and in addition, another pool of 
these proteins exists in a site that is not susceptible to the protease.  Consistent with the 
susceptibility of CagH-HA, CagI-FLAG, and CagL-HA to cleavage by proteinase K, 
surface exposure of all three proteins was detected by flow cytometry analysis (Figure 2-
6B).   
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Figure 2-6.  Localization of CagH and CagI. (A) Whole bacteria expressing CagL-HA, 
CagH-HA, or CagI-FLAG were harvested after 24 h of growth and subjected to 
proteolytic digestion by Proteinase K (PK).  Susceptibility to cleavage by Proteinase K 
was monitored by immunoblotting using antibodies against the appropriate epitope tags. 
As a control, cleavage of VacA (a surface-exposed protein) and carbonic anhydrase 
(CA, an inner membrane protein with a periplasmic domain) was monitored.  Heat shock 
protein (HspB) served as a loading control, and densitometry was performed as 
described in Methods.   Numbers above bands representing CagL-HA, CagH-HA, and 
CagI-FLAG indicate the percent of protein remaining after cleavage by PK. (B) Flow 
cytometry analysis indicates that CagL-HA, CagH-HA, and CagI-FLAG proteins are 
detectable on the bacterial surface.    
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Immunogold labeling studies also revealed localization of CagH-HA, CagI-FLAG, 
and CagL-HA on the surface of H. pylori (Figure 2-7).   Typically fewer than 10 gold 
particles per bacterial cell were visualized on the peripheral margins of bacteria, which 
suggests either that the number of CagH, CagI, and CagL proteins on the bacterial 
surface under these conditions is relatively small, or that there may be limitations with 
the use of these monoclonal antibodies for immunogold labeling.  
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Figure 2-7. Immunoelectron microscopy analysis of whole bacterial cells.  H. pylori 
strains were grown on blood agar plates and immunogold labeling was performed as 
described in Methods.  (A)  ΔcagH/CagH-HA, stained with anti-HA and gold-labeled 
secondary antibody.  (B) ΔcagI/CagI-FLAG, stained with anti-FLAG and gold-labeled 
secondary antibody.  (C)  ΔcagL/CagL-HA, stained with anti-HA and gold-labeled 
secondary antibody.  (D)  WT strain, stained with anti-HA and gold-labeled secondary 
antibody.  (E) WT strain, stained with anti-FLAG and gold-labeled secondary antibody.  
(F) WT strain, stained with secondary antibody only (representative image for all strains 
when treated with secondary antibody only).  Magnification bars indicate 100 nm.  
Arrowheads indicate location of gold-labeled secondary antibody. 
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As another approach for analyzing the subcellular localization of CagH, CagI, 
and CagL, H. pylori strains expressing CagH-HA, CagI-FLAG, or CagL-HA were 
sonicated and fractionated in the absence of detergent.   Soluble fractions (which are 
expected to contain cytoplasmic and periplasmic proteins) and total membrane fractions 
were analyzed by immunoblotting using monoclonal antibodies directed against the 
appropriate epitope tags.  In agreement with a previous report [80,92], the native form of 
CagL was localized mainly in the soluble fraction, and lesser amounts were present in 
the membrane fraction; similar results were observed for CagL-HA (Figure 2-8A, B, C).  
Both CagH-HA and CagI-FLAG were localized exclusively in the membrane fraction 
(Figure 2-8B, C).   The insolubility of CagH and CagI in this experiment compared to 
previous experiments is attributed to the absence of detergent in these fractionated 
samples and the presence of detergent in earlier samples.   We propose that, when 
complexed together, CagL is loosely tethered to membrane-associated CagH and CagI, 
and that in the absence of detergent, the shear forces or heat generated by sonication 
are sufficient to disrupt this interaction and solubilize CagL, but not CagH and CagI.  An 
additional possibility is that the CagH-CagI-CagL complexes include the relatively small 
portion of membrane-associated CagL.    
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Figure 2-8. Localization of CagL, CagH, and CagI in detergent-free lysates.  (A) 
Bacteria expressing epitope-tagged CagL (CagL-HA), (B) CagH (CagH-HA), or (C) CagI 
(CagI-FLAG) were fractionated into total membrane (M) and soluble (S) fractions as 
described in Methods.   CagL-HA, CagH-HA, CagI-FLAG, and untagged CagL were 
detected by immunoblotting.  As a control, fractions were immunoblotted with a 
monoclonal antibody that recognizes an H. pylori outer membrane protein (α-OMP) 
(Santa Cruz).    
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In summary, these experiments provide evidence that CagL, CagH, and CagI 
exist in multiple subcellular locations, including the surface of H. pylori.  The existence of 
these proteins in multiple subcellular locations potentially reflects multiple stages of 
T4SS assembly. Localization of CagL mainly to the soluble fraction as well as on the 
bacterial surface helps to reconcile apparent contradictions in previous publications, 
which reported CagL localization to either the soluble fraction or surface-exposed sites 
[64,66,80,92].    In agreement with a previous study [80], we propose that CagL exists 
mainly in a periplasmic pool, but it can also be associated with the outer membrane, 
perhaps loosely tethered to the cell surface.   Distribution of at least two other Cag 
proteins (Cag3 and CagY) into multiple pools with different localizations has been 
suggested previously [78,92].   Complexes comprised of CagH, CagI, and CagL could 
potentially exist in multiple sites, including the bacterial surface and the periplasm 
(where periplasmic CagL may interact with membrane-associated CagH and CagI 
proteins).   
Discussion 
One of the important mechanisms by which H. pylori infection leads to severe 
gastric disease is through the actions of the bacterial oncoprotein CagA [45,46,126]. 
Translocation of CagA into gastric epithelial cells occurs through a T4SS-mediated 
process and requires multiple proteins encoded by the cag PAI [42,43,79,97,125].  
Several H. pylori proteins required for CagA translocation are distantly related to 
components of T4SSs in other bacterial species and presumably have conserved 
functions [42,55,69,80].  Herein, we provide new insights into three components of the 
cag T4SS that lack homologs in other T4SSs – CagH, CagI, and CagL.    
Prior to the current study, it was known that CagL can bind α5β1 integrin and can 
cause several alterations in host cells [55,64,65,66,67]. CagL was localized in various 
studies to several bacterial subcellular sites, including a soluble bacterial fraction [80,92], 
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the bacterial surface [66], and pili on the surface of H. pylori [64].    We reasoned that 
CagL might physically interact with other T4SS components, and that such interactions 
might be required for CagL export, localization, stability, or activity.   Therefore, we 
conducted studies designed to identify H. pylori proteins that interact with CagL.  In initial 
experiments involving affinity purification of CagL, we observed a highly reproducible co-
purification of CagH and CagI with CagL, and we subsequently detected the same 
pattern of co-purification when either CagH or CagI was targeted for purification.  We 
detected evidence of CagH-CagI-CagL interactions not only in experiments involving 
bacteria grown in pure culture, but also in experiments involving H. pylori that were 
attached to gastric epithelial cells.  We were unable to undertake analysis of direct 
interactions among CagL, CagI and CagH because recombinant CagI and CagH could 
not be expressed in a soluble form under non-denaturing conditions.   However, several 
other results provided evidence of a physical relationship among these proteins.  
Specifically, CagL stability was decreased in the absence of either CagI or CagH, and 
co-purification of CagI or CagH with CagL was dependent on the presence of all three 
proteins.   All three proteins are required for functional activity of the cag T4SS, and all 
three proteins have a role in formation of pili at the interface between H. pylori and 
gastric epithelial cells.  Other intriguing relationships among these proteins include their 
linkage within a single operon in the cag PAI [121], and ability of both CagI and CagL to 
bind β1 integrin [64,65]. Collectively, the data suggest that CagL, CagI, and CagH are 
components of one or more T4SS subassemblies involved in pilus biogenesis.     
Recognition of the relationships among CagH, CagI, and CagL in the current 
study was facilitated by using immunoaffinity purifications and a robust multidimensional 
mass spectrometry protein identification technique. In comparison to traditional co-
immunoprecipitation experiments, which rely upon the availability of antibodies to detect 
potential interacting partners of a target protein by immunoblotting, the mass 
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spectrometry-based approach used in the current study allowed a comprehensive 
analysis that was not limited by the availability of antibodies. In addition, this approach 
affords advantages compared to two-hybrid screens, because it allows detection of 
interactions among native proteins expressed in H. pylori, as well as the potential to 
detect indirect secondary and tertiary interactions.   Analysis of the appropriate control 
strains allowed for assessment of non-specific protein interactions and statistical 
evaluation of results.    
 Prior to the current study, CagH and CagI had not been investigated in detail.  
Neither CagH nor CagI was detected in analyses of H. pylori using 2D gel proteomic 
methodology [81,127], and immunologic detection of CagI expression has been hindered 
by difficulty in raising antibodies against the protein [65].    Similarly, our efforts to raise 
polyclonal antisera against CagH or CagI proteins failed to yield antisera that recognized 
the appropriate antigens.   However, we were able to detect CagH and CagI expression 
by mass spectrometry, and we were also able to detect epitope-tagged forms of these H. 
pylori proteins.    One study reported that CagI was capable of binding β1 integrin in a 
yeast two hybrid assay, and CagI interactions with integrin were confirmed by analyzing 
binding of a CagI-GST fusion protein to cell lines deficient in β1 integrin or cell lines that 
had been genetically complemented with human β1 integrin [65].   Another study 
reported that H. pylori mutant strains containing transposon insertions in cagH or cagI 
were defective in their ability to translocate CagA into host cells, and that CagH (but not 
CagI) was required for induction of IL-8 synthesis and secretion by cultured gastric 
epithelial cells [55].  Herein, we report that cagH and cagI mutant strains were defective 
in both CagA translocation and IL-8 induction. The discrepancy in results pertaining to 
CagI and IL-8 induction might be attributable to differences in the mutagenesis methods 
utilized to generate ΔcagI isogenic mutants.  We analyzed unmarked strains containing 
deletions of the relevant cag genes, and complementation of the unmarked mutants 
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confirmed that CagH and CagI are required for CagA translocation and stimulation of IL-
8 secretion by cultured gastric epithelial cells. 
Localization analyses performed in the current study indicated that CagH, CagI, 
and CagL can all be exported to the surface of H. pylori, and in addition, provided 
evidence for the existence of non-surface-exposed pools of these proteins (Figures 2-6, 
2-8).  The existence of these proteins in multiple subcellular locations potentially reflects 
multiple stages of T4SS assembly.  Detection of CagL on the surface of H. pylori in the 
current study agrees with previous reports, which reported localization of CagL to either 
the bacterial surface or to pilus structures, based on immunogold EM staining [64,66].   
Other lines of evidence supporting a surface-exposed localization of CagI and CagL 
include the ability of both proteins to bind β1 integrin [64,65], signatures of positive 
selection in the genes encoding these two proteins, and the presence of a predicted 
signal sequence in both proteins (Figure 2-2A) [128].   The detection of a non-surface-
exposed pool of CagL in the current study is consistent with results of previous studies, 
which detected CagL in a soluble bacterial fraction consistent with the periplasm [80,92].   
Determining the subcellular site at which CagH, CagI, and CagL assemble into 
complexes is complicated by the presence of these proteins in multiple subcellular sites.  
All three proteins can localize to the bacterial surface, and this is one site where the 
formation of CagH-CagI-CagL complexes may be relevant.   In addition, since a large 
proportion of CagL is localized to a soluble fraction, it seems likely that periplasmic CagL 
may interact with membrane-associated CagH or CagI proteins that have domains in the 
periplasm.   We detected evidence of CagH-CagI-CagL complexes not only in pure 
bacterial cultures, but also in co-cultures of H. pylori with gastric epithelial cells (Tables 
2-1, 2-3, 3-2).   Since the CagH-CagI-CagL complexes were detected in pure bacterial 
cultures (which lack detectable surface pili), the complexes must clearly be localized to 
sites distinct from pili under these conditions.   
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Because CagH, CagI, and CagL are present on the surface of H. pylori under 
conditions in which the T4SS is not fully assembled, and CagA is not translocated, we 
speculate that these proteins are involved in biogenesis of the T4SS pilus structure 
when H. pylori is in contact with gastric epithelial cells.  The requirement of these unique 
surface-exposed Cag proteins in formation of the T4SS pilus structure sheds light on the 
dramatic differences that exist between the H. pylori T4SS and T4SSs of other Gram-
negative bacteria. 
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CHAPTER III 
 
ROLE OF UNIQUE HELICOBACTER PYLORI CAG PROTEINS IN BIOGENESIS OF 
THE TYPE IV SECRETION SYSTEM PILUS AT THE INTERFACE OF BACTERIA 
AND GASTRIC EPITHELIAL CELLS 
 
 
Introduction 
 
Surface-exposed pili are an important feature of T4SSs [69,93]. The T4SS pili of 
A. tumefaciens are comprised of VirB2 (the major pilin subunit), VirB5 (the minor pilin 
subunit), and the pilus-associated protein VirB7 [69,93,129].  In the Agrobacterium 
T4SS, the presence of the membrane-associated and surface-exposed T pilus structure 
is indispensable for delivery of the nucleoprotein complex cargo to its host cell.    VirB2 
is processed and cyclized via peptide bond linkage of the N- and C-terminal residues, 
generating the T pilin [129].  The T pilin subunits are exported across both bacterial 
membranes to the surface of the cell, where the pilin subunits are able to be assembled 
into a filamentous pilus structure having a diameter of approximately 10 nm [129].  All 11 
Vir proteins encoded by the vir operon are required for transport of the VirB2 pilin 
subunits to the surface of the bacteria.  However, processing and cyclization of VirB2 
propilin does not require the presence of any other Vir protein [129]. 
Thus far, the mechanisms by which the cag T4SS delivers CagA and 
peptidoglycan to the host cell in order to mediate myriad diverse effects are unknown.  
The possibility exists that in addition to CagA and peptidoglycan [43,46,56], multiple 
other H. pylori proteins can utilize the cag PAI-encoded T4SS as a conduit for delivery 
into the gastric epithelium.  In many Gram-negative pathogens, including Salmonella, 
Shigella, and Yersinia, a type III secretion system (T3SS) is exploited for delivery of 
multiple effector proteins to the host cell [130,131].  T3SSs purified from Salmonella and 
Shigella clearly contain a surface-exposed needle-like appendage which presumably 
serves to inject effector proteins directly into the cytoplasm of the recipient cell 
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[130,131,132].  Despite extensive characterization of T3SS apparatuses, including 
analysis by electron microscopy [131,132,133,134] and generation of atomic-scale 
resolution models of T3SS complexes by crystallization [131,135,136], only low 
resolution analyses of T4SS pilus organelles exist for the T pilus of Agrobacterium and 
pilus structures involved in bacterial conjugation [137,138]. 
When H. pylori is in contact with gastric epithelial cells, the bacteria express pili 
that are associated with the cag T4SS [64,92,94,95].  Relatively little is known about the 
composition and biogenesis of these H. pylori pili.  In contrast to T4SS pili from other 
bacterial species, the H. pylori T4SS pili are reported to be sheathed organelles [92].  H. 
pylori CagC is reported to be a VirB2 homolog [94], but there is not yet convincing 
evidence that CagC is a major component of H. pylori pili.   Several of the H. pylori 
proteins (CagY, CagT, and CagX) that have been localized to the pili by immunogold 
staining [92,95] are distantly related to core complex components in other T4SS (VirB10, 
VirB7, and VirB9, respectively).   H. pylori CagL has also been localized to pili by 
immunogold staining and it is suggested that it is a minor pilus component [64]; however, 
CagL and VirB5 do not exhibit any detectable sequence similarity.   Taken together, 
these findings suggest that the pili associated with the H. pylori cag T4SS are 
considerably different from the T4SS pili of A. tumefaciens and other known bacterial 
T4SSs.  
 Based on surface-exposure of CagH, CagI, and CagL in the absence of host cell 
contact, localization of CagL to a pilus structure formed when H. pylori is in contact with 
gastric epithelial cells, and a potential interaction of CagL and CagI with β1 integrin on 
the surface of gastric cells, we hypothesized that CagH, CagI, and CagL each have a 
role in biogenesis of the T4SS pilus.  Herein, we utilize scanning electron microscopy 
studies to reveal that CagI and CagL are required for formation of pili at the interface 
between H. pylori and gastric epithelial cells.  We demonstrate that a ΔcagH mutant 
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strain produces pili with a distorted morphology compared to the pili of wild-type 
bacteria.  This suggests that CagH functions as a regulator of pilus dimensions.  We 
identify a conserved flagellar hook protein K (FlgK) domain within the N-terminal region 
of CagH that may contribute to the ability of CagH to control T4SS pilus dimensions.  
Furthermore, we show that CagH, CagI, and CagL proteins contain a conserved C-
terminal hexapeptide motif that is critical for T4SS functionality, and in the case of CagI 
and CagL, this motif is required for T4SS pilus formation.   These studies highlight the 
important functions of these unique H. pylori cag T4SS components and illustrate the 
marked variation that exists among bacterial T4SSs. 
Methods 
Bacterial strains and growth conditions, AGS cell culture, mutagenesis of H. pylori, IL-8 
ELISA, CagA translocation assay, bacterial subcellular fractionation, and statistical 
analysis were performed as described in Chapter II.  
FESEM of H. pylori in contact with gastric epithelial cells. H. pylori and AGS human 
gastric cells were co-cultured at a MOI of 100:1 on tissue culture-treated coverslips (BD 
Biosciences) for 4 h at 37°C in the presence of 5% CO2.  Cells were fixed with 2.0% 
paraformaldehyde, 2.5% glutaraldehyde in 0.05M sodium cacodylate buffer for 1 h at 
37°C.  Coverslips were washed with sodium cacodylate buffer and secondary fixation 
was performed with 1% osmium tetroxide at room temperature for 2 h.  Coverslips were 
washed with sodium cacodylate buffer and dehydrated with sequential washes of 
increasing concentrations of ethanol.  Samples were then dried at the critical point, 
mounted onto sample stubs, grounded with a thin strip of silver paint at the sample edge, 
and sputter-coated with gold before viewing with a Zeiss Supra 35V FEG SEM.  Analysis 
of pilus dimensions and image analysis was performed using Image J software. 
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Results 
CagH, CagI, and CagL have key roles in T4SS pilus formation.  To investigate a 
possible mechanism by which CagH, CagI, and CagL might contribute to activity of the 
cag T4SS, we used scanning electron microscopy (FESEM) to analyze interactions of H. 
pylori with AGS gastric epithelial cells.   Specifically, we tested the hypothesis that 
CagH, CagI, or CagL might be required for formation of pili at the bacterial-host cell 
interface.    As expected, we detected pili at the interface between WT H. pylori and AGS 
cells (Figure 3-1A), and consistent with previous reports [64,92,95], these pili were not 
visualized when a Δcag PAI mutant (Figure 3-1B), cagT (virB7 homolog) mutant, or 
cagE mutant (data not shown) were co-cultured with AGS cells.  Adherent WT bacteria 
exhibited pili on surfaces that were contiguous to the epithelial cells, and we did not 
observe pili on non-adherent bacteria.  The dimensions of the pili were approximately 14 
nm in width and 65 nm in length (Table 3-1), and the pili were distributed along the 
lateral and polar surfaces of the bacteria. When co-cultured with AGS cells, neither the 
ΔcagL nor the ΔcagI mutant strains produced detectable pili (Figure 3-1C, F).  This 
defect was rescued by complementation of the ΔcagI and ΔcagL mutants (Figure 3-1D, 
E, G). 
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Figure 3-1.  Role of CagI and CagL in pilus formation.  WT H. pylori, mutant strains, 
and complemented mutant strains were co-cultured with AGS cells and then analyzed by 
FESEM. (A) WT. (B) Δcag PAI. (C) ΔcagL. (D) ΔcagL/CagL-HA. (E) High magnification 
of pilus structures observed in ΔcagL/CagL-HA (panel D). (F) ΔcagI. (G)  ΔcagI/CagI.  
Arrowheads indicate T4SS pilus structures. Magnification bars indicate 200 nm. 
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Table 3-1. Analysis of type IV secretion system pili a  
 
  Width (nm) Length (nm) Pili/cell 
WT 13.7 ± 2.4 65.1 ± 30.7 3.8 ± 2.6 
ΔcagH 21.5 ± 4.3 ***  115.1 ± 65.1 *** 8.0 ± 4.3 *** 
ΔcagH/CagH-HA 14.4 ± 2.8 65.6 ± 29.9 3.3 ± 2.9 
ΔcagH/CagH-HAΔCT 15.8 ± 5.1 53.4 ± 18.5 3.5 ± 2.7 
ΔcagI/CagI 15.7 ± 3.8 91.1 ± 46.1 3.1 ± 1.7 
ΔcagL/CagL-HA 14.6 ± 2.8 81.7 ± 27.2 3.8 ± 2.8 
a Quantification of pilus width, length, and number is based on a minimum of 2 biological 
replicates and a minimum of 5 representative micrographs containing a total of at least 20 
adherent H. pylori cells. 
***, p<0.001 compared to WT, based on two-tailed T-test analysis. 
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In contrast to the ΔcagI and ΔcagL mutant strains, the ΔcagH mutant strain was 
capable of producing pili.  However, there were several striking differences when 
comparing the ΔcagH mutant strain (Figure 3-2B, C, D, F) with the WT strain (Figure 3-
2A, E).   First, the number of pili produced by the ΔcagH mutant was significantly higher 
than the number of pili produced by the WT strain (8.0 ± 4.3 vs. 3.8 ± 2.6 visible pili per 
adherent bacteria, p <0.0001) (Table 3-1).    Second, the length of pili produced by the 
ΔcagH mutant was significantly greater than that of pili produced by the WT strain (115.1 
± 65.1 nm vs. 65.1 ± 30.7 nm, p <0.0001).  Third, the width of pili produced by the 
ΔcagH mutant was significantly greater than that of pili produced by the WT strain (21.5 
± 4.3 nm vs. 13.7 ± 2.4 nm, p <0.0001).    A complemented ΔcagH mutant strain 
produced pili that were indistinguishable from the pili produced by the WT strain (Figure 
3-2G and Table 3-1).  These results suggest that CagH may be a regulator of pilus 
dimensions.  As considered further in the Discussion, an analysis of highly conserved 
domains within CagH (Figure 3-2H) provides clues into possible mechanisms by which 
CagH controls dimensions of the H. pylori T4SS pilus. 
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Figure 3-2. Analysis of pili formed by a ΔcagH mutant strain. WT H. pylori, a ΔcagH 
mutant, and a complemented mutant (ΔcagH/CagH-HA) were co-cultured with AGS cells 
and then analyzed by FESEM. (A) WT strain. (B, C, D) Multiple images of the ΔcagH 
mutant.  (E) High magnification of panel A (WT strain). (F) High magnification of panel B 
(ΔcagH mutant). (G) ΔcagH/CagH-HA.  Magnification bars indicate 200 nm.  (H)  Use of 
a position-specific scoring matrix (PSSM) within the NCBI Conserved Domain Database 
[139] identified a conserved flagellar hook protein K (FlgK) domain in CagH.  The 
alignment compares the region of CagH corresponding to the FlgK domain, FlgK domain 
sequences of Burkholderia spp., and sequences of two members of the flagellar hook 
superfamily that function as molecular rulers  (FliK from Salmonella and YscP from 
Yersinia) [140,141,142,143].  Arrows above the alignment indicate three portions of the 
FlgK domain identified in CagH.  
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In all of the initial experiments (Tables 2-1, 2-3, 2-6), interactions among CagH, 
CagI, and CagL were detected in H. pylori that were cultured in the absence of gastric 
epithelial cells.  Our electron microscopy experiments indicate that pili associated with 
the cag T4SS are not detected when the bacteria are cultured in the absence of gastric 
epithelial cells (data not shown), and in agreement with previous reports [64,92], we 
found that contact of H. pylori with gastric epithelial cells stimulates the formation of pili 
that are associated with the cag T4SS.   This suggests that the cag T4SS is not yet fully 
assembled when bacteria are cultured in the absence of gastric epithelial cells.  To 
determine whether interactions among CagH, CagI, and CagL are detectable under 
conditions in which the cag T4SS is fully assembled, we sought to detect the presence 
of this subassembly in H. pylori that are co-cultured with gastric epithelial cells.   We co-
cultured bacteria expressing CagH-HA with AGS cells, affinity purified CagH-HA from 
adherent bacteria, and then analyzed the protein content of the affinity purified 
preparation. Wild-type bacteria were co-cultured with AGS cells and were processed in 
parallel as a control. As shown in Table 3-2, we again observed co-purification of CagH, 
CagI, and CagL.   Therefore, a CagH-CagI-CagL subassembly is detectable not only 
when bacteria are cultured in the absence of gastric epithelial cells, but also under 
conditions in which the cag T4SS is fully assembled.    
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Table 3-2.  Co-purification of CagH, CagI, and CagL from H. pylori attached to 
gastric epithelial cells 
 
anti-HAb 
Gene Number a Protein WT CagH-HA 
HP0539 CagL 0 24 *** 
HP0540 CagI 0 25 *** 
HP0541 CagH 0 20 ** 
HP0527 CagY 0 2 
Total Spectral Counts 35 220 
a Based on the H. pylori 26695 genome annotation  
b An H. pylori strain expressing CagH-HA and a WT strain were each co-cultured with AGS cells for 5 h.  
CagH-HA was affinity purified using an anti-HA antibody, and the WT co-culture sample was processed 
in parallel as a control.  The Table shows numbers of spectral counts observed by MudPIT analysis for 
each identified Cag protein.   
** p<0.01; *** p<0.001 when compared to WT control, according to the G-test likelihood ratio, post-
spectral count normalization.  
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Since CagL was previously detected as a pilus component [64], we hypothesized 
that CagI and CagH might also localize to pili.  To test this hypothesis, we used scanning 
EM and immunogold labeling studies to analyze H. pylori that were co-cultured with 
gastric epithelial cells.   Using this approach, we were unable to detect localization of 
CagH or CagI to the pili, and we were also unable to detect CagH or CagI in any other 
sites.   Since we were able to detect surface localization of CagH, CagI, and CagL in 
transmission EM experiments and flow cytometry experiments but not FESEM 
experiments, there are probably limitations associated with the use of these monoclonal 
antibodies for immunogold labeling in the context of FESEM.  Specifically, the FESEM 
methodology requires multiple extra washing steps (a series of seven sequential ethanol 
dehydration steps and three liquid carbon dioxide washing steps) that are not required 
for transmission EM, and monoclonal antibodies often are considered suboptimal 
compared to polyclonal antisera for immunogold EM studies [144].         
Analysis of a conserved C-terminal motif.  Careful inspection of the sequences of 
CagH, CagI, and CagL revealed that all three proteins contain a conserved C-terminal 
motif (Figure 3-3) consisting of the distal six amino acids of each protein.   The C-
terminal motifs of CagH, CagI, and CagL are encoded by divergent DNA sequences 
(Figure 3-3).   
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Figure 3-3.  Identification of a conserved C-terminal motif in CagH, CagI, and 
CagL.  A conserved 6-amino acid C-terminal motif is present in CagH, CagI, and CagL 
(WebLogo [145]).   Numbers indicate position of the amino acid residue from the C-
terminus of CagH, CagI, or CagL.   This C-terminal motif is encoded by divergent DNA 
sequences in cagH, cagI, and cagL.    
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To investigate whether this C-terminal motif is functionally important, we 
generated H. pylori mutant strains expressing forms of CagH, CagI, or CagL in which 
this hexapeptide motif was deleted, as described in Methods.  Deletion of the C-terminal 
motif individually in CagH, CagI, and CagL resulted in reduced levels of the mutated 
proteins compared to levels of the corresponding WT proteins (Figure 3-4A), along with 
a marked reduction in ability of the mutant bacteria to induce IL-8 secretion by AGS cells 
(Figure 3-4B) and  abolishment of CagA translocation (Figure 3-4C).   
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Figure 3-4.  Functional analysis of a conserved C-terminal motif in CagH, CagI, 
and CagL.  (A) Immunoblot analysis of mutants expressing C-terminally truncated forms 
of CagL, CagH-HA, or CagI-FLAG, each lacking a six-residue C-terminal motif.  
CagLΔCT was expressed from the endogenous cagL locus in the cag PAI, and CagH-
HAΔCT and CagI-FLAGΔCT were expressed from the ureA locus.   CagL expression 
was detected with anti-CagL serum, CagH-HA expression was detected with an anti-HA 
monoclonal antibody, and CagI-FLAG expression was detected with an anti-FLAG 
antibody.   Truncated forms of CagL, CagH, and CagI were detected in each of the 
mutant strains, but the levels of the truncated proteins were reduced compared to levels 
of the full-length proteins.  (B)  AGS cells were co-cultured with WT H. pylori or the 
indicated mutants, and IL-8 expression was analyzed by ELISA as described in 
Methods.  Values from six replicate samples were compared to the wild-type control by 
ANOVA followed by Dunnett's post hoc correction; # indicates p<0.05. (C) AGS cells 
were co-cultured with WT H. pylori or the indicated mutants, and tyrosine-
phosphorylated CagA was detected with an anti-phosphotyrosine antibody (α-PY99).  
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In contrast to wild-type CagH-HA and CagI-FLAG, which each localize to the 
membrane fraction (Figure 2-8 and 3-5A), CagH-HAΔCT and CagI-FLAGΔCT are 
partially mislocalized to the soluble fraction (Figure 3-5A).  Furthermore, in the absence 
of the C-terminal motif of CagH-HA or CagI-FLAG, CagL stability is markedly reduced at 
the 48 h growth timepoint compared to CagL stability at the 24 h growth timepoint 
(Figure 3-5B).  This result further supports the conclusion that CagH, CagI, and CagL 
are all members of a protein subassembly.    
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Figure 3-5.  Localization of C-terminally truncated CagH and CagI.  (A) Bacteria 
expressing CagH-HA, a C-terminally truncated form of CagH-HA (CagH-HAΔCT), CagI-
FLAG, or a C-terminally truncated form of CagI (CagI-FLAGΔCT) were fractionated into 
total membrane (M) and soluble (S) fractions as described in Methods, and the tagged 
proteins were detected by immunoblotting.   Intact CagH-HA and CagI-FLAG proteins 
were detected mainly in the membrane fraction.   Deletion of the C-terminal motif from 
CagH-HA (CagH-HAΔCT) or CagI (CagI-FLAGΔCT) results in partial mislocalization of 
these proteins to the soluble fractions. (B) Bacteria expressing C-terminally truncated 
CagH (CagH-HAΔCT) or CagI (CagI-FLAGΔCT) were cultured for 24 or 48 h prior to 
lysis and immunoblotting to detect CagL.  HspB was monitored as a loading control.  
CagL levels are markedly reduced at 48 h of growth in strains expressing truncated 
CagH or CagI, compared to strains expressing full-length proteins.   
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Finally, we conducted experiments to determine whether the C-terminal motifs 
found in CagH, CagI, and CagL were required for formation of pili at the interface 
between H. pylori and gastric epithelial cells.   Mutant strains lacking the C-terminal motif 
in CagH, CagI, or CagL were co-cultured with AGS cells, and the samples were then 
analyzed by FESEM.    Bacteria expressing CagI-FLAGΔCT or CagLΔCT each failed to 
produce detectable pili (Figure 3-6C, D), and thus had a phenotype indistinguishable 
from ΔcagI and ΔcagL mutants (Figure 3-6).   Bacteria expressing CagH-HAΔCT 
expressed pili that were indistinguishable from those produced by the WT strain (Figure 
3-6A, B and Table 3-1).   Despite producing normal-appearing pili, the CagH-HAΔCT 
mutation rendered the cag T4SS non-functional (Figure 3-4B, C).  These experiments 
reveal that physical contact of the T4SS secretion pilus with gastric epithelial cells is not 
sufficient to induce IL-8 production, and indicate that the C-terminal motif present in 
CagH, CagI, and CagL is critical for functionality of the T4SS.  
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Figure 3-6.  The C-terminal motif of CagI and CagL is required for pilus formation. 
WT H. pylori or mutant strains expressing C-terminally (CT) truncated forms of CagH, 
CagI, or CagL were co-cultured with AGS cells and imaged by FESEM. (A) WT. (B) 
CagH-HAΔCT. (C) CagI-FLAGΔCT. (D) CagLΔCT.  Magnification bars indicate 200 nm. 
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Discussion 
Herein, we describe the requirement for both CagL and CagI are required for 
formation of T4SS pili.  Complementation of ΔcagL and ΔcagI mutant strains resulted in 
restoration of pilus formation and T4SS function. In previous studies, CagY, CagT, and 
VirB11 ATPase were reported to be required for formation of pili [64,92,95], but the role 
of these proteins in H. pylori pilus formation has not yet been verified by testing of 
complemented mutant strains. CagT, CagY, and the VirB11 ATPase are each 
homologous to proteins found in T4SSs of other bacteria, but in contrast, CagI and CagL 
do not have homologues in other T4SSs.   
A previous study used immunogold labeling methods and polyclonal antiserum to 
detect localization of CagL to pilus structures [64].  We were unable to detect localization 
of CagH or CagI to pilus structures, probably due to limitations associated with the use 
of monoclonal antibodies for immunogold labeling in the context of scanning electron 
microscopy.  Specifically, the FESEM methodology requires multiple extra washing 
steps (a series of seven sequential ethanol dehydration steps and three liquid carbon 
dioxide washing steps) that are not required for transmission EM, and monoclonal 
antibodies often are considered suboptimal compared to polyclonal antisera for 
immunogold EM studies  [144].    Therefore, at present it is not known whether CagL 
localization to pili requires dissociation of CagL from CagH and CagI, or whether all 
three proteins eventually localize to pili.        
Interestingly, a ΔcagH mutant strain was hyperpiliated and expressed pili that 
were elongated and thickened in comparison to pili of the WT strain.     The increased 
number of pili visualized in images of the ΔcagH mutant strain might be attributable to 
their increased thickness and decreased fragility, resulting in a greater likelihood that the 
structures are preserved and visualized. Complementation of the ΔcagH mutant strain 
resulted in production of pili with a WT morphology. These results suggest that CagH is 
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a regulator of pilus dimensions.  Analysis of the CagH sequence using a conserved 
domain database search (NCBI) [139] indicates that it contains a flagellar hook-
associated protein (FlgK) domain (PRK06945) (Figure 3-2H).  The FlgK domain within 
CagH is most closely related to the corresponding domains found in FlgK proteins of 
Burkholderia spp., rather than the corresponding domain found in H. pylori FlgK.   The 
FlgK domain in CagH also exhibits similarity to portions of the FliK flagellar protein of 
Salmonella and the YscP type III secretion system protein of Yersinia pestis, two 
proteins that are known to be determinants of either flagellar hook length 
[140,141,142,146,147,148] or type III secretion system needle length [143].   We 
speculate that, analogous to the role of FlgK (a flagellar hook-junction protein) in 
terminating flagellar hook assembly, CagH may have a role in terminating pilus 
assembly.  Alternatively, analogous to FliK and YscP, CagH may serve as a molecular 
ruler to control the dimensions of cag T4SS pili in H. pylori.   It will be important in future 
studies to dissect the molecular mechanisms by which CagH regulates pilus dimensions.    
Similar to previous studies [64,92,94,95], we observed that H. pylori contact with 
gastric epithelial cells stimulated the production of pili, and in agreement with previous 
studies [64,95], we observed that Δcag PAI mutant, ΔcagT mutant, and ΔcagE mutant 
strains failed to produce pili.   However, the dimensions of the pili visualized in the 
current study differed from what was reported in a previous study.   Specifically, a 
previous study [92] reported that the pili were between 45 and 75 nm in width, 
depending on presence or absence of a sheath structure, whereas in the current study, 
we found that the pili were much thinner.   The same strain of H. pylori was used in both 
studies, so this difference is probably not attributable to strain-dependent variation.    We 
speculate that the difference in reported dimensions might be attributable to differences 
in methods for scanning EM, such as the use of a relatively thin layer of gold in the 
current study and a thicker layer of coating in the previous study.   
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 A striking feature shared by CagH, CagI, and CagL is a conserved C-terminal 
hexapeptide motif (Figure 3-3).   This C-terminal motif is not found in any other protein 
encoded by H. pylori strain 26695.   We show that this motif is required for functional 
activity of the T4SS, and that the C-terminal motifs of CagI and CagL are required for 
pilus formation.  Deletion of the C-terminal motif leads to partial mislocalization of CagH 
and CagI to a soluble fraction instead of a membrane fraction (Figure 3-5A).  Based on 
the observed mislocalization of C-terminally truncated CagH and CagI proteins, we 
hypothesize that this C-terminal motif plays a role in protein sorting or localization.  In 
several other bacterial species, C-terminal motifs are required for recognition of proteins 
by the T4SS machinery.  For example, RalF, an effector molecule of the Legionella 
Dot/Icm system, has a C-terminal motif consisting of hydrophobic residues flanked by 
lysine/arginine moieties [149].  Mutagenesis studies indicated that deletion of the distal 3 
terminal amino acid residues of RalF leads to loss of recognition by the T4SS 
machinery, and thus loss of translocation [149].  C-terminal translocation signals in T4SS 
substrates also have been detected in A. tumefaciens and Bartonella henselae 
[150,151].  In a similar manner, we propose that the conserved C-terminal motifs in 
CagH, CagI, and CagL target these proteins to appropriate sites within the H. pylori 
T4SS.  Interestingly, a mutant strain expressing a C-terminally truncated form of CagH 
produced normal-appearing pili, but this strain was nevertheless defective in both CagA 
translocation and ability to stimulate IL-8 induction.  This result reveals that contact of H. 
pylori pili with the AGS cell surface is not sufficient to induce IL-8 production. 
T4SSs are a diverse collection of macromolecular machines, found in a broad 
phylogenetic range of bacteria.   It has been proposed that all T4SSs employ a common 
mechanism for secretion across the cytoplasmic membrane, and that diversity has 
arisen primarily as a consequence of variation in the types of cell envelopes that must be 
spanned, along with variation in donor-host cell interactions [70].  Our current 
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understanding of the architecture of T4SSs is based on elegant work with several model 
systems, including the VirB/VirD4 system of A. tumefaciens and several plasmid 
conjugation systems.    There are limitations, however, when comparing these model 
systems with the T4SSs found in distantly related bacteria.   Several components of the 
H. pylori cag T4SS are distantly related to components of the VirB/VirD4 system, and as 
highlighted in the current study, other key constituents of the cag T4SS lack homology to 
components of T4SSs in other bacterial species.    In addition to the three H. pylori 
proteins analyzed in the current study, cag T4SS functionality probably requires at least 
six other proteins that lack homology to VirB/VirD4 proteins [55].    In future studies, it 
will be important to investigate the functional roles of these proteins in further detail, and 
from a broader perspective, it will be important to investigate the structural correlates of 
biological diversity among T4SSs.     
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CHAPTER IV 
 
FURTHER STUDIES OF THE HELICOBACTER PYLORI CAG TYPE IV SECRETION 
SYSTEM 
  
 
Introduction 
The cag pathogenicity island-encoded T4SS of H. pylori differs considerably from 
the prototypical T4SS found in the plant pathogen Agrobacterium.  The Agrobacterium 
T-DNA transfer system is comprised of 11 essential components (VirB1-VirB11) and one 
essential accessory protein (VirD4) that is utilized during recognition and delivery of 
translocation substrate to the T4SS apparatus [69,129].  The cag T4SS is distantly 
related to T4SSs found in many other bacteria, and only a few of the predicted 27 cag 
genes encode components have recognizable sequence similarity to Vir proteins [7,55].  
Only the ATPases CagE (VirB4) and VirB11 homolog, the presumed structural 
components CagX (VirB9) and CagY (VirB10), and the coupling protein Cag5 (VirD4) 
have obvious homology to Vir components [79,125].  However, the VirB10 homolog 
CagY is much larger than its counterpart in the Agrobacterium T4SS, and contains 
numerous repeated sequences that are not present in the sequence of VirB10 
[96,125,152].    
In addition to the use of DNA and protein sequence similarity to identify T4SS 
protein homologs in the Cag T4SS, protein topology predictions, functional studies, and 
protein localization studies have also been employed to identify and analyze VirB 
homologs.  Based on these analyses, it is suggested that the Cag T4SS contains 
homologs to the lytic transglycosylase VirB1 (Cag4), the major pilin VirB2 (CagC), the 
minor pilus component VirB5 (CagL), and the structural components VirB8 (CagV), 
VirB7 (CagT), and VirB6 (CagW) [80,94,153,154,155]. 
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The current model of assembly of the Cag T4SS is based largely on studies of 
T4SS assembly in other bacterial species.  Recently, structural details of the core 
complex of a conjugative T4SS have emerged with determination of the crystal structure 
encoded by the E. coli plasmid pKM101 [68,156].  The core complex of this T4SS was 
determined to contain 14 monomers of each component VirB7 (CagT), VirB9 (CagX), 
and VirB10 (CagY) [68].  Assembly of this core complex was not dependent upon the 
presence of additional Vir homologs [68].  Based on the presence of homologs to these 
Vir components in the Cag T4SS, it is reasonable to presume that assembly of the H. 
pylori T4SS core complex assembles in a manner similar to the pKM101 conjugative 
T4SS [125]. 
Assembly of the T4SS core complex in H. pylori is likely to occur under basal 
conditions (i.e., bacteria cultured in the absence of gastric epithelial cells), but it is 
unlikely that the T4SS would assemble constitutively in the absence of host cell contact.  
Based on what is observed in Agrobacterium, it seems possible that assembly and 
localization of the cag T4SS may occur preferentially at either the bacterial pole or along 
the lateral surface.  In Agrobacterium, assembly of the T4SS occurs in a spatial manner, 
with the polar positioning of the secretion system directed by the action of the nucleating 
factor VirB8 [157], potentially through the action of the transglycosylase VirB1 [70].  
CagV, the VirB8 homolog in H. pylori, may contribute to formation or preferential 
localization of the Cag T4SS in a similar manner [125].  CagV may act as a nucleator by 
interacting with core components that are required for their proper localization and 
activity.  
Formation of the inner channel of the T4SS is thought to require additional 
essential components.  One component predicted to be required for formation of the 
secretion system channel which opens to the cytoplasmic space is the VirB6 homolog 
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CagW [80].  CagW is thought to contain several transmembrane helices, with a 
presumed localization to the inner membrane [80].  Another essential component of the 
Cag T4SS is CagU [55].  CagU does not have a homolog in other bacterial T4SSs.  It is 
also predicted to be localized to the inner membrane [125], where it may be involved in 
formation of the secretion channel.  CagH has been previously predicted to be localized 
to the inner membrane and is speculated to be involved in channel formation [80].  
However, we have previously demonstrated surface-exposure of CagH (Chapter II) 
[158].  This observation does not preclude the possibility that CagH is involved in 
forming the secretion system channel, and may be localized to several sites within the 
T4SS apparatus.  Functional studies of proteins potentially involved in secretion system 
channel formation, such as CagU and CagW, have not been performed. 
One of the most striking differences that exists between the H. pylori Cag T4SS 
and virulence-associated T4SSs of other bacterial species is the observation that CagA 
is the only protein effector that is translocated by the cag T4SS into the host cell [69].  In 
contrast, virulence-associated T4SSs of other bacteria are known to translocate multiple 
protein effectors, or nucleoprotein complexes [69].  Although multiple host cellular 
consequences can be attributed to interactions of CagA with host proteins 
[42,43,45,46,47], the mechanism by which H. pylori injects the CagA oncoprotein into 
the cytoplasm of the host cell is largely unknown.  Like other T4SS effector proteins [70], 
CagA contains a C-terminal translocation signal comprised of approximately 20 largely 
basic residues [122].  In contrast to other T4SS effector proteins, the C-terminal 
translocation signal of CagA is necessary but not sufficient for translocation [125].   
CagA must be directed to the secretion system channel in order to be 
translocated.  There are multiple essential Cag proteins known to be localized to the 
bacterial cytoplasm, any of which may serve as a CagA translocation signal recognition 
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protein.  One of these proteins, CagF, is believed to be the chaperone-like molecule, 
based on numerous protein-protein interaction studies [89,122]. Although CagF interacts 
with approximately 100 residues of in the C-terminal region of CagA, the predicted C-
terminal translocation signal of CagA is not encompassed within the CagF-interacting 
region [122].  This suggests that other Cag proteins required for CagA translocation may 
be involved in recognizing the C-terminal secretion signal of CagA.  Two possible 
proteins that may fulfill such a role are CagZ and the coupling protein homolog Cag5 
[90].  The most likely scenario for recognition of the CagA C-terminal translocation signal 
involves interaction of the coupling protein Cag5 with CagA, as Cag5 is required for 
CagA translocation, but is not necessary for stimulation of IL-8 synthesis and secretion 
by cultured gastric epithelial cells [55,60].  Furthermore, Cag5 has been reported to 
interact with core components of the T4SS apparatus [81].  Similar to coupling proteins 
in other T4SSs, Cag5 has ATPase activity and contains several transmembrane helices, 
with a C-terminal segment that protrudes into the cytoplasm [80].  The positioning of the 
coupling protein at the base of the T4SS apparatus supports the view that it has a role in 
controlling T4SS substrate specificity. 
In contrast to the process of nucleoprotein complex translocation in the 
Agrobacterium T4SS, the molecular mechanism of CagA translocation through the H. 
pylori Cag T4SS remains largely uncharacterized.  Interactions of nucleoprotein complex 
with structural components of the Vir T4SS have been well defined [159].  Although 
homologous structural components exist in the cag T4SS, the vast differences between 
Cag proteins and their counterparts in Agrobacterium, as well as the presence of many 
additional proteins in the Cag T4SS that have no homologous components in other 
T4SSs [7,55], suggests that the CagA translocation process varies considerably from 
that of nucleoprotein delivery.  Many Cag protein interactions with other Cag proteins 
 
 
89 
 
that have been identified in yeast 2-hybrid assays [64,81,90] have not been validated in 
H. pylori.  Furthermore, it is unclear whether the T4SS pilus structure is utilized as a 
conduit for CagA and peptidoglycan translocation, or if the pilus is simply required during 
infection to draw the bacteria closer to the surface of the host epithelial cell prior to 
release and delivery of CagA.  Surprisingly, the composition of the pilus structure itself 
has not been conclusively determined.  Analysis of CagA protein-protein interactions 
during transport into the host epithelial cell may help to elucidate the architecture and 
topology of the T4SS apparatus. 
This chapter describes the use of chemical cross-linking, immunoaffinity 
purification, and mass spectrometry strategies to provide further insights into the 
structural organization of the cag T4SS.  As one approach, we conducted experiments to 
identify CagA protein interactions occurring in H. pylori in the context of bacteria-host cell 
contact.  We identify several CagA interactions occurring in bacteria in contact with the 
host cell that differ from interactions of CagA in bacteria that have not been co-cultured 
with gastric epithelial cells. In another series of experiments, we analyze the suspected 
inner channel component CagU.  The experiments presented in this chapter provide 
evidence suggesting that CagU may homodimerize during T4SS apparatus assembly, 
and we identify candidate proteins with which CagU may interact.  Finally, we describe 
experiments designed to elucidate the composition of the cag T4SS pilus organelle.  The 
findings presented in this chapter provide the foundation for additional studies directed 
toward understanding the assembly of the cag PAI-encoded T4SS, as well as the 
molecular mechanism by which the oncoprotein CagA is translocated into the host 
gastric cell. 
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Methods 
Bacterial strains and growth conditions, AGS cell culture, mutagenesis of H. pylori, and 
bacterial subcellular fractionation were performed as described in the Methods section of 
Chapter II.  
Reversible cross-linking of whole bacteria cells.  H. pylori were grown for 48 h on blood 
agar prior to harvesting.  Bacteria were washed once in 1X PBS, and whole cells were 
pelleted by centrifugation at 5,000 rpm for 10 min.  Cells were re-suspended in 1 ml PBS 
containing 0.5 mM Dithiobis[succinimidyl propionate] (DSP).  Cells that remained un-
cross-linked were mock treated by addition of 50 µl dimethyl sulfoxide (DMSO) 
[equivalent to the volume of DSP] to the PBS.   Cross-linking occurred by incubation at 
room temperature with constant rotation.  At the end of the incubation, cross-linking was 
quenched by addition of 20 mM Tris, final concentration, for 15 min with constant 
rotation.  Whole cells were pelleted at the end of the quenching reaction by 
centrifugation at 7,000 x g for 5 min.  Cell pellets were lysed by re-suspension in 1 ml 
RIPA buffer (10 mM Tris, 100 mM NaCl, 1% NP-40, 0.25% deoxycholic acid, Complete 
Mini EDTA-free Protease Inhibitor (Roche), pH 7.2), and 5 pulses of sonication on ice 
(10 s each pulse).  Complete cell lysis occurred overnight at 4°C in RIPA buffer.  Cellular 
debris was removed by high speed centrifugation. Immunoaffinity purification of Cag 
protein from bacterial lysate was performed using polyclonal anti-CagA antibodies that 
had been covalently cross-linked to a Protein G support (Dynal, Invitrogen), or anti-HA 
monoclonal antibodies (Sigma) immobilized to a Protein G support (Dynal, Invitrogen).  
Target proteins were immunoaffinity purified at room temperature.  Immunoaffinity 
purified proteins were washed in 100 bed volumes of PBS containing 0.1% Tween-20 
(PBST 0.1%).  Binding partners of CagA were eluted by incubation of the beads in 50 
mM DTT for 1 h at 37°C with constant rotation to reverse the DSP cross-links.  
Immunoaffinity-purified CagA was eluted from the bead by boiling in 1X SDS buffer (0.3 
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M Tris-HCl, 1% SDS, 10% glycerol, 100 mM DTT, Pierce) for 5 min.  Purified CagU-HA 
complexes were eluted from the anti-HA beads by HA peptide competition (20 µg/ml HA 
peptide (Sigma), final concentration).  In each case, the presence of the targeted protein 
in the immunoaffinity purified sample was verified by immunoblotting.   
Reversible cross-linking of H. pylori attached to gastric epithelial cells.  H. pylori was co-
cultured with AGS cells (80% confluent) at an MOI of 100 for 5 h prior to removal of 
unattached bacteria by several washes of the monolayer with 10 ml PBS.  Cross-linking 
of H. pylori and AGS cells occurred by addition of 2 ml PBS containing 0.5 mM DSP per 
flask (2 x 107 AGS cells per flask) for 30 min at room temperature.  The cross-linking 
reaction was quenched by addition of Tris (20 mM final concentration) to each flask for 
15 min with occasional agitation.  The cross-linking solution was removed, and the 
cross-linked monolayers were washed once in PBS to remove any detached AGS cells. 
Differential lysis of eukaryotic cells cross-linked to H. pylori. H. pylori were added to AGS 
monolayers at an MOI of 100, and were subsequently cross-linked surface of AGS cells, 
as previously described. The cross-linked monolayers were treated with 0.05% saponin.  
Monolayers were harvested by mechanical disruption, and eukaryotic cells were lysed 
occurred at room temperature for 10 min with constant rotation.  Cellular debris and H. 
pylori were separated from the soluble eukaryotic fraction by centrifugation at 5,000 x g 
for 5 min.  
Shearing of H. pylori surface structures.  H. pylori that had been co-cultured and 
chemically cross-linked to the surface of AGS cells were pelleted by centrifugation at 
5,000 x g for 5 min following differential lysis of the eukaryotic cells.  The bacterial pellets 
were gently re-suspended in 1 ml of 1X PBS.  Shearing of H. pylori surface structures 
was performed by passage of the re-suspended bacterial pellets three times through a 
25 gauge needle.  The bacterial suspension was the centrifuged at 13,000 x g for 5 min 
to separate the bacterial fraction (pellet) from the surface structure-enriched fraction 
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(supernatant).  Proteins in the sheared fraction were concentrated by precipitation using 
20% trichloroacetic acid (TCA).  The presence of suspected pilus components was 
analyzed by immunoblotting of the precipitated protein samples.  Proteins present in the 
sheared fraction were analyzed by MudPIT mass spectrometry.   
Purification of CagA from cross-linked H. pylori.  Bacterial pellets remaining after 
shearing of surface structures were lysed by sonication in RIPA buffer (5 pulses each 
pellet, 10 s each pulse), followed by overnight incubation with constant rotation at 4°C.  
CagA was immunoaffinity purified from the cross-linked bacteria lysates as previously 
described in the Methods.  Proteins interacting with CagA were eluted by incubation of 
the beads in 50 mM DTT [160], and CagA was eluted from the beads by boiling in 1X 
SDS buffer.  The presence of CagA and its interacting partner CagF was verified by 
immunoblot.  Additional proteins that interact with CagA were identified by mass 
spectrometry as described in Chapter II.   
Results 
Chemical cross-linking and immunoaffinity purification of T4SS complexes 
containing CagU.  CagU, a 25 kDa protein that is required for the translocation of CagA 
and induction of IL-8 synthesis and secretion [55], has no homologous component in 
T4SSs of other bacterial species.  It is predicted to contain several transmembrane 
helices, and is thought to be localized to the inner bacterial membrane.  We 
hypothesized that CagU interacts with other components of the cag T4SS to form one or 
more subassemblies that are required for formation of the T4SS apparatus.  Therefore, 
we sought to identify H. pylori proteins that co-purify with CagU.   To facilitate these 
studies, CagU was expressed in H. pylori with an N-terminal HA epitope tag, as 
described in the Methods section (Chapter II), using a system in which CagU-HA was 
expressed from the ureA locus in WT 26695.  Expression of CagU-HA of the expected 
size was verified by immunoblot of whole cell lysate using monoclonal anti-HA.  A single 
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band corresponding to the predicted molecular mass of CagU (approximately 25 kDa) 
was detected in SDS lysate of CagU-HA-expressing bacteria, but not an SDS lysate of 
WT bacteria (Figure 4-1).  Integration into the chromosomal ureA locus was verified by 
PCR amplification of the relevant region from 26695/CagU-HA genomic DNA, followed 
by sequencing of the PCR product.   
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Figure 4-1.  Immunoaffinity purification of CagU-HA from whole cell lysate.  N-
terminally epitope-tagged CagU-HA was expressed from the ureA locus in WT H. pylori.  
A single band corresponding to the predicted molecular mass of CagU (25 kDa) can be 
detected in whole cell lysate derived from bacteria expressing CagU-HA (CagU-HA 
lysate).  Immunoblot analysis of CagU-HA that had been immunoaffinity purified from 
bacterial lysate by monoclonal anti-HA (CagU-HA anti-HA) contains two distinct bands 
corresponding to molecular masses of approximately 25 and 45 kDa.  
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As a next step, CagU-HA was immunoffinity purified using monoclonal anti-HA 
immobilized to a Protein G support, and eluted from the antibody by HA peptide 
competition.  Immunoaffinity purification of CagU-HA was confirmed by immunoblot 
(Figure 4-1).  In contrast to whole cell lysate in which a single band corresponding to the 
predicted molecular mass of CagU-HA was detected, two distinct bands were detected 
by monoclonal anti-HA immunoblot of preparations of purified CagU-HA (Figure 4-1).  In 
addition to the band corresponding to the CagU-HA monomer in whole cell lysate at 
approximately 25 kDa, a strong band at approximately 45 kDa is present in 
immunoaffinity purified preparations of CagU-HA.  The appearance of this 45 kDa band 
had not previously been observed in whole cell lysate derived from bacteria expressing 
CagU-HA.  Furthermore, the presence of the 45 kDa band in preparations of affinity-
purified CagU-HA purifications was not dependent upon the location of the HA epitope 
tag.  Specifically, a 25 kDa and 45 kDa band were also detected by monoclonal anti-HA 
immunoblot analysis of purified CagU-HA in experiments using CagU with the HA 
epitope relocated to the C-terminus (data not shown).  It is possible that the 45 kDa band 
detected in the CagU-HA immunoaffinity purification preparations represents a homo- or 
heterodimer of CagU-HA that is covalently bonded, or alternatively, it may be a homo- or 
heterodimer of CagU-HA that is non-covalently associated and resistant to dissociation 
by SDS.  Because immunoaffinity purified CagU-HA was specifically eluted from the 
anti-HA support by peptide competition, we believe that the 25 kDa band and 45 kDa 
represent CagU-HA species, rather than mouse IgG heavy chain (50 kDa) or light chain 
(25 kDa). 
 In order to further characterize CagU-HA interactions, we employed a chemical 
cross-linking strategy prior to immunoaffinity purification of CagU-HA. We hypothesized 
that chemical cross-linking by a cell membrane-permeable cross-linker (DSP) would 
capture transient or stable interactions of CagU-HA with other proteins that might be 
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required for formation of the cag T4SS apparatus. When lysate derived from bacteria 
that had been treated with DSP was analyzed, we observed a 25 kDa band with strong 
signal intensity by monoclonal anti-HA immunoblot, and a band of approximately 45 kDa 
with much weaker signal intensity (Figure 4-2, lane 2).  Immunoaffinity purification of 
CagU-HA from lysate derived from H. pylori cross-linked by DSP treatment recapitulated 
results of initial CagU-HA purifications, with the presence of two bands corresponding to 
approximately 25 kDa and 45 kDa (Figure 4-2).   
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Figure 4-2.  Chemical cross-linking strategy to capture CagU-HA interactions.  H. 
pylori expressing CagU-HA was cultured for 48 h on solid media.  Lanes 1 and 2 of show 
immunoblot of CagU-HA lysate prior to immunoaffinity purification; Lanes 3-6 show 
immunoblot analysis of samples in which CagU-HA was immunoaffinity purified from 
bacteria that had either been mock treated (– DSP) or  treated (+ DSP) with the cell-
permeable cross-linker DSP.  CagU-HA could be immunoaffinity purified from both 
cross-linked and mock cross-linked bacteria.  Addition of the reducing agent BME was 
able to cleave DSP cross-links.  The prominent band at 50 kDa represents the presence 
of mouse IgG heavy chain. 
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Anti-HA monoclonal immunoblot analysis of CagU-HA purifications from bacteria 
treated with DSP revealed a smear of CagU-HA protein complexes under conditions in 
which the cross-links were not reversed (– BME), indicating efficient cross-linking of 
CagU-HA to other H. pylori proteins (Figure 4-2).  Addition of reducing agent to these 
cross-linked immunoaffinity purified preparations efficiently cleaved the DSP cross-links, 
as demonstrated by appearance of two prominent bands corresponding to 25 kDa and 
45 kDa, and to a lesser extent, a weak band at approximately 70 kDa (Figure 4-2, lane 
6).  These results suggest that CagU is able to interact with a number of H. pylori 
proteins, and may potentially form homo- or heterodimers.  Alternatively, the 45 kDa 
band present in immunoaffinity purifications of CagU-HA may be represent enrichment 
of a population of CagU that is post-translationally modified. The 45 kDa band is clearly 
distinct from that of IgG heavy chain at 50 kDa (Figure 4-2).   In future analyses, we will 
use an HRP-labeled anti-HA monoclonal antibody for immunoblot of CagU-HA 
purifications in order to definitively distinguish between CagU-HA species and the heavy 
chain of mouse IgG. 
 We next sought to identify proteins that interact with CagU-HA, by using mass 
spectrometry.  Immunoaffinity purifications of CagU-HA from bacteria that had not been 
treated with chemical cross-linker were compared to CagU-HA purifications obtained 
from bacteria that had been treated with DSP prior to purification.  CagU-HA complexes 
were eluted with HA peptide competition, and each preparation was analyzed by 
MudPIT (Table 4-1).  As expected, we identified the target protein CagU in each of the 
purification samples.  There were a number of striking differences when comparing 
preparations derived from cross-linked bacteria to preparations from bacteria that had 
not been cross-linked prior to CagU-HA purification.  The proteins present in the 
preparations from cross-linked bacteria, but absent in preparations from the mock 
treated bacteria, represent many potential CagU-HA interaction partners (Table 4-1).  
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The only Cag protein that statistically differed when comparing the cross-linked and non-
cross-linked CagU-HA preparations was the presence of the VirB6 homolog CagW in the 
sample that had been treated with DSP.  Of note, the protease encoded by prc 
(HP1350), a non-Cag protein, appears to be associated with CagU-HA in the non-cross-
linked form, and to a lesser extent, the DSP treated CagU-HA.  Prc is known to be 
surface exposed, and contains a highly conserved PDZ domain characteristic of C-
terminal processing proteases [161,162].  The carboxy-terminal proteases are often 
involved in post-translational protein processing, maturation of proteins, or disassembly 
or degradation of proteins in bacteria. The PDZ domain is required for binding of the 
protease to C-terminal peptides of target proteins, and may also be implicated in binding 
of the protease to internal recognition sites as well as lipids [161,162,163].  As 
considered further in the Discussion, we hypothesize that Prc carboxy-terminal protease 
plays a role in processing of T4SS components.  
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Table 4-1. Cag proteins that interact with CagU-HA in the presence or absence of 
chemical cross-links 
 
anti-HA 
Gene Number a  Protein CagU-HA – DSP b CagU-HA + DSP c 
HP0531 CagU 15 15 
HP0547 CagA 4 9 
HP0527 CagY 5 1 
HP0529 CagW 0 9 *** 
HP1350 Prc Protease 611 *** 66 
Total Spectral Counts 1256 1079 
a Based on the H. pylori 26695 genome annotation  
b Bacteria expressing CagU-HA were cultured in the absence of host cell contact.  These bacteria 
were mock cross-linked, and CagU-HA was immunoaffinity purified using an anti-HA antibody.  
The Table shows numbers of spectral counts observed by MudPIT analysis for each identified 
Cag protein and the Prc protease.   
c Bacteria expressing CagU-HA were cultured in the absence of host cell contact.  These bacteria 
were cross-linked by treatment with DSP, and CagU-HA was immunoaffinity purified using an 
anti-HA antibody.  The Table shows numbers of spectral counts observed by MudPIT analysis for 
each identified Cag protein and the Prc protease.   
*** p<0.001, according to the G-test likelihood ratio, post-spectral count normalization. 
 
  
 
 
101 
 
Localization of CagU. The mass spectrometry results suggested that CagU-HA 
specifically interacts with the VirB6 homolog (CagW), based on experiments in which 
chemical cross-linkers are utilized to capture protein-protein interactions occurring 
endogenously in H. pylori.  VirB6 is a known secretion system channel protein in the 
Agrobacterium T4SS apparatus that is localized to the bacterial pole [157,164].  It is 
therefore reasonable to suspect that CagW has a similar localization within the H. pylori 
cag T4SS.  CagW is predicted to encode several transmembrane helices, and computer 
modeling predicts localization of CagW to the inner bacterial membrane [80].  Based on 
the apparent interaction of CagU-HA with CagW detected by mass spectrometry, as well 
as the prediction of transmembrane helices within the CagU sequence [125], we 
hypothesized that CagU-HA is a membrane-associated protein.  In order to test this 
hypothesis, we fractionated H. pylori grown on solid media into a total membrane 
fraction and a soluble fraction (representing total cytoplasmic and periplasmic proteins).  
We analyzed each protein fraction by immunoblot.  Immunoblot analysis by anti-HA 
indicates that CagU-HA is localized to the total membrane fraction (Figure 4-3).  We 
were unable to localize CagW to a particular sub-cellular fraction due to lack of 
antibodies against this protein. 
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Figure 4-3.  Localization of CagU. Bacteria expressing epitope-tagged CagU (CagU-
HA) were fractionated into total membrane (TM, total membrane) and soluble fractions 
containing the cytoplasmic and periplasmic proteins (SP, soluble proteins) as described 
in Methods.   CagU-HA was detected by immunoblotting (α-HA).  As a fractionation 
control, fractions were immunoblotted with a monoclonal antibody that recognizes an H. 
pylori outer membrane protein (α-OMP) (Santa Cruz).  CagL, a protein known to be 
localized to multiple subcellular fractions, and CagX, a protein known to be localized to 
the bacterial membrane, were utilized as additional fractionation controls. 
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CagU has no known homolog in other bacterial secretion systems.  However, we 
speculate that CagU may be involved in formation of the H. pylori T4SS channel via 
interactions with the VirB6 homolog CagW.  As considered further in the Discussion, 
CagU may serve as a functional homolog to IcmQ, a channel forming component of the 
Legionella pneumophila T4SS. 
Analysis of CagA interactions during type IV secretion.  The molecular mechanism 
by which CagA is shuttled into the host gastric epithelium via the cag T4SS is virtually 
unknown.  We hypothesized that CagA must interact with multiple proteins in order to be 
translocated into the host cell, and that such protein interactions would occur 
sequentially as CagA is first recognized, directed to the T4SS channel, and finally 
translocated through the T4SS pilus into the host cell.   
In order to analyze CagA interactions during type IV secretion, we employed a 
chemical cross-linking strategy to capture both stable and transient CagA interactions in 
bacteria that were harvested from solid media, or H. pylori that had been co-cultured 
with gastric epithelial cells [160].  H. pylori that had been in contact with gastric epithelial 
cells for a period of 5 h (a period of time sufficient for the T4SS to form and translocate 
CagA) were chemically cross-linked by DSP as described in the Methods.  Subsequent 
to cross-linking, the gastric epithelial monolayer and attached bacteria were harvested 
by mechanical disruption, and the eukaryotic cells were differentially lysed by addition of 
saponin (a detergent that is insufficient to lyse bacterial cells).  The bacterial pellet 
remaining after lysis and removal of the soluble eukaryotic fraction was sonicated and 
lysed overnight in RIPA buffer.  Anti-CagA polyclonal sera was covalently immobilized to 
a Protein G support, and utilized to immunoaffinity purify CagA from the cross-linked 
bacterial cell lysate.  Subsequent to CagA purification, proteins that interact with CagA 
were specifically eluted from the CagA protein by addition of reducing agent (DTT) to 
reverse the DSP cross-links.  In this strategy, the target protein (CagA) remains 
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associated with the antibody-bead support, while interacting proteins are eluted and can 
be identified by mass spectrometry.  Elution of CagA from the antibody-bead subsequent 
to DTT elution of interacting partners was accomplished by boiling in SDS buffer. 
We were able to successfully immunoaffinity purify CagA from H. pylori grown on 
solid medium, as well as from WT H. pylori and several mutant strains that had been co-
cultured with gastric epithelial cells prior to chemical cross-linking.  We purified similar 
quantities of CagA from a non-piliated strain (ΔcagL), a hyperpiliated strain (ΔcagH), and 
a complemented strain with WT phenotype (CagH-HA) that had each been co-cultured 
with AGS cells for 5 h.  Therefore, our ability to purify CagA from H. pylori attached to 
gastric epithelial cells was not dependent upon formation of T4SS pili.  Our ability to 
purify CagA was also not impaired by introduction of covalent chemical cross-links in H. 
pylori via treatment with DSP (Figure 4-4).   
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Figure 4-4.  Purification of CagA and interacting proteins from H. pylori.  H. pylori 
was grown on solid media (WT and ΔcagA) or cultured with gastric epithelial cells for 5 h 
(ΔcagH/CagH-HA, ΔcagL, ΔcagH) prior to cross-linking with the membrane permeable 
cross-linker DSP.  CagA was immunoaffinity purified from cross-linked H. pylori lysates, 
and interacting proteins were specifically eluted by cleavage of DSP cross-links by 
incubation in 50 mM DTT (left portion of immunoblot) [160].  The known CagA interacting 
partner CagF could be detected in DTT elutions from plate-grown H. pylori, as well as 
various H. pylori strains in contact with gastric epithelial cells. CagF was not eluted from 
mock purifications of DSP cross-linked lysate derived from a ΔcagA isogenic mutant 
control strain.  CagA was immunoffinity purified in similar levels from each strain, and 
could be recovered from the anti-CagA matrix by boiling in SDS (right portion of 
immunoblot).  Cleavage of DSP cross-links by DTT was not completely efficient, as 
demonstrated by anti-CagF immunoblot of SDS elutions from the anti-CagA matrix 
(lower anti-CagF panel).  CagA-CagF complexes can be detected in the immunoblot 
region corresponding to approximately 140-250 kDa. 
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As a control, isogenic mutant bacteria deficient in CagA (ΔcagA) that had been 
grown on solid medium were treated with DSP, and anti-CagA was used to mock-purify 
bacterial lysate derived from this strain.  CagF, a well-characterized protein that is known 
to interact with the C-terminal region of CagA, was found to co-purify with CagA from 
WT, ΔcagH, and ΔcagL lysates (Figure 4-4), but not a mock purification of ΔcagA lysate.  
Cleavage of DSP cross-links by DTT was not completely efficient, as demonstrated by 
anti-CagF immunoblot of CagA elutions, which reveal residual CagF that remained 
bound to CagA, or non-specifically to the Protein G bead support (band corresponding to 
approximately 140-250 kDa, lower panel of Figure 4-4). 
Proteins eluted from immunoaffinity-purified CagA by DTT cleavage of DSP 
cross-links were analyzed by mass spectrometry.  Preparations from H. pylori that had 
not been in contact with gastric epithelial cells were compared to preparations from 
bacteria that had been cultured with gastric epithelial cells for 5 h prior to cross-linking 
and CagA purification.  In both cases, only a few Cag proteins were identified in addition 
to CagA (Table 4-2).  As expected, the CagA chaperone-like molecule CagF was 
identified by mass spectrometry.  CagZ, a cytoplasmic protein thought to stabilize the 
coupling protein Cag5 [90], and CagY, a presumed structural component of the T4SS 
apparatus [92], were also identified in anti-CagA purifications by mass spectrometry.  
There were no significant differences in the Cag proteins immunoaffinity purified by anti-
CagA from H. pylori cultured either in the presence or absence of host cell contact 
(Table 4-2). 
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Table 4-2. Cag proteins purified by anti-CagA from H. pylori in the presence or 
absence of host cell contact 
 
 
 anti-CagA 
Gene Number a  Protein WT + DSP b CagH-HA + DSP c 
HP0547 CagA 214 175 
HP0522 CagF 13 9 
HP0526 CagZ 4 3  
HP0527 CagY 4 3 
Total Bacterial Protein Spectral 
Counts 4515 3830 
a  Based on the H. pylori 26695 genome annotation  
b CagA was immunoaffinity purified from bacteria that had been grown on solid media prior to 
DSP cross-linking.  DTT was utilized to reverse DSP chemical cross-links in order to elute 
proteins from the anti-CagA support.  Polyclonal anti-CagA was utilized for CagA purification.  
The Table shows numbers of spectral counts observed by MudPIT analysis for each identified 
Cag protein. 
c  CagA was immunoaffinity purified from CagH-HA bacteria (WT phenotype) that had been co-
cultured with AGS cells for 5 h prior to chemically cross-linking by DSP.  DTT was utilized to 
reverse DSP chemical cross-links in order to elute proteins from the anti-CagA support.  
Polyclonal anti-CagA utilized for CagA purification.  The Table shows numbers of spectral 
counts observed by MudPIT analysis for each identified Cag protein. 
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In addition to a few Cag proteins, many other proteins were co-immunoaffinity 
purified with CagA from H. pylori.  Numerous outer membrane proteins (OMP) were 
detected in significantly greater abundance in preparations from H. pylori co-cultured 
with gastric epithelial cells than in H. pylori that had not been in contact with host cells 
(Table 4-3).  For example, significantly more HopQ was co-purified with CagA purified 
from chemically cross-linked H. pylori in contact with gastric epithelial cells than from 
cross-linked H. pylori alone.  In addition, more iron-regulated outer membrane protein 
FrpB and putative lipoprotein HP0596 were co-purified with CagA from H. pylori that had 
been in contact with gastric cells compared to the plate-cultured bacteria control (Table 
4-3).   Taken together, these results suggest that CagA is able to differentially interact 
with a number of proteins depending upon the presence or absence of host cell contact.   
Furthermore, these results indicate that upon contact with the host gastric cell, CagA 
may become associated with one or several outer membrane protein complexes, which 
may also contain important bacterial outer membrane proteins and adhesins. 
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Table 4-3. Selected outer membrane proteins purified by anti-CagA from H. pylori 
in the presence or absence of host-cell contact 
 
anti-CagA 
Gene Number a Protein (gene name) WT + DSP b 
CagH-HA + AGS + 
DSP c 
HP1512 FrpB 0 13*** 
HP0913 HopB (omp21) 0 5** 
HP0912 HopC (omp20) 0 17*** 
HP0025 HopD (omp2) 0 25*** 
HP0706 HopE (omp15) 0 6** 
HP0227 HopM (omp5) 0 8*** 
HP1177 HopQ (omp27) 0 15*** 
HP0317 HopU (omp9) 0 22*** 
HP0596 Lipoprotein 1 22*** 
HP1456 Lipoprotein 0 12*** 
Total Bacterial Protein Spectral Counts 4254 3421 
a  Based on the H. pylori 26695 genome annotation  
b CagA was immunoaffinity purified from bacteria that had been grown on solid media prior to 
DSP cross-linking.  Polyclonal anti-CagA utilized for CagA purification. DTT was utilized  to 
reverse DSP chemical cross-links in order to elute proteins from the anti-CagA support.   The 
Table shows numbers of spectral counts observed by MudPIT analysis for selected outer 
membrane proteins. 
c  CagA was immunoaffinity purified from CagH-HA bacteria (WT phenotype) that had been co-
cultured with AGS cells for 5 h prior to chemically cross-linking by DSP.  Polyclonal anti-CagA 
utilized for CagA purification.  DTT was utilized to reverse DSP chemical cross-links in order to 
elute proteins from the anti-CagA support.  The Table shows numbers of spectral counts 
observed by MudPIT analysis for selected outer membrane proteins. 
**, p<0.01,*** p<0.001, according to the G-test likelihood ratio, post-spectral count 
normalization. 
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Shearing of H. pylori surface structures.  Upon contact with the host cell, H. pylori 
may alter its surface properties to facilitate adhesion and optimal interactions with host 
cells.  One important surface structure that forms in cag PAI-positive H. pylori upon 
contact with host gastric epithelial cells is the T4SS pilus [64,94,95].  The composition of 
these pilus structures is largely unknown.  It is thought that H. pylori T4SS pilus 
structures may contain several Cag proteins, including the VirB2 homolog CagC [94], the 
VirB10 homolog CagY [92], and the VirB5 functional homolog CagL [64].  In addition, the 
effector protein CagA is thought to be associated with the pilus structure as it is 
translocated into the host gastric epithelial cell [64].  We hypothesized that chemical 
cross-linking of H. pylori to the surface of gastric epithelial cells would preserve fragile 
surface features such as the T4SS pilus, and that such cross-linked surface structures 
could be mechanically sheared from the surface of the bacteria after the gastric epithelial 
cells had been removed through a differential lysis procedure.  
 In an attempt to enrich for T4SS pili and other surface features of H. pylori 
formed in response to attachment to gastric epithelial cells, we stimulated formation of 
surface structures by co-culture of several bacterial strains with gastric epithelial cells.  
Included in the analysis were a non-piliated ΔcagL strain, a strain producing many non-
functional T4SS pili (ΔcagH), and ΔcagH/CagH-HA, which produces functional T4SS pili 
at WT levels.  We utilized DSP to cross-link the H. pylori strains to the host cell after a 
period of 5 h as described in the Methods.  This period of time is sufficient to induce 
formation of T4SS pili, and in the case of ΔcagH/CagH-HA, sufficient for CagA 
translocation and IL-8 induction.  Surface structures were mechanically sheared from the 
surface of the bacteria after removal of the host cell monolayer by selective lysis in 
saponin.   
 We first analyzed each sheared fraction for the presence of suspected pilus 
components by immunoblot.  We were able to detect appreciable amounts of CagA in 
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the sheared fractions from CagH-HA and the hyperpiliated ΔcagH. Markedly reduced 
levels of CagA were detected in sheared fractions from the non-piliated ΔcagL strain 
(Figure 4-5), even though ΔcagL bacteria express WT levels of CagA.  CagL, a 
suspected pilus component [64], was also detectable by immunoblot in sheared 
preparations derived from the hyperpiliated ΔcagH strain (Figure 4-5).  However, CagL 
could not be detected by immunoblot analysis of sheared preparations derived from 
CagH-HA bacteria that produce functional T4SS pili at WT levels.  We were unable to 
detect the presence of CagY in sheared fractions from H. pylori co-cultured with gastric 
epithelial cells (data not shown).  These findings could be reproduced in multiple 
biological replicates.  Because we could detect differences in the levels of specific Cag 
proteins in sheared preparations derived from different bacterial mutant strains, we 
sought to investigate the composition of these sheared fractions by mass spectrometry.  
Because sheared fractions derived from the hyperpiliated ΔcagH strain appeared to 
contain higher levels of CagA and CagL proteins as determined by immunoblot analysis, 
we selected this sheared fraction for further analysis by mass spectrometry (Table 4-4). 
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Figure 4-5.  Analysis of sheared fractions from several H. pylori strains.   Surface 
features sheared from H. pylori after 5 h of host cell contact and chemical cross-linking 
to preserve structural integrity were analyzed by immunoblot.  CagA was readily 
detected in sheared fractions derived from ΔcagH/CagH-HA bacteria (which have a 
functional T4SS with pili that are the same size and abundance as those of WT H. pylori) 
as well as bacteria that produce abundant T4SS pili that are nonetheless non-functional 
(ΔcagH).  CagL could also be detected in sheared fractions derived from the 
hyperpiliated ΔcagH strain.  Sheared preparations derived from ΔcagL, which does not 
produce T4SS pili, contained markedly reduced levels of CagA. 
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Table 4-4. Cag proteins identified in sheared fractions of a hyperpiliated H. pylori 
strain 
 
Gene Number a  Protein  ΔcagH Sheared Fraction b 
HP0520 Cag1 3 
HP0543 CagF 5 
HP0545 CagD 16 
HP0547 CagA 21 
Total Bacterial Protein Spectral Counts 6437 
a  Based on the H. pylori 26695 genome annotation  
b ΔcagH was co-cultured with gastric epithelial cells for 5 h prior to cross-linking by DSP to 
preserve morphology of structural surface features.  Bacteria were pelleted after lysis of 
eukaryotic cells by saponin, and surface features were removed from H. pylori by mechanical 
shearing. The Table shows numbers of spectral counts observed by MudPIT analysis of 
identified Cag proteins. 
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As expected, CagA was identified by mass spectrometry as a component of the 
sheared fraction derived from ΔcagH.  In addition to CagA, CagD was also identified as 
a component of the sheared preparation (Table 4-4).  CagD has been characterized as 
being membrane-associated, and is thought to be present on the surface of H. pylori 
[85].  Two additional Cag proteins, CagF and Cag1, were identified in lesser quantities.  
These two Cag proteins are hypothesized to be localized to the inner bacterial 
membrane or cytoplasm [78,89,122], and may be present in low abundance in the 
sheared fractions as a result of bacterial lysis during the mechanical shearing process. 
 Our ability to detect additional Cag proteins in the sheared fraction of H. pylori by 
mass spectrometry is possibly limited by the overwhelming signal from gastric proteins 
present in the preparations.  It is likely that gastric membrane components are covalently 
cross-linked to the surface of H. pylori during DSP treatment, and that such membrane 
fragments are also sheared from the surface of H. pylori.  Although a differential lysis 
procedure is utilized in an attempt to enrich for bacterial cells from co-culture [43], 
residual gastric proteins that remain cross-linked to the surface of H. pylori are much 
more abundant than H. pylori proteins in bacterial sheared fractions, as indicated by 
mass spectrometry analysis (11,103 spectral counts representing human gastric proteins 
versus 6437 total spectral counts representing H. pylori proteins).  
In addition to a few Cag proteins, a number of non-Cag proteins were identified in 
the ΔcagH sheared fraction by mass spectrometry.  Several outer membrane proteins, 
as well as multiple membrane-associated lipoproteins were present in the ΔcagH 
sheared fraction.  We also identified several proteins known to be localized to the 
surface of H. pylori, including the major virulence factor VacA, and surface-associated 
carboxy-terminal protease Prc. Taken together with immunoblot analysis, the mass 
spectrometry results indicate that we are able to shear a number of proteins from the 
surface of H. pylori after the bacteria have been in contact with gastric epithelial cells.  
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However, it is difficult to interpret the significance of proteins identified in H. pylori 
sheared preparations by mass spectrometry due to lack of an appropriate control.  In 
future investigations, it will be important to optimize shearing protocols in order to 
increase our ability to detect low abundant bacterial proteins in sheared preparations, 
and distinguish between proteins that are surface-exposed and those that are present in 
sheared preparations as a result of non-specific lysis of H. pylori during the shearing 
process. 
Discussion 
  
The H. pylori T4SS encoded by the cag pathogenicity island is markedly different 
from T4SSs found in other bacterial species.  Although nine components of the cag 
T4SS have a low degree of sequence similarity to constituents of the T4SS found in 
Agrobacterium [7,55,125], the function and localization of these homologs within the cag 
T4SS remain largely uncharacterized.  Furthermore, the functions of many components 
unique to the H. pylori T4SS are virtually unknown.  Major deviations of the cag T4SS 
from the prototypical Agrobacterium T4SS are likely a result of strong evolutionary 
pressures that have guided divergence and adaptation of the H. pylori T4SS system to 
the human host [128].  Furthermore, H. pylori has refined its T4SS over the course of 
many thousands of years of intimate association with humans to facilitate efficient 
translocation of CagA, and possibly other, effector molecules into the host cell [6,7,8].  It 
is reasonable to assume that incorporation of multiple unique, essential components into 
the cag T4SS, along with alteration of homologous components, has occurred in order to 
effectively subvert the host defense system during chronic infection.  The structure of the 
cag T4SS has ultimately evolved to translocate effector cargo into the host cell in a 
specific, well-defined manner.   
 
 
116 
 
 CagU, a component of the Cag T4SS that is essential for translocation of CagA 
and induction of IL-8 synthesis and secretion by cultured gastric epithelial cells [55], is 
unique to H. pylori.  Thus far, the function of CagU is not understood.  It is predicted to 
be an inner membrane protein that may be a structural component of the T4SS 
apparatus [125].  We hypothesized that CagU interacts with other components of the 
cag T4SS to form one or more subassemblies.  Using immunoaffinity purification 
methods to purify epitope-tagged CagU from H. pylori lysate and subsequent analysis of 
purified proteins by mass spectrometry, we were able to detect multiple candidate 
interactions of CagU with other Cag proteins (Figure 4-1, Table 4-1). Chemical cross-
linking strategies were also utilized to detect probable interactions of CagU with the 
VirB6 homolog CagW (Figure 4-3, Table 4-1).  CagW is thought to serve a role similar to 
VirB6 as a constituent of the inner channel of the T4SS apparatus [80].  However, the 
role of CagW in the cag T4SS has not been elucidated.  Both CagU and CagW are 
predicted to contain several transmembrane helices, suggesting localization to the 
bacterial membrane [80].  We demonstrate membrane localization of CagU to the total 
bacterial membrane fraction in a detergent-free lysate of H. pylori, providing the first 
direct evidence that CagU is localized to the membrane (Figure 4-3).  
 Interestingly, when CagU-HA was purified from H. pylori in the absence of 
chemical cross-linkers, we recovered an abundance of the surface-exposed carboxy-
terminal protease encoded by prc (HP1350) (Table 4-1).  In the presence of chemical 
cross-linker, we recover 10-fold less Prc compared to the CagU-HA purifications in 
which chemical cross-linker has been omitted.  Co-purification of Prc with CagU-HA is 
reproducible (data not shown), and the relative abundance of Prc by spectral count is 
astoundingly high in CagU-HA purifications.  Prc accounts for approximately 49% of the 
total protein content of CagU-HA purifications from un-cross-linked bacteria, versus 
approximately 6% of the total protein content of CagU-HA purifications from bacteria 
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treated with chemical cross-linker (Table 4-1).  The significance of the observed 
association of this carboxy-terminal protease with CagU-HA is unclear.  The high 
abundance of the protease in association with un-cross-linked CagU may indicate the 
presence of oligomers of Prc in complex with CagU-HA.  The protein coverage (i.e., the 
proportion of protein represented by detected peptides) of Prc that co-purifies with 
CagU-HA is similar in the presence (44%) or absence (40%) of cross-linker.  Prc may be 
required for post-translational processing of CagU prior to incorporation of CagU into the 
T4SS apparatus.  It is also possible that association of CagU-HA with Prc occurs on the 
surface of the cell, as Prc is known to be surface-exposed.  Furthermore, co-purification 
of Prc with other Cag proteins, including the surface-exposed pilus component CagL, 
has been detected (Table 2-4) [158].  It will therefore be important to elucidate the 
potential role that Prc may have in processing CagU or other bacterial or host proteins, 
and whether this carboxy-terminal protease plays a role in formation and function of the 
H. pylori T4SS. 
 CagU shares some similarities to the IcmQ component of the T4SS in Legionella.  
A BLAST search query of the CagU sequence against the Legionella proteome identifies 
weak sequence similarity to IcmQ, the only Legionella T4SS component with detectable 
similarity to CagU.  CagU may serve a similar role to IcmQ in formation of the H. pylori 
T4SS.  In the Legionella T4SS, IcmQ, a 22 kDa protein, is involved in formation of the 
T4SS channel [165].  IcmQ is essential for T4SS function, intracellular growth, high 
multiplicity of infection, and proper intracellular trafficking during Legionella infection.  
IcmQ is prevented from forming the secretion system channel pore by association with 
its chaperone IcmR [166].  In the absence of IcmR, IcmQ forms high molecular weight 
complexes [167], a phenotype that is reminiscent of the behavior of T3SS substrates in 
the absence of their corresponding chaperone.  In addition, the IcmQ chaperone IcmR 
forms SDS-resistant dimers [165].  Unlike CagU, which is associated with the bacterial 
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membrane, IcmQ and IcmR are soluble proteins [166].  However, in spite of its soluble 
subcellular localization, IcmQ efficiently inserts into lipid membranes during formation of 
the Legionella T4SS apparatus [166] in a manner similar to soluble membrane-active 
toxins such as Staphylococcus aureus α-toxin [168].  IcmQ also has similar pore-forming 
activity to Shigella flexneri IpaB [169] and the Agrobacterium VirE2 protein [170], which 
are both translocated into the host cell.  In addition, IcmQ can be detected on the 
surface of Legionella during bacterial contact with the host cell [166].  It is proposed that 
during infection, a portion of the available IcmQ is translocated to the outer part of the 
translocation machinery, and that regulation of the pore-forming capacity of IcmQ by 
association with IcmR could be involved in controlling the opening or closing of the T4SS 
channel when in contact with the host cell [166]. 
Based on these observations, we speculate that CagU may be involved in 
formation of the H. pylori T4SS channel.  The appearance of high molecular weight 
complexes of CagU-HA during the immunoprecipitation procedure, but not in bacterial 
lysate, may be the result of disruption of CagU/chaperone interactions.  In a manner 
analogous to the IcmQ/IcmR interaction, a chaperone may bind CagU and prevent 
formation of high molecular weight complexes.  In our studies, it is possible that CagU is 
interacting with a chaperone molecule similar to that of IcmR, and forming SDS-resistant 
heterodimers that we are able to detect by immunoblot. Another possibility is that the 
immunoprecipitation procedure brings CagU-HA monomers within close proximity, 
permitting formation of CagU-HA complexes in a manner similar to what may occur 
during formation of the T4SS channel.  These oligomeric CagU complexes may fold or 
associate in such a way that the complexes are resistant to denaturation by SDS.  It is 
also possible that CagU is post-translationally modified (for example, by addition of N-
linked glycans), which could also result in drastic shifts in migration patterns during SDS-
PAGE resolution of CagU-HA.  It will be important in future investigations to discern 
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whether CagU is post-translationally modified or forms multimeric complexes during 
T4SS apparatus assembly. 
Chemical cross-linking strategies to capture stable or transient interactions of 
Cag proteins have been used in only a limited numbers of studies.  The use of the 
reversible, membrane-permeable chemical cross-linker DSP was successfully utilized to 
detect candidate interactions of both CagU (Figure 4-3, Table 4-1) and CagA (Figure 4-
4, Table 4-2) with other Cag proteins.  The use of DSP cross-linking strategies and 
purification of CagA complexes was of particular interest.  We were able to cross-link 
CagA complexes in H. pylori harvested from solid media, as well as H. pylori that had 
been co-cultured with gastric epithelial cells (Figure 4-4).  Surprisingly, CagA interactions 
captured by chemical cross-linking did not differ when comparing bacteria grown in the 
presence or absence of host cells (Table 4-2).  In contrast to H. pylori grown on solid 
media, CagA was associated with a number of outer membrane proteins in response to 
contact with host gastric cells (Table 4-3).  This result suggests that the localization of 
CagA changes in response to host cell contact, during the process of translocation into 
the gastric epithelial cell.  The association of CagA with multiple outer membrane 
proteins in response to contact with the host cell may also be the result of association of 
CagA with T4SS pilus structures that are anchored to the outer membrane.  These 
results suggest that CagA is associated with one or several complexes on the surface of 
H. pylori during interaction with the host cell. 
In experiments performed under conditions in which H. pylori were attached to 
gastric epithelial cells, the preparations of purified CagA contained a substantial amount 
of human components.  These human components were probably present in CagA 
purifications as a result of introduction of chemical cross-links between the surface of the 
bacteria and the surface of the gastric cells.  It is likely that the high signal intensity from 
the abundant human proteins in the CagA purification samples greatly diminish the 
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signal intensity generated by the low-abundant H. pylori proteins.  Eukaryotic cell lysis 
and CagA purification methods will require optimization in future studies in order to 
increase the signal-to-noise ratio of low-abundant Cag proteins for detection by mass 
spectrometry.  
Another potentially valuable approach for identifying surface features of H. pylori 
that are generated in response to bacterial contact with gastric epithelial cells is the use 
of chemical cross-linking to preserve surface structure morphology, prior to mechanical 
shearing to remove the structures from the surface of the bacteria.  One important 
structure that is formed only in response to host cell contact in cag PAI-positive H. pylori 
strains is the T4SS pilus [64,92,95].  The pilus structure is required for CagA 
translocation [64], and we have shown that WT pili are necessary, but not sufficient, for 
induction of IL-8 synthesis and secretion [158].   
We were able to identify a few Cag proteins by mass spectrometry analysis of 
sheared fractions derived from a hyperpiliated ΔcagH strain of H. pylori that had been in 
contact with gastric cells (Table 4-4).  Furthermore, we were able to detect the presence 
of CagA and CagL in sheared fractions of ΔcagH bacteria or the complemented CagH-
HA, but not a non-piliated ΔcagL strain (Figure 4-5).  In addition to CagA, mass 
spectrometry analysis of ΔcagH sheared fractions indicated the presence of CagD, and 
to a lesser extent, Cag1 and the CagA chaperone-like molecule CagF.  It is likely that 
the presence of small quantities of CagF in the sheared fraction is the result of non-
specific bacterial lysis during the shearing protocol.  Interestingly, Cag3, a protein known 
to be localized to multiple subcellular sites including the surface of the bacteria, was 
found to interact with the accessory proteins CagD and Cag1 when immunoaffinity 
purified from H. pylori lysate [78].  The requirement for CagD in the process of CagA 
translocation and induction of IL-8 is unclear [55,85].  However, CagD is thought to be a 
component of both periplasmic and outer membrane T4SS subassemblies based on 
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protein localization studies and analysis of CagD surface-exposure by 
immunofluorescence microscopy [85].   
In addition to the presence of a few Cag proteins in sheared fractions from 
ΔcagH bacteria, several known outer membrane proteins were identified in the fractions 
by mass spectrometry.  The sheared fraction also contained the important surface-
exposed toxin VacA, multiple outer membrane proteins, and the surface-exposed 
carboxy-terminal protease encoded by prc.  Taken together with immunoblot analysis of 
sheared fractions obtained from several strains, these results suggest that the 
composition of the surface of H. pylori is complex, and the surface of the bacteria varies 
depending on the presence or absence of a functional T4SS. 
As with the case of CagA purifications from H. pylori that had been cross-linked 
to the surface of gastric cells, sheared fractions derived from ΔcagH bacteria contained 
a high proportion of human gastric proteins.  The presence of the gastric proteins in the 
sheared fractions may have diminished our capability to detect the low abundant H. 
pylori proteins in the sheared preparation.  Optimization of the shearing protocol and 
enrichment of surface proteins from the sheared fraction will be imperative for future 
studies of H. pylori proteins exposed to the extracellular milieu during infection and in 
response to host cell contact. 
The studies presented in this chapter provide the foundation for additional 
investigations of Cag protein-protein interactions.  Despite nearly two decades of work, 
significant knowledge gaps exist in multiple facets of type IV secretion processes that 
occur in H. pylori and other pathogenic bacteria.  The methods employed in this Chapter 
may be applied to future investigations of Cag interactions during assembly and function 
of the H. pylori T4SS, and such interaction studies may provide the basis for functional 
examination that will shed light on the molecular mechanisms of CagA translocation into 
the host cell.  Because infection by H. pylori that harbors a functional T4SS can lead to 
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development of severe gastric disease, it is imperative that we understand the process 
by which CagA is introduced into the host cell so that we may then formulate strategies 
to preclude its adverse cellular effects. 
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CHAPTER V 
 
 
CONCLUSIONS 
 
 
Summary 
 
The type IV secretion system (T4SS) encoded by the cag pathogenicity island 
(cag PAI) is a major virulence determinant of H. pylori [42,45,46,97], and it is present in 
approximately 50% of all H. pylori strains [35]. While the T4SSs of other bacterial 
species have been characterized in detail, significant gaps exist in our understanding of 
the architecture and topology of the cag T4SS.  It is unclear how the T4SS apparatus 
assembles prior to translocation of CagA into gastric epithelial cells.  Moreover, the 
molecular mechanism by which CagA is translocated into the host cell has not been 
elucidated.  The functions of many Cag proteins, especially those without homologs in 
other bacterial T4SSs, remain largely unexplored.   
In my thesis, I have established methods for enriching Cag protein complexes 
and identifying candidate protein-protein interactions by mass spectrometry.  
Furthermore, I have identified a number of Cag proteins that lack homologs in other 
T4SSs and are involved in biogenesis of the T4SS pilus structure at the bacteria-host 
cell interface.  Additionally, I have provided preliminary evidence that chemical cross-
linking and immunoaffinity purification strategies can be utilized to identify protein-protein 
interactions occurring between unique H. pylori Cag proteins and Cag proteins that are 
homologous to components of the prototypical T4SS found in Agrobacterium. 
In Chapter II, we utilized immunoaffintiy purification and subsequent mass 
spectrometry analysis of purified proteins to identify a T4SS subassembly that contains 
the T4SS pilus component CagL and two other previously uncharacterized proteins, 
CagH and CagI.  The methods presented in Chapter II established a powerful new tool 
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for screening Cag protein-protein interactions.  Understanding Cag protein interactions in 
the presence and absence of host cell contact may provide important clues as to how 
the Cag T4SS assembles.  Furthermore, developing a robust methodology for high-
throughput screening of potential Cag protein-protein interactions is instrumental in 
dissecting the architecture of the T4SS apparatus.   
We provided evidence that CagH, CagI, and CagL are each required for CagA 
translocation and induction of IL-8 synthesis and secretion by cultured gastric epithelial 
cells.  In addition, these components share multiple properties, including co-transcription 
and protein sequence relatedness.  We demonstrated that formation of the CagHIL 
complex occurred in both the presence and absence of bacteria-host cell contact.  
Maintenance of the complex was dependent upon the presence of all three proteins.  
Furthermore, deletion of either cagH or cagI resulted in markedly decreased stability of 
CagL, supporting our hypothesis that these three proteins are constituents of a T4SS 
subassembly or complex.  CagH, CagI, and CagL are all detectable on the surface of H. 
pylori in the absence of host cell contact.  We demonstrated that these three proteins 
may exist in multiple cellular sites, including the periplasm and the bacterial membrane.   
In Chapter III, we provided evidence that CagH, CagI, and CagL each play a role 
in biogenesis of the T4SS pilus structure at the bacteria-host cell interface.  We 
demonstrated that CagL and CagI are required for formation of the T4SS pili, and that 
formation of T4SS pili was not dependent upon the presence of CagH.  However, H. 
pylori that are deficient in cagH exhibit a hyperpiliated phenotype, producing T4SS pili 
that have a dramatically altered morphology compared to those of wild-type (WT) H. 
pylori.  To our knowledge, description of a hyperpiliated phenotype has not been 
described in the literature for T4SSs of any bacterial species.   
We identified a conserved flagellar hook protein K (FlgK) domain near the N-
terminus of CagH that is evolutionarily-related to the corresponding domain in FlgK of 
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Burkholderia species.  This domain may contribute to the role of CagH as a modified 
capping protein or molecular ruler involved in controlling dimensions of the Cag T4SS 
pilus.  Furthermore, we identified nearly identical hexapeptide C-terminal motifs present 
in CagH, CagI, and CagL that also contribute to T4SS pilus biogenesis.  We showed that 
this motif in CagI and CagL is required for pilus formation.  In contrast, bacteria 
expressing CagH that lacks this C-terminal motif produce pili with morphology and 
abundance similar to those of the WT strain.  These T4SSs are nonetheless non-
functional, as deletion of the CagH C-terminal motif results in ablation of both CagA 
translocation and induction of IL-8 synthesis and secretion by gastric epithelial cells.  We 
demonstrate that deletion of this motif from CagH or CagI results in partial 
mislocalization of the truncated proteins to the soluble fraction, rather than the total 
membrane fraction, of a detergent-free H. pylori lysate.  Based on the observed 
mislocalization of C-terminally truncated CagH and CagI proteins, we hypothesize that 
this C-terminal motif plays a role in protein sorting or localization.   
The studies presented in Chapters II and III highlight the marked variation that 
exists among bacterial T4SSs, and illustrate the important role that is played by proteins 
that are unique to H. pylori in the assembly and function of the cag PAI-encoded T4SS.  
Although the basis for most of the studies of the H. pylori T4SS have been elegant 
studies of the VirB/VirD4 Agrobacterium T4SS, there are limitations when comparing this 
model system with the T4SSs found in distantly related bacteria.   Several components 
of the H. pylori cag T4SS are distantly related to components of the VirB/VirD4 system, 
and as highlighted in Chapters II and III, other key constituents of the cag T4SS lack 
homology to components of T4SSs in other bacterial species.    In addition to CagH, 
CagI, and CagL, H. pylori T4SS functionality likely requires at least six other proteins 
that lack homology to VirB/VirD4 proteins [55].  In future studies, it will be important to 
investigate the functional roles of these proteins in further detail, and from a broader 
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perspective, it will be important to investigate the structural correlates of biological 
diversity among T4SSs. 
In Chapter IV, we further developed our methodology for identification of 
subassemblies or complexes involved in assembly and function of the cag PAI-encoded 
T4SS.  We employed a chemical cross-linking strategy prior to immunoffinity purification 
and identification of proteins by mass spectrometry to analyze interactions of the unique 
T4SS component CagU.  Experiments with epitope-tagged CagU suggest that CagU 
may homo- or heterodimerize during T4SS apparatus assembly.  Analysis of CagU that 
had been chemically cross-linked to interacting proteins by mass spectrometry reveals a 
probable interaction of CagU with the VirB6 homolog CagW, which was not identified in 
the absence of cross-linking.  We utilized a similar chemical cross-linking strategy to 
identify candidate interactions of the effector molecule CagA in both the presence and 
absence of host cell contact. We identified several CagA interactions occurring in 
bacteria in contact with the host cell that differed from interactions of CagA in bacteria 
that had not been co-cultured with gastric epithelial cells.   
Finally, we utilized mass spectrometry to analyze sheared preparations, which 
are predicted to contain surface-exposed structural components of H. pylori. CagA was a 
component of sheared preparations derived from WT and hyperpiliated ΔcagH bacteria 
that had been in contact with gastric epithelial cells, but was not a major constituent of 
sheared preparations derived from a non-piliated ΔcagL mutant that had been co-
cultured with gastric epithelial cells.  Findings described in Chapter IV provide the 
foundation for additional studies to elucidate the assembly of the cag PAI-encoded 
T4SS, as well as the molecular mechanism by which the oncoprotein CagA is 
translocated into the host gastric cell. 
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Future Directions 
Elucidate the mechanism by which dimensions and abundance of T4SS pili are 
controlled.  We have shown that H. pylori that are deficient in cagH exhibit a 
hyperpiliated phenotype, and produce T4SS pili that have a drastically altered 
morphology compared to pili produced by WT bacteria (Figure 3-2).  A striking feature of 
CagH is the presence of a large domain spanning approximately 60 amino acid residues 
near the N-terminus that shares remarkable conservation to flagellar hook protein K 
(FlgK) sequences of Burkholderia spp. (Figure 3-2H) [158].  FlgK is flagellar hook-
associated capping protein that is utilized in flagellar systems to cap polymerization of 
the flagellar hook in order to signal the switch to filament polymerization during flagella 
biosynthesis [146,148].  
In an attempt to further understand the role, if any, that the conserved FlgK 
domain of CagH plays in controlling dimensions of the T4SS pilus, a CagH mutant has 
been generated in which 36 amino acid residues within the FlgK domain were deleted 
(CagH-HAΔFlgK).  The FlgK domain of CagH could not be recognized by the Conserved 
Domain Database (CDD) within NBCI when these residues were deleted.  CagH-
HAΔFlgK was expressed in ΔcagH bacteria at significantly decreased levels compared 
to full-length CagH-HA (data not shown), indicating that the stability of CagH is 
compromised in the absence of residues within the FlgK domain.  Potentially, deletion of 
these residues may cause CagH to be misfolded, resulting in decreased detection of 
CagHΔCT expression.  We will utilize our established scanning electron microscopy 
analysis to assess whether bacteria expressing CagH-HAΔFlgK cells produce pili with 
abundance and dimensions similar to those of either WT or ΔcagH bacteria.  Because of 
the decreased stability of CagH in the absence of the FlgK domain residues, we 
hypothesize that bacteria expressing CagH-HAΔFlgK will have a T4SS pilus phenotype 
that mimics a ΔcagH strain. 
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We will also investigate if CagH is serving as a regulator to signal increased 
T4SS pilus biogenesis in the presence of host cell contact.  During infection, it is 
probable that H. pylori senses changes in the environment such as available iron or pH 
of the extracellular milieu [103,171,172].  We will investigate changes in cagH 
transcription by RT-PCR in response to a number of environmental conditions, including 
changes in pH, changes in salt concentration, and changes in iron availability.  The level 
of cagH transcription, as well as transcription of cagI and cagL, in the presence of host 
cell contact will be established.  We will compare cag gene transcription levels in the 
absence of host cells to the level of transcription of the corresponding genes in a co-
culture system in which we can control availability of exogenous iron, as well as shifts in 
pH.  It is also possible that CagH is acting as a DNA binding protein that can negatively 
regulate transcription of genes within the cagHIL operon.  If this is the case, 
complementation of the ΔcagH mutant at a secondary chromosomal site would result in 
restoration of WT levels of cagI and cagL transcription as compared to the nearly 5 fold 
up-regulation of cagI and cagL transcription occurring in the ΔcagH mutant in the 
absence of host cell contact (Figure 2-5). 
Transcription of cagH is known to be induced during iron starvation [172].  In 
iron-deplete conditions, H. pylori is known to have increased virulence in the animal 
model (J Noto et al., abstract presented at CHRO, Vancouver, Canada 2011).  It is 
reasonable to suspect that cagI and cagL, which are required for T4SS pilus formation 
and are encoded by overlapping genes downstream of cagH, are negatively regulated 
by the presence of available iron, potentially through the action of the H. pylori ferric 
uptake regulator (Fur) protein [172].  In other words, when iron is available, the Fur-Fe2+ 
complex may bind a Fur consensus region near the cagHIL operon too down-regulate 
expression of cagI and cagL, resulting in loss of T4SS pilus biogenesis.  However, in the 
absence of available iron, a condition that is expected to be encountered during infection 
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of the host, Fur is unable to bind a nearby Fur consensus sequence, resulting in up-
regulation of cagI and cagL transcription, and a subsequent increase in T4SS pilus 
biogenesis at the bacteria-host cell interface.  Recently, it has been shown that CagA 
translocation is an important event that alters the host cell physiology to allow H. pylori to 
obtain iron during infection [173].  It is therefore plausible that formation of the T4SS 
apparatus occurs in response to iron deficiency, as formation and functionality of the 
T4SS are important during the process of iron nutrient acquisition. 
Although a comprehensive map of transcription start sites within the H. pylori 
26695 genome has been generated [121], we will analyze the structure of the cagHIL 
operon in more detail.  To do so, we will utilize multiple approaches, including primer 
extension analysis to map the 5’ end of RNA transcripts, and Tobacco Acid 
Pyrophosphatase (TAP) assay to map the transcription start sites within the cagHIL 
operon [174].  In addition to the typical cagH-containing transcript, an anti-sense 
transcript is also encoded within the same region of chromosomal DNA [121].  This cagH 
antisense transcript may negatively regulate the cagHIL operon.  Furthermore, cagI is 
predicted to encode an internal transcription start site for cagL [121].  These alternate 
transcription start sites may be involved in regulating levels of gene transcription within 
the cagHIL operon.  For example, transcription of the H. pylori urease operon produces 
three main transcripts, two of which are degraded post-transcriptionally in order to 
generate various transcription products; cleavage of these urease polycistrons occurs in 
response to shifts in environmental pH [174].  Post-transcriptional control of operons 
within the cag PAI may be occurring in a similar manner. It is also possible that deletion 
of a Fur consensus region predicted in cagI results in loss of regulation of cagL 
transcription by Fur, and may account for the nearly 10 fold increase of cagL transcript 
levels observed in a ΔcagI mutant (Figure 2-5) in the absence of host cell contact [158]. 
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Determine the role that non-homologous components play in formation of the 
T4SS apparatus.  CagU is one of approximately nine non-homologous Cag proteins 
required for CagA translocation and function of the T4SS [55].  We have successfully 
generated a strain of H. pylori that expresses an N-terminal HA epitope-tagged form of 
CagU from the ureA chromosomal locus.  In Chapter IV, we demonstrated interaction of 
this epitope-tagged CagU with other components of the T4SS, including the VirB6 
homolog CagW.  This result, along with a previous report analyzing a cagU mutant [55], 
suggests that CagU is likely involved in formation of the T4SS apparatus.  Construction 
of ΔcagU mutant will be important for future studies.   
A ΔcagU mutant will be generated using the methods presented in Chapter II, 
whereby the CagU coding region will be replaced with an in-frame kanamycin resistance 
cassette that is transcribed in the same direction as cagU and the downstream gene 
cagV.   Maintenance of cagV transcription will be monitored by anti-CagV immunoblot to 
ensure that insertion of the kanamycin resistance cassette into the cagU locus does not 
have polar effects that disrupt transcription of the essential T4SS gene cagV.  The 
ΔcagU mutant will then be assayed for loss of T4SS function by analysis of IL-8 
induction by gastric epithelial cells co-cultured with ΔcagU bacteria, as well as CagA 
translocation in the same co-culture system.  We expect that deletion of cagU will ablate 
CagA translocation as well as the ability of the bacteria to induce secretion of IL-8 [55].  
The ΔcagU strain will be complemented in a heterologous chromosomal locus by a 
construct designed to express either N- or C-terminally epitope-tagged CagU-HA [158].  
We anticipate that complementation of ΔcagU with either of these constructs will restore 
the T4SS phenotype to that of WT H. pylori. 
We will repeat CagU-HA immunoaffinity purifications using our previously 
established protocol and peptide competition elution of CagU-HA complexes from H. 
pylori lysate.  CagU-HA purifications will be performed under conditions in which the 
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T4SS is formed and functional (bacteria-gastric epithelial cell co-culture), or conditions 
under which the T4SS is assembled at basal levels, or exists in an intermediate state of 
assembly (bacteria in the absence of host cell contact).  We will evaluate purified CagU-
HA by immunoblot, and identify co-purified proteins by mass spectrometry.  We expect 
to recapitulate the results presented in Chapter IV with respect to detection of CagU-HA 
species that can be detected at multiple molecular masses by immunoblot.  In order to 
discern whether CagU is dimerizing during the purification process, we will utilize 
targeted peptide mass spectrometry (MRM) to identify specific CagU peptides in various 
molecular mass ranges of an SDS-PAGE gel.  This approach may allow us to quantify 
abundance of CagU existing in the monomer form (at the predicted molecular mass of 
approximately 25 kDa), for comparison to CagU peptides at a higher molecular mass (of 
approximately 45 kDa), which could represent a dimerized or complexed form of CagU. 
We will also evaluate the possibility that CagU is acquiring post-translational 
modifications, such as N-linked glycosylations, that could be leading to the apparent size 
shift to approximately 45 kDa after enrichment by immunoaffinity purification.  CagU is 
predicted to encode several N-linked glycosylation sites (5 glycosylation sites predicted 
by NetNGlyc server) distributed throughout amino acid residues 1-28.  In order to assess 
whether the shift in molecular mass is due to the presence of an N-linked glycan, we will 
purify CagU-HA from bacteria alone, or bacteria in co-culture with gastric epithelial cells, 
and treat the purified CagU-HA with PNGase F to cleave any N-linked glycans from the 
purified protein.  We will monitor any shift in molecular mass of CagU-HA by 
immunoblot.  If treatment of CagU-HA with PNGase F results in loss of the 45 kDa band 
and appearance of one or several new lower molecular mass bands, we will repeat the 
CagU-HA purifications and titrate the level of PNGaseF enzyme in order to estimate the 
number of glycosylation events occurring on CagU.  CagU-HA purifications that have 
been treated with PNGase F will be analyzed in collaboration with investigators in the 
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Vanderbilt Mass Spectrometry and Proteomics Research Facility. If CagU is 
glycosylated and present on the surface of the bacteria, it may play a role in adherence 
to the gastric epithelial cell surface during type IV secretion.   
We will also evaluate the localization of CagU-HA in H. pylori in more detail in 
order to ascertain if CagU is localized to the inner or outer bacterial membrane.  To do 
so, we will evaluate CagU-HA susceptibility to cleavage by trypsin and proteinase K, 
utilize immunofluorescence to detect CagU on the surface of bacteria in co-culture with 
gastric epithelial cells, and utilize flow cytometry or immunogold labeling to detect 
surface-exposure of CagU in the absence of host cell contact [158].  CagU is predicted 
to be an inner membrane protein, but as is the case with CagH, which was also 
predicted to be localized to the inner bacterial membrane, CagU may exist in multiple 
subcellular sites, which may include the surface of the bacteria.  Additionally, we will 
utilize our scanning electron microscopy assay to evaluate the ability of ΔcagU bacteria 
to form T4SS pili in response to contact with gastric epithelial cells.  If CagU is a channel 
protein required for assembly and formation of the T4SS core complex, we would expect 
a ΔcagU strain to be deficient in T4SS pilus formation.  Furthermore, if CagU is involved 
in formation of the central channel of the secretion system, other components of the 
T4SS pilus structure, such as CagL, may not reach the surface of the bacteria.  This 
phenomenon could be assayed by analyzing Cag protein localization to the bacterial 
surface as determined by flow cytometry, immunogold labeling, or protection from 
cleavage by proteinase K in ΔcagU bacteria. 
Mass spectrometry results suggest that CagU potentially interacts with the 
surface-exposed carboxy-terminal protease encoded by prc (HP1350).  This protease 
has also been identified in immunoaffinity purifications of CagL, a T4SS pilus component 
that is known to be localized to the outer membrane in the absence of host cell contact 
(Table 2-4).  The protease encoded by prc is also known to be surface-exposed 
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[175,176].  We will investigate the significance of the CagU-protease interaction, and the 
interaction of this protease with other Cag proteins, by evaluating effect of deletion of prc 
on type IV secretion.  We hypothesize that this protease is involved in processing of 
multiple cag T4SS components, and that deletion of the protease will abolish T4SS 
function.  It is possible that deletion of prc will have numerous cellular effects.  If the Δprc 
strain is viable and has growth characteristics similar to those of WT H. pylori, we will 
evaluate T4SS function by assay of CagA translocation, and induction of IL-8 synthesis 
and secretion by gastric epithelial cells in co-culture with the Δprc isogenic mutant.  If 
deletion of prc abrogates T4SS function, it will be the first report of a gene encoded 
outside of the cag PAI involved in assembly and function of the H. pylori cag T4SS. 
Identify T4SS pilus components in sheared fractions from H. pylori-gastric 
epithelial cell co-culture.  We have previously utilized chemical cross-linking strategies 
to detect protein-protein interactions that occur when H. pylori is co-cultured with gastric 
epithelial cells.  However, identification of proteins or structures sheared from the 
surface of H. pylori that had been cross-linked to gastric epithelial cells was largely 
unsuccessful.  The greatest obstacle to identification of H. pylori proteins present in 
sheared preparations from a bacteria-gastric cell mixture by mass spectrometry is the 
overwhelming proportion of human gastric proteins that are also present in the sheared 
preparations.  The protocol for selectively lysing eukaryotic cells in a gastric epithelial 
cell–H. pylori co-culture involves incubation of harvested cell monolayers in low 
concentrations of saponin.  However, when chemical cross-linker is added to the co-
culture system, it becomes more difficult to lyse the eukaryotic cells, and large sections 
of eukaryotic membranes presumably remain chemically cross-linked to the surface of 
H. pylori.  Therefore, we will optimize selective eukaryotic cell lysis conditions and 
recovery of attached H. pylori from gastric cell co-culture for subsequent bacterial 
manipulation and downstream mass spectrometry applications. 
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 Mechanical shearing to enrich for surface structures of H. pylori will be employed 
after optimization of eukaryotic lysis conditions. As an additional step for enrichment of 
Cag proteins from sheared fractions, we will utilize immunoaffinity purification strategies 
to isolate T4SS components of interest.  This enrichment step may be performed under 
conditions in which the bacteria have been treated with chemical cross-linker, or 
remained un-cross-linked in co-culture with gastric epithelial cells.  Alternatively, 
chemical cross-linker may be utilized to preserve surface structure morphology in the 
context of bacteria-host cell co-culture, and the chemical cross-links can be cleaved by 
addition of DTT to the sheared fraction prior to isolation of Cag proteins.  We 
hypothesize that enrichment of Cag proteins from the sheared preparations will allow us 
to identify a number of bacterial proteins by mass spectrometry that would normally be 
difficult to detect in a very complex sheared fraction that contains both host and bacterial 
proteins.  Initially, we will focus on isolating Cag proteins thought to be involved in 
formation of the T4SS pilus structure, including CagL, CagI, and CagH.  The use of 
monoclonal antibodies for epitope-tagged protein purifications will be preferential to 
polyclonal sera to allow for specific elution of purified protein complexes by peptide 
competition.  Epitope-tagged versions of several suspected T4SS pilus components 
have been generated, including CagI and CagL. 
Evaluate protein-protein interactions and functions of additional T4SS 
components.  In addition to studies of non-homologous Cag proteins within the H. pylori 
T4SS, it will also be important to evaluate interactions and functions of Cag proteins that 
have homology to T4SS components found in Agrobacterium.  Although low-level 
sequence similarity to Vir proteins can be detected in nine components of the cag T4SS 
[55,125], the H. pylori homologs have likely diverged from ancestral Vir proteins.  
Therefore, we hypothesize that although some Cag proteins have maintained sequence 
homology, the H. pylori Vir homologs have adapted to function within the human host, 
 
 
135 
 
and by doing so, perform functions in the cag T4SS that are different than the functions 
of the corresponding proteins within the Agrobacterium T4SS. 
 We have previously generated polyclonal antisera against a number of Vir 
homologs in H. pylori, including CagT (VirB7), CagV (VirB8), CagY (VirB10), CagX 
(VirB9), and CagC (VirB2).  We hypothesize that many of these Vir homologs will 
interact with other Cag components that are involved in formation of the T4SS 
apparatus.  We will utilize chemical cross-linking in bacteria alone, or bacteria in co-
culture with gastric epithelial cells in order to compare Cag protein interactions that 
potentially differ depending on whether the bacteria are cultured in the presence or 
absence of host cell contact.  Mass spectrometry and immunoblot will be utilized to 
evaluate Cag protein purification, and to assess co-purification of additional Cag 
proteins.  We will generate the appropriate isogenic mutants to serve as negative 
controls in immunoaffinity purifications.  Epitope-tagged versions of Cag proteins of 
particular interest will be generated for use in further analyses.  These epitope-tagged 
proteins are often better suited for isolation and subsequent identification of co-purifying 
proteins by mass spectrometry because of our ability to specifically compete purified 
complexes from the monoclonal antibody.  
 We predict that we will identify a number of Cag protein interactions among Vir 
homologs and non-homologous components of the cag T4SS.  As demonstrated with 
CagU, a component of the T4SS that is unique to H. pylori, Vir homologs (such as 
CagW) may interact with one or numerous novel components during T4SS apparatus 
assembly.  In addition, we predict that in many cases, Cag proteins encoded within an 
operon will interact and serve related functions within the cag T4SS. In studies 
presented in Chapters II and III, we established that cag genes positioned within an 
operon (cagHIL) encode proteins that have related functions and localization to the 
same subcellular site, and our analyses indicate that each encoded protein has an 
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essential role in biogenesis of the T4SS pilus organelle at the bacteria-host cell interface 
[158].  Further investigation of protein-protein interactions occurring among components 
of the H. pylori T4SS may therefore shed light on the function or localization of unique 
proteins encoded by the cag PAI. 
  
 
 
137 
 
LIST OF PUBLICATIONS 
 
Shaffer, CL, JA Gaddy,  JT Loh, EM Johnson, S Hill, EE Hennig, MS McClain, WH 
McDonald, TL Cover (2011).  Helicobacter pylori exploits a unique repertoire of type IV 
secretion system components for pilus assembly at the bacteria-host cell interface.  
PLoS Pathogens 7(9): e1002237. 
 
Loh, JT,  CL Shaffer, MB Piazuelo, LE Bravo, MS McClain, P Correa, TL Cover (2011). 
Analysis of cagA in Helicobacter pylori Strains from Colombian populations with 
contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer 
Epidemiology, Biomarkers & Prevention 20(10):2237-49. 
 
Saltet de Sablet, T*, MB Piazuelo*, CL Shaffer*, BG Schneider, M Asim, R Chaturvedi, LE 
Bravo, L Sicinschi, AG Delgado, RM Mera, DA Israel, J Romero-Gallo, RM Peek, Jr., TL 
Cover, P Correa, KT Wilson (2011) Phylogeographic origin of Helicobacter pylori is a 
determinant of gastric cancer risk.  Gut 60(9):1189-95.   *Co-First Author 
 
Gangwer, KA, CL Shaffer, S Suerbaum, DB Lacy, TL Cover, SR Bordenstein (2010). 
Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. J 
Bacteriology 192: 6126-6135. 
 
McClain MS, CL Shaffer, DA Israel, RM Peek, Jr., TL Cover (2009). Genome sequence 
analysis of Helicobacter pylori strains associated with gastric ulceration and gastric 
cancer. BMC Genomics 10: 3. 
 
 
 
 
 
 
 
  
 
 
138 
 
BIBLIOGRAPHY 
 
1. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients 
with gastritis and peptic ulceration. Lancet 1: 1311-1315. 
2. Langenberg ML, Tytgat GNJ, Schipper MEI, Rietra PJGM, Zanen HC, et al. (1984) 
Campylobacter-like organisms in the stomach of patients and healthy individuals. 
The Lancet 323: 1348-1349. 
3. Jones D, Lessells, AM, Eldridge, J (1984) Campylobacter like organisms on the 
gastric mucosa: culture, histological, and serological studies. Journal of Clinical 
Pathology 37: 1002-1006. 
4. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ (1985) Attempt to fulfil Koch's 
postulates for pyloric Campylobacter. Med J Aust 142: 436-439. 
5. Anonymous. Schistosomes, liver flukes and Helicobacter pylori IARC monographs on 
the evaluation of carcinogenic risks to humans. 1994 7-14 June 1994; Lyon, 
France. pp. 1-241. 
6. Linz B, Balloux F, Moodley Y, Manica A, Liu H, et al. (2007) An African origin for the 
intimate association between humans and Helicobacter pylori. Nature 445: 915-
918. 
7. Suerbaum S, Josenhans C (2007) Helicobacter pylori evolution and phenotypic 
diversification in a changing host. Nat Rev Microbiol 5: 441-452. 
8. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, et al. (2003) Traces of human 
migrations in Helicobacter pylori populations. Science 299: 1582-1585. 
9. Ghose C, Perez-Perez GI, Dominguez-Bello MG, Pride DT, Bravi CM, et al. (2002) 
East Asian genotypes of Helicobacter pylori strains in Amerindians provide 
evidence for its ancient human carriage. Proc Natl Acad Sci U S A 99: 15107-
15111. 
10. Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347: 
1175-1186. 
11. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, et al. (1989) 
Prevalence of Helicobacter pylori infection and histologic gastritis in 
asymptomatic persons. N Engl J Med 321: 1562-1566. 
12. Figueiredo C, Machado J, Pharoah P, Seruca R, Sousa S, et al. (2002) Helicobacter 
pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals 
for gastric carcinoma. J Natl Cancer Inst 94: 1680 - 1687. 
13. Nomura A, Stemmermann GN, Chyou PH, Kato I, Pérez-Pérez GI, et al. (1991) 
Helicobacter pylori Infection and gastric carcinoma among Japanese Americans 
in Hawaii. N Engl J Med 325: 1132-1136. 
14. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter 
pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338: 
1175-1176. 
15. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, et al. (1993) Regression 
of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid 
tissue type after eradication of Helicobacter pylori. Lancet 342: 575-577. 
16. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, et al. (1991) 
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 
1127-1131. 
17. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, et al. (1994) 
Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 1267-
1271. 
 
 
139 
 
18. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Jr., et al. (1992) Effect of 
treatment of Helicobacter pylori infection on the long-term recurrence of gastric or 
duodenal ulcer. A randomized, controlled study. Ann Intern Med 116: 705-708. 
19. Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ (1994) 
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann 
Intern Med 120: 977-981. 
20. Anonymous (1994) NIH Consensus Conference. Helicobacter pylori in peptic ulcer 
disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic 
Ulcer Disease. Jama 272: 65-69. 
21. Peek RM, Jr., Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract 
adenocarcinomas. Nat Rev Cancer 2: 28-37. 
22. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333: 32-41. 
23. Annibale B, Capurso G, Chistolini A, D'Ambra G, DiGiulio E, et al. (2001) 
Gastrointestinal causes of refractory iron deficiency anemia in patients without 
gastrointestinal symptoms. The American Journal of Medicine 111: 439-445. 
24. Perry S, de Jong BC, Solnick JV, Sanchez MdlL, Yang S, et al. (2010) Infection with 
Helicobacter pylori Is Associated with Protection against Tuberculosis. PLoS 
ONE 5: e8804. 
25. Chen Y, Blaser MJ (2008) Helicobacter pylori colonization is inversely associated 
with childhood asthma. J Infect Dis 198: 553-560. 
26. Blaser MJ, Berg DE (2001) Helicobacter pylori genetic diversity and risk of human 
disease. J Clin Invest 107: 767-773. 
27. de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, et al. 
Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer 
risk. Gut. doi:10.1136/gut.2010.234468. 
28. McClain MS, Shaffer CL, Israel DA, Peek RM, Jr., Cover TL (2009) Genome 
sequence analysis of Helicobacter pylori strains associated with gastric 
ulceration and gastric cancer. BMC Genomics 10: 3. 
29. Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, et al. (2001) Helicobacter 
pylori genetic diversity within the gastric niche of a single human host. Proc Natl 
Acad Sci U S A 98: 14625-14630. 
30. Salama N, Guillemin K, McDaniel TK, Sherlock G, Tompkins L, et al. (2000) A 
whole-genome microarray reveals genetic diversity among Helicobacter pylori 
strains. Proc Natl Acad Sci U S A 97: 14668-14673. 
31. Tomb J-F, White O, Kerlavage AR, Clayton RA, Sutton GG, et al. (1997) The 
complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 
388: 539-547. 
32. Alm RA, Ling LS, Moir DT, King BL, Brown ED, et al. (1999) Genomic-sequence 
comparison of two unrelated isolates of the human gastric pathogen Helicobacter 
pylori. Nature 397: 176-180. 
33. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, et al. (1996) cag, a 
pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-
associated virulence factors. Proc Natl Acad Sci 93: 14648-14653. 
34. Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, et al. (1998) 
Analyses of the cag pathogenicity island of Helicobacter pylori. Molecular 
Microbiology 28: 37-53. 
35. Gressmann H, Linz B, Ghai R, Pleissner KP, Schlapbach R, et al. (2005) Gain and 
loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet 1: 
e43. 
 
 
 
140 
 
36. Atherton J, Cao P, Peek R, Tummuru M, Blaser M, et al. (1995) Mosaicism in 
vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA 
types with cytotoxin production and peptic ulceration. J Biol Chem 270: 17771 - 
17777. 
37. Parsonnet J, Friedman GD, Orentreich N, Vogelman H (1997) Risk for gastric cancer 
in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 
40: 297-301. 
38. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, et al. (1995) 
Infection with Helicobacter pylori strains possessing cagA is associated with an 
increased risk of developing adenocarcinoma of the stomach. Cancer Res 55: 
2111-2115. 
39. van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, et al. (1998) 
Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. 
Gastroenterology 115: 58-66. 
40. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, et al. (1999) Clinical relevance of 
the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl 
Acad Sci U S A 96: 12778-12783. 
41. Cao P, Cover TL (2002) Two different families of hopQ alleles in Helicobacter pylori. 
J Clin Microbiol 40: 4504-4511. 
42. Bourzac KM, Guillemin K (2005) Helicobacter pylori-host cell interactions mediated 
by type IV secretion. Cell Microbiol 7: 911-919. 
43. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, et al. (2000) Translocation 
of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. 
Science 287: 1497-1500. 
44. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS (1999) Altered states: involvement of 
phosphorylated CagA in the induction of host cellular growth changes by 
Helicobacter pylori. Proc Natl Acad Sci USA 96: 14559-14564. 
45. Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA 
protein. Nat Rev Cancer 4: 688-694. 
46. Backert S, Selbach M (2008) Role of type IV secretion in Helicobacter pylori 
pathogenesis. Cellular Microbiology 10: 1573-1581. 
47. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, et al. (2003) 
Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. 
Science 300: 1430-1434. 
48. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, et al. (2002) SHP-2 tyrosine 
phosphatase as an intracellular target of Helicobacter pylori CagA protein. 
Science 295: 683-686. 
49. Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, et al. (2003) The 
Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin 
rearrangement by c-Src inactivation. Embo J 22: 515-528. 
50. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, et al. (2002) Grb2 is a key 
mediator of Helicobacter pylori CagA protein activities. Mol Cell 10: 745-755. 
51. Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, et al. (2003) Helicobacter 
pylori CagA protein targets the c-Met receptor and enhances the motogenic 
response. J Cell Biol 161: 249-255. 
52. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR (2005) Helicobacter pylori 
CagA induces a transition from polarized to invasive phenotypes in MDCK cells. 
Proc Natl Acad Sci U S A 102: 16339-16344. 
53. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, et al. (2005) Activation of 
β-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 102: 
10646-10651. 
 
 
141 
 
54. Guillemin K, Salama NR, Tompkins LS, Falkow S (2002) Cag pathogenicity island-
specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc 
Natl Acad Sci U S A 99: 15136-15141. 
55. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, et al. (2001) Systematic 
mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes 
for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 
42: 1337-1348. 
56. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, et al. (2004) Nod1 responds 
to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. 
Nat Immunol 5: 1166-1174. 
57. Brandt S, Kwok T, Hartig R, Konig W, Backert S (2005) NF-kappaB activation and 
potentiation of proinflammatory responses by the Helicobacter pylori CagA 
protein. Proc Natl Acad Sci U S A 102: 9300-9305. 
58. Kim SY, Lee YC, Kim HK, Blaser MJ (2006) Helicobacter pylori CagA transfection of 
gastric epithelial cells induces interleukin-8. Cell Microbiol 8: 97-106. 
59. Argent RH, Hale JL, El-Omar EM, Atherton JC (2008) Differences in Helicobacter 
pylori CagA tyrosine phosphorylation motif patterns between western and East 
Asian strains, and influences on interleukin-8 secretion. Journal of Medical 
Microbiology 57: 1062-1067. 
60. Selbach M, Moese S, Meyer TF, Backert S (2002) Functional analysis of the 
Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent 
and VirD4-CagA-independent mechanisms. Infect Immun 70: 665-671. 
61. Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, et al. (2003) 
Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro 
and within gastric mucosa. Gastroenterology 125: 1125-1136. 
62. Keates S, Keates AC, Nath S, Peek RM, Jr., Kelly CP (2005) Transactivation of the 
epidermal growth factor receptor by cag+ Helicobacter pylori induces 
upregulation of the early growth response gene Egr-1 in gastric epithelial cells. 
Gut 54: 1363-1369. 
63. Keates S, Sougioultzis S, Keates AC, Zhao D, Peek RM, Jr., et al. (2001) cag+ 
Helicobacter pylori induce transactivation of the epidermal growth factor receptor 
in AGS gastric epithelial cells. J Biol Chem 276: 48127-48134. 
64. Kwok T, Zabler D, Urman S, Rohde M, Hartig R, et al. (2007) Helicobacter exploits 
integrin for type IV secretion and kinase activation. Nature 449: 862-866. 
65. Jiménez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, et al. (2009) Helicobacter 
pylori Type IV Secretion Apparatus Exploits β1 Integrin in a Novel RGD-
Independent Manner. PLoS Pathog 5: e1000684. 
66. Tegtmeyer N, Hartig R, Delahay RM, Rohde M, Brandt S, et al. (2010) A Small 
Fibronectin-mimicking Protein from Bacteria Induces Cell Spreading and Focal 
Adhesion Formation. Journal of Biological Chemistry 285: 23515-23526. 
67. Saha A, Backert S, Hammond CE, Gooz M, Smolka AJ (2010) Helicobacter pylori 
CagL Activates ADAM17 to Induce Repression of the Gastric H, K-ATPase α 
Subunit. Gastroenterology 139: 239-248. 
68. Fronzes R, Schafer E, Wang L, Saibil HR, Orlova EV, et al. (2009) Structure of a 
type IV secretion system core complex. Science 323: 266-268. 
69. Cascales E, Christie PJ (2003) The versatile bacterial type IV secretion systems. Nat 
Rev Microbiol 1: 137-149. 
70. Alvarez-Martinez CE, Christie PJ (2009) Biological diversity of prokaryotic type IV 
secretion systems. Microbiol Mol Biol Rev 73: 775-808. 
71. Yeo HJ, Waksman G (2004) Unveiling molecular scaffolds of the type IV secretion 
system. J Bacteriol 186: 1919-1926. 
 
 
142 
 
72. Fronzes R, Christie PJ, Waksman G (2009) The structural biology of type IV 
secretion systems. Nat Rev Micro 7: 703-714. 
73. Hofreuter D, Odenbreit S, Haas R (2001) Natural transformation competence in 
Helicobacter pylori is mediated by the basic components of a type IV secretion 
system. Mol Microbiol 41: 379-391. 
74. Bacon DJ, Alm RA, Hu L, Hickey TE, Ewing CP, et al. (2002) DNA Sequence and 
Mutational Analyses of the pVir Plasmid of Campylobacter jejuni 81-176. Infect 
Immun 70: 6242-6250. 
75. Hofreuter D, Odenbreit S, Püls Jr, Schwan D, Haas R (2000) Genetic competence in 
Helicobacter pylori: mechanisms and biological implications. Research in 
Microbiology 151: 487-491. 
76. Dillard JP, Seifert HS (2001) A variable genetic island specific for Neisseria 
gonorrhoeae is involved in providing DNA for natural transformation and is found 
more often in disseminated infection isolates. Molecular Microbiology 41: 263-
277. 
77. Li SD, Kersulyte D, Lindley IJ, Neelam B, Berg DE, et al. (1999) Multiple genes in the 
left half of the cag pathogenicity island of Helicobacter pylori are required for 
tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. 
Infect Immun 67: 3893-3899. 
78. Pinto-Santini DM, Salama NR (2009) Cag3 Is a Novel Essential Component of the 
Helicobacter pylori Cag Type IV Secretion System Outer Membrane 
Subcomplex. J Bacteriol 191: 7343-7352. 
79. Terradot L, Waksman G (2011) Architecture of the Helicobacter pylori Cag-type IV 
secretion system. FEBS Journal 278: 1213-1222. 
80. Kutter S, Buhrdorf R, Haas J, Schneider-Brachert W, Haas R, et al. (2008) Protein 
subassemblies of the Helicobacter pylori Cag type IV secretion system revealed 
by localization and interaction studies. J Bacteriol. 
81. Busler VJ, Torres VJ, McClain MS, Tirado O, Friedman DB, et al. (2006) Protein-
Protein Interactions among Helicobacter pylori Cag Proteins. J Bacteriol 188: 
4787-4800. 
82. Yeo HJ, Savvides SN, Herr AB, Lanka E, Waksman G (2000) Crystal structure of the 
hexameric traffic ATPase of the Helicobacter pylori type IV secretion system. Mol 
Cell 6: 1461-1472. 
83. Cendron L, Seydel A, Angelini A, Battistutta R, Zanotti G (2004) Crystal structure of 
CagZ, a protein from the Helicobacter pylori pathogenicity island that encodes for 
a type IV secretion system. J Mol Biol 340: 881-889. 
84. Cendron L, Tasca E, Seraglio T, Seydel A, Angelini A, et al. (2007) The crystal 
structure of CagS from the Helicobacter pylori pathogenicity island. Proteins: 
Structure, Function, and Bioinformatics 69: 440-443. 
85. Cendron L, Couturier M, Angelini A, Barison N, Stein M, et al. (2009) The 
Helicobacter pylori CagD (HP0545, Cag24) Protein Is Essential for CagA 
Translocation and Maximal Induction of Interleukin-8 Secretion. Journal of 
Molecular Biology 386: 204-217. 
86. Nesic D, Miller MC, Quinkert ZT, Stein M, Chait BT, et al. (2010) Helicobacter pylori 
CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat 
Struct Mol Biol 17: 130-132. 
87. Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, et al. (2001) The protein-
protein interaction map of Helicobacter pylori. Nature 409: 211-215. 
88. Terradot L, Durnell N, Li M, Li D, Ory J, et al. (2004) Biochemical characterization of 
protein complexes from the Helicobacter pylori protein interaction map: strategies 
 
 
143 
 
for complex formation and evidence for novel interactions within type IV secretion 
systems. Mol Cell Proteomics. 
89. Couturier MR, Tasca E, Montecucco C, Stein M (2006) Interaction with CagF is 
required for translocation of CagA into the host via the Helicobacter pylori type IV 
secretion system. Infect Immun 74: 273-281. 
90. Jurik A, Hausser E, Kutter S, Pattis I, Prassl S, et al. (2010) The Coupling Protein 
Cagβ and Its Interaction Partner CagZ Are Required for Type IV Secretion of the 
Helicobacter pylori CagA Protein. Infect Immun 78: 5244-5251. 
91. Bourzac KM, Satkamp LA, Guillemin K (2006) The Helicobacter pylori cag 
pathogenicity island protein CagN is a bacterial membrane-associated protein 
that is processed at its C terminus. Infect Immun 74: 2537-2543. 
92. Rohde M, Puls J, Buhrdorf R, Fischer W, Haas R (2003) A novel sheathed surface 
organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol 
49: 219-234. 
93. Yuan Q, Carle A, Gao C, Sivanesan D, Aly KA, et al. (2005) Identification of the 
VirB4-VirB8-VirB5-VirB2 pilus assembly sequence of type IV secretion systems. 
J Biol Chem 280: 26349-26359. 
94. Andrzejewska J, Lee SK, Olbermann P, Lotzing N, Katzowitsch E, et al. (2006) 
Characterization of the pilin ortholog of the Helicobacter pylori type IV cag 
pathogenicity apparatus, a surface-associated protein expressed during infection. 
J Bacteriol 188: 5865-5877. 
95. Tanaka J, Suzuki T, Mimuro H, Sasakawa C (2003) Structural definition on the 
surface of Helicobacter pylori type IV secretion apparatus. Cell Microbiol 5: 395-
404. 
96. Aras RA, Fischer W, Perez-Perez GI, Crosatti M, Ando T, et al. (2003) Plasticity of 
repetitive DNA sequences within a bacterial (Type IV) secretion system 
component. J Exp Med 198: 1349-1360. 
97. Tegtmeyer N, Wessler S, Backert S (2011) Role of the cag-pathogenicity island 
encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS 
Journal 278:1190-1202. 
98. Anderson LB, Hertzel AV, Das A (1996) Agrobacterium tumefaciens VirB7 and VirB9 
form a disulfide-linked protein complex. Proc Natl Acad Sci U S A 93: 8889-8894. 
99. Baron C, Thorstenson YR, Zambryski PC (1997) The lipoprotein VirB7 interacts with 
VirB9 in the membranes of Agrobacterium tumefaciens. J Bacteriol 179: 1211-
1218. 
100. Das A, Xie YH (2000) The Agrobacterium T-DNA transport pore proteins VirB8, 
VirB9, and VirB10 interact with one another. J Bacteriol 182: 758-763. 
101. Kutter S, Buhrdorf R, Haas J, Schneider-Brachert W, Haas R, et al. (2008) Protein 
Subassemblies of the Helicobacter pylori Cag Type IV Secretion System 
Revealed by Localization and Interaction Studies. J Bacteriol 190: 2161-2171. 
102. Ivie S, McClain M, Algood H, Lacy DB, Cover T (2010) Analysis of a beta-helical 
region in the p55 domain of Helicobacter pylori vacuolating toxin. BMC 
Microbiology 10: 60. 
103. Loh JT, Torres VJ, Cover TL (2007) Regulation of Helicobacter pylori cagA 
expression in response to salt. Cancer Res 67: 4709-4715. 
104. Dailidiene D, Dailide G, Kersulyte D, Berg DE (2006) Contraselectable 
Streptomycin Susceptibility Determinant for Genetic Manipulation and Analysis of 
Helicobacter pylori. Appl Environ Microbiol 72: 5908-5914. 
105. Copass M, Grandi G, Rappuoli R (1997) Introduction of unmarked mutations in the 
Helicobacter pylori vacA gene with a sucrose sensitivity marker. Infect Immun 65: 
1949-1952. 
 
 
144 
 
106. Loh JT, Forsyth MH, Cover TL (2004) Growth phase regulation of flaA expression 
in Helicobacter pylori is luxS dependent. Infect Immun 72: 5506-5510. 
107. Hopp TP, Woods KR (1981) Prediction of protein antigenic determinants from 
amino acid sequences. Proc Natl Acad Sci U S A 78: 3824-3828. 
108. MacCoss MJ, McDonald WH, Saraf A, Sadygov R, Clark JM, et al. (2002) Shotgun 
identification of protein modifications from protein complexes and lens tissue. 
Proc Natl Acad Sci U S A 99: 7900-7905. 
109. Yates JR, Eng JK, McCormack AL, Schieltz D (1995) Method to Correlate Tandem 
Mass Spectra of Modified Peptides to Amino Acid Sequences in the Protein 
Database. Analytical Chemistry 67: 1426-1436. 
110. Ma ZQ, Dasari S, Chambers MC, Litton MD, Sobecki SM, et al. (2009) IDPicker 
2.0: Improved protein assembly with high discrimination peptide identification 
filtering. J Proteome Res 8: 3872-3881. 
111. Wessel D, Flügge UI (1984) A method for the quantitative recovery of protein in 
dilute solution in the presence of detergents and lipids. Analytical Biochemistry 
138: 141-143. 
112. Ilver D, Barone S, Mercati D, Lupetti P, Telford J (2004) Helicobacter pylori toxin 
VacA is transferred to host cells via a novel contact-dependent mechanism. Cell 
Microbiol 6: 167 - 174. 
113. Fischer W, Buhrdorf R, Gerland E, Haas R (2001) Outer membrane targeting of 
passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter 
pylori. Infection and Immunity 69: 6769-6775. 
114. Schraw W, Li Y, McClain M, Goot F, Cover T (2002) Association of Helicobacter 
pylori vacuolating toxin (VacA) with lipid rafts. J Biol Chem 277: 34642 - 34650. 
115. Marcus EA, Moshfegh AP, Sachs G, Scott DR (2005) The Periplasmic α-Carbonic 
Anhydrase Activity of Helicobacter pylori Is Essential for Acid Acclimation. J 
Bacteriol 187: 729-738. 
116. Abramoff MD, Magelhaes, P.J., Ram, S.J (2004) Image Processing with ImageJ. 
Biophotonics International 11: 36-42. 
117. Zhang B, VerBerkmoes NC, Langston MA, Uberbacher E, Hettich RL, et al. (2006) 
Detecting Differential and Correlated Protein Expression in Label-Free Shotgun 
Proteomics. Journal of Proteome Research 5: 2909-2918. 
118. Zar JH (1999) Biostatistical Analysis. New Jersey: Prentice Hall. 
119. Nakai K, Kanehisa M (1991) Expert system for predicting protein localization sites 
in gram-negative bacteria. Proteins: Structure, Function, and Bioinformatics 11: 
95-110. 
120. Nielsen H, Engelbrecht J, Brunak S, von Heijne G (1997) A neural network method 
for identification of prokaryotic and eukaryotic signal peptides and prediction of 
their cleavage sites. Int J Neural Syst 8: 581-599. 
121. Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeisz S, et al. (2010) The 
primary transcriptome of the major human pathogen Helicobacter pylori. Nature 
464: 250-255. 
122. Pattis I, Weiss E, Laugks R, Haas R, Fischer W (2007) The Helicobacter pylori 
CagF protein is a type IV secretion chaperone-like molecule that binds close to 
the C-terminal secretion signal of the CagA effector protein. Microbiology 153: 
2896-2909. 
123. Fernandez D, Spudich G, Zhou X, Christie P (1996) The Agrobacterium 
tumefaciens VirB7 lipoprotein is required for stabilization of VirB proteins during 
assembly of the T-complex transport apparatus. J Bacteriol 178: 3168-3176. 
 
 
145 
 
124. Hapfelmeier S, Domke N, Zambryski PC, Baron C (2000) VirB6 Is Required for 
Stabilization of VirB5 and VirB3 and Formation of VirB7 Homodimers in 
Agrobacterium tumefaciens. J Bacteriol 182: 4505-4511. 
125. Fischer W (2011) Assembly and molecular mode of action of the Helicobacter pylori 
Cag type IV secretion apparatus. FEBS Journal 278: 1203-1212. 
126. Cover TL, Blaser MJ (2009) Helicobacter pylori in health and disease. 
Gastroenterology 136: 1863-1873. 
127. Backert S, Kwok T, Schmid M, Selbach M, Moese S, et al. (2005) Subproteomes of 
soluble and structure-bound Helicobacter pylori proteins analyzed by two-
dimensional gel electrophoresis and mass spectrometry. Proteomics 5: 1331-
1345. 
128. Olbermann P, Josenhans C, Moodley Y, Uhr M, Stamer C, et al. (2010) A Global 
Overview of the Genetic and Functional Diversity in the Helicobacter pylori cag 
Pathogenicity Island. PLoS Genet 6: e1001069. 
129. Lai E-M, Eisenbrandt R, Kalkum M, Lanka E, Kado CI (2002) Biogenesis of T Pili in 
Agrobacterium tumefaciens Requires Precise VirB2 Propilin Cleavage and 
Cyclization. J Bacteriol 184: 327-330. 
130. Blocker A, Komoriya K, Aizawa S-I (2003) Type III secretion systems and bacterial 
flagella: Insights into their function from structural similarities. Proc Natl Acad Sci 
U S A 100: 3027-3030. 
131. Galan JE, Wolf-Watz H (2006) Protein delivery into eukaryotic cells by type III 
secretion machines. Nature 444: 567-573. 
132. Kubori T, Matsushima Y, Nakamura D, Uralil J, Lara-Tejero M, et al. (1998) 
Supramolecular Structure of the Salmonella typhimurium Type III Protein 
Secretion System. Science 280: 602-605. 
133. Tamano K, Aizawa S-I, Katayama E, Nonaka T, Imajoh-Ohmi S, et al. (2000) 
Supramolecular structure of the Shigella type III secretion machinery: the needle 
part is changeable in length and essential for delivery of effectors. Embo J 19: 
3876-3887. 
134. Sekiya K, Ohishi M, Ogino T, Tamano K, Sasakawa C, et al. (2001) 
Supermolecular structure of the enteropathogenic Escherichia coli type III 
secretion system and its direct interaction with the EspA-sheath-like structure. 
Proc Natl Acad Sci U S A 98: 11638-11643. 
135. Deane JE, Roversi P, Cordes FS, Johnson S, Kenjale R, et al. (2006) Molecular 
model of a type III secretion system needle: Implications for host-cell sensing. 
Proc Natl Acad Sci U S A 103: 12529-12533. 
136. Yip CK, Kimbrough TG, Felise HB, Vuckovic M, Thomas NA, et al. (2005) Structural 
characterization of the molecular platform for type III secretion system assembly. 
Nature 435: 702-707. 
137. Aly KA, Baron C (2007) The VirB5 protein localizes to the T-pilus tips in 
Agrobacterium tumefaciens. Microbiology 153: 3766-3775. 
138. Aguilar J, Zupan J, Cameron TA, Zambryski PC (2010) Agrobacterium type IV 
secretion system and its substrates form helical arrays around the circumference 
of virulence-induced cells. Proc Natl Acad Sci U S A 107: 3758-3763. 
139. Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, et 
al. (2009) CDD: specific functional annotation with the Conserved Domain 
Database. Nucleic Acids Research 37: D205-D210. 
140. Erhardt M, Hirano T, Su Y, Paul K, Wee DH, et al. (2010) The role of the FliK 
molecular ruler in hook-length control in Salmonella enterica. Molecular 
Microbiology 75: 1272-1284. 
 
 
146 
 
141. Kawagishi I, Homma M, Williams A, Macnab R (1996) Characterization of the 
flagellar hook length control protein FliK of Salmonella typhimurium and 
Escherichia coli. J Bacteriol 178: 2954-2959. 
142. Williams A, Yamaguchi S, Togashi F, Aizawa S, Kawagishi I, et al. (1996) 
Mutations in fliK and flhB affecting flagellar hook and filament assembly in 
Salmonella typhimurium. J Bacteriol 178: 2960-2970. 
143. Journet L, Agrain Cl, Broz P, Cornelis GR (2003) The Needle Length of Bacterial 
Injectisomes Is Determined by a Molecular Ruler. Science 302: 1757-1760. 
144. Zerovnik E, Zavasnik-Bergant V, Kopitar-Jerala N, Pompe-Novak M, Skarabot M, et 
al. (2002) Amyloid Fibril Formation by Human Stefin B in vitro: Immunogold 
Labelling and Comparison to Stefin A. Biological Chemistry 383: 859-863. 
145. Crooks GE, Hon G, Chandonia J-M, Brenner SE (2004) WebLogo: A Sequence 
Logo Generator. Genome Research 14: 1188-1190. 
146. Muramoto K, Makishima S, Aizawa S-I, Macnab RM (1999) Effect of Hook Subunit 
Concentration on Assembly and Control of Length of the Flagellar Hook of 
Salmonella. J Bacteriol 181: 5808-5813. 
147. Kutsukake K, Minamino T, Yokoseki T (1994) Isolation and characterization of FliK-
independent flagellation mutants from Salmonella typhimurium. J Bacteriol 176: 
7625-7629. 
148. Makishima S, Komoriya K, Yamaguchi S, Aizawa S-I (2001) Length of the Flagellar 
Hook and the Capacity of the Type III Export Apparatus. Science 291: 2411-
2413. 
149. Nagai H, Cambronne ED, Kagan JC, Amor JC, Kahn RA, et al. (2005) A C-terminal 
translocation signal required for Dot/Icm-dependent delivery of the Legionella 
RalF protein to host cells. Proc Natl Acad Sci U S A 102: 826-831. 
150. Vergunst AC, van Lier MCM, den Dulk-Ras A, Grosse Stüve TA, Ouwehand A, et 
al. (2005) Positive charge is an important feature of the C-terminal transport 
signal of the VirB/D4-translocated proteins of Agrobacterium. Proc Natl Acad Sci 
U S A 102: 832-837. 
151. Schulein R, Guye P, Rhomberg TA, Schmid MC, Schöder G, et al. (2005) A 
bipartite signal mediates the transfer of type IV secretion substrates of Bartonella 
henselae into human cells. Proc Natl Acad Sci U S A 102: 856-861. 
152. Liu G, McDaniel TK, Falkow S, Karlin S (1999) Sequence anomalies in the Cag7 
gene of the Helicobacter pylori pathogenicity island. Proc Natl Acad Sci U S A 
96: 7011-7016. 
153. Zahrl D, Wagner M, Bischof K, Bayer M, Zavecz B, et al. (2005) Peptidoglycan 
degradation by specialized lytic transglycosylases associated with type III and 
type IV secretion systems. Microbiology 151: 3455-3467. 
154. Backert S, Fronzes R, Waksman G (2008) VirB2 and VirB5 proteins: specialized 
adhesins in bacterial type-IV secretion systems? Trends in Microbiology 16: 409-
413. 
155. Buhrdorf R, Förster C, Haas R, Fischer W (2003) Topological analysis of a putative 
virB8 homologue essential for the cag type IV secretion system in Helicobacter 
pylori. International Journal of Medical Microbiology 293: 213-217. 
156. Chandran V, Fronzes R, Duquerroy S, Cronin N, Navaza J, et al. (2009) Structure 
of the outer membrane complex of a type IV secretion system. Nature 462: 1011-
1015. 
157. Judd PK, Kumar RB, Das A (2005) Spatial location and requirements for the 
assembly of the Agrobacterium tumefaciens type IV secretion apparatus. Proc 
Natl Acad Sci U S A 102: 11498-11503. 
 
 
147 
 
158. Shaffer CL, Gaddy JA, Loh JT, Johnson EM, Hill S, et al. (2011) Helicobacter pylori 
Exploits a Unique Repertoire of Type IV Secretion System Components for Pilus 
Assembly at the Bacteria-Host Cell Interface. PLoS Pathog 7: e1002237. 
159. Cascales E, Christie PJ (2004) Definition of a Bacterial Type IV Secretion Pathway 
for a DNA Substrate. Science 304: 1170-1173. 
160. Smith AL, Friedman DB, Yu H, Carnahan RH, Reynolds AB (2011) ReCLIP 
(Reversible Cross-Link Immuno-Precipitation): An Efficient Method for 
Interrogation of Labile Protein Complexes. PLoS ONE 6: e16206. 
161. Fanning AS, Anderson JM (1996) Protein-protein interactions: PDZ domain 
networks. Current Biology 6: 1385-1388. 
162. Beebe KD, Shin J, Peng J, Chaudhury C, Khera J, et al. (2000) Substrate 
Recognition through a PDZ Domain in Tail-Specific Protease. Biochemistry 39: 
3149-3155. 
163. Tadokoro A, Hayashi H, Kishimoto T, Makino Y, Fujisaki S, et al. (2004) Interaction 
of the Escherichia coli Lipoprotein NlpI with Periplasmic Prc (Tsp) Protease. 
Journal of Biochemistry 135: 185-191. 
164. Judd PK, Kumar RB, Das A (2005) The type IV secretion apparatus protein VirB6 of 
Agrobacterium tumefaciens localizes to a cell pole. Molecular Microbiology 55: 
115-124. 
165. Raychaudhury S, Farelli JD, Montminy TP, Matthews M, Ménétret J-Fo, et al. 
(2009) Structure and Function of Interacting IcmR-IcmQ Domains from a Type 
IVb Secretion System in Legionella pneumophila. Structure 17: 590-601. 
166. Duménil G, Montminy TP, Tang M, Isberg RR (2004) IcmR-regulated Membrane 
Insertion and Efflux by the Legionella pneumophila IcmQ Protein. Journal of 
Biological Chemistry 279: 4686-4695. 
167. Duménil G, Isberg RR (2001) The Legionella pneumophila IcmR protein exhibits 
chaperone activity for IcmQ by preventing its participation in high-molecular-
weight complexes. Molecular Microbiology 40: 1113-1127. 
168. Bhakdi S, Tranum-Jensen J (1991) Alpha-toxin of Staphylococcus aureus. 
Microbiol Mol Biol Rev 55: 733-751. 
169. De Geyter C, Wattiez R, Sansonetti P, Falmagne P, Ruysschaert J-M, et al. (2000) 
Characterization of the interaction of IpaB and IpaD, proteins required for entry of 
Shigella flexneri into epithelial cells, with a lipid membrane. European Journal of 
Biochemistry 267: 5769-5776. 
170. Dumas F, Duckely M, Pelczar P, Van Gelder P, Hohn B (2001) An Agrobacterium 
VirE2 channel for transferred-DNA transport into plant cells. Proc Natl Acad Sci U 
S A 98: 485-490. 
171. Merrell DS, Goodrich ML, Otto G, Tompkins LS, Falkow S (2003) pH-regulated 
gene expression of the gastric pathogen Helicobacter pylori. Infect Immun 71: 
3529-3539. 
172. Merrell DS, Thompson LJ, Kim CC, Mitchell H, Tompkins LS, et al. (2003) Growth 
phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun 
71: 6510-6525. 
173. Tan S, Noto JM, Romero-Gallo J, Peek RM, Jr., Amieva MR (2011) Helicobacter 
pylori Perturbs Iron Trafficking in the Epithelium to Grow on the Cell Surface. 
PLoS Pathog 7: e1002050. 
174. Akada JK, Shirai M, Takeuchi H, Tsuda M, Nakazawa T (2000) Identification of the 
urease operon in Helicobacter pylori and its control by mRNA decay in response 
to pH. Molecular Microbiology 36: 1071-1084. 
 
 
 
148 
 
175. Sabarth N, Lamer S, Zimny-Arndt U, Jungblut PR, Meyer TF, et al. (2002) 
Identification of surface proteins of Helicobacter pylori by selective biotinylation, 
affinity purification, and two-dimensional gel electrophoresis. J Biol Chem 277: 
27896-27902. 
176. Smith TG, Lim J-M, Weinberg MV, Wells L, Hoover TR (2007) Direct analysis of the 
extracellular proteome from two strains of Helicobacter pylori. Proteomics 7: 
2240-2245. 
 
 
